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Abstract 
The ability to optimize or to find new catalysts for enantioselective transformations has a 
major impact in today’s chemistry. Artificial metalloenzymes lie at the interface between 
organometallic and enzymatic catalysis and have an immense optimization potential, which 
combines chemical and genetic methods to screen diversity space. In terms of activity, 
reaction repertoire, substrate range and operating conditions, they take advantage of the 
versatility of the organometallic chemistry. In contrast, the enantioselectivity is determined by 
the biomolecular scaffold, which provides a well defined second coordination sphere to the 
organometallic moiety, reminiscent of enzymes. 
 Incorporation of catalytically active biotinylated complexes within streptavidin affords 
artificial metalloenzymes for the transfer hydrogenation of prochiral ketones. The activity and 
selectivity trends of the catalysts are ensured by the choice of the chemical fragment in a first 
screening round. Insight into the structure of an artificial enzyme forms the basis of a 
designed evolution step, which relies on successive rounds of saturation mutagenesis at 
carefully selected positions and screening for enantioselectivity. This procedure allows the 
identification of highly selective scaffolds for the reduction of challenging substrates, such as 
dialkyl ketones.  
 The well-tailored hydrogen bond network of streptavidin’s binding cavity can also 
accommodate non-biotinylated frameworks, such as catalytically active metal ions. The 
enantiodiscriminating environment provided by the host protein can be exploited to perform 
highly enantioselective vanadium-catalyzed oxidations of several prochiral sulfides, 
demonstrating that specific metal binding can transform a non-enzymatic protein into an 
enantioselective biocatalyst with synthetic utility. 
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Résumé 
La capacité d’optimiser ou de créer de nouveaux catalyseurs pour des transformations 
énantioselectives a un impact majeur dans les applications de la chimie actuelle. Les 
métalloenzymes artificielles se situent à l’interface entre la catalyse organométallique et celle 
enzymatique et ont un immense potentiel d’optimisation, qui combine des méthodes 
chimiques et génétiques pour créer la diversité. En termes d’activité, répertoire de réactions et 
de substrats ou conditions opératoires, elles exploitent la versatilité de la chimie 
organométallique. Par contre, l’énantiosélectivité est déterminée par la protéine, qui assure 
une seconde sphère de coordination très bien définie, réminiscente des biocatalyseurs. 
 L’incorporation des complexes biotinylés catalytiquement actifs dans la streptavidine 
permet la création des métalloenzymes artificielles pour le transfert hydrogénant des cètones 
prochirales. Les tendances générales de l’activité et de la sélectivité des catalyseurs sont 
assurées par le choix de la partie organométallique suite à un premier criblage. L’étude de la 
structure d’une telle enzyme artificielle est à la base d’une « évolution rationnelle », dans 
laquelle des étapes successives de mutagenèse de saturation à des positions attentivement 
choisies sont combinées avec un criblage de l’énantiosélectivité. Cette méthode permet 
l’identification des catalyseurs hautement sélectifs pour la réduction de substrats difficiles, 
comme par exemple les dialkyl cètones. 
 Le réseau des liaisons hydrogène dans le site actif de la streptavidine est très bien défini et 
permet également l’insertion de composés non-biotinylés, tels des ions métalliques 
catalytiquement actifs. L’environnement asymétrique assuré par la protéine peut être exploité 
dans des réactions de sulfoxydation énantiosélective catalysée par du vanadium. Ces réactions 
montrent que l’incorporation spécifique d’un métal peut transformer une protéine sans activité 
enzymatique en un biocatalyseur utilisé en synthèse organique. 
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1 Asymmetric Catalysis 
Catalysis is the phenomenon by which a substance, called a catalyst, accelerates a chemical 
reaction without undergoing any permanent chemical change.  
 Catalysis plays an important role in many aspects of human progress: in the efficient 
manufacture of many kinds of materials, from fuels to plastics, in creating new energy sources 
and protecting the environment and in developing effective, safer medicines. Over recent 
decades, there has been enormous progress in understanding the molecular mechanisms 
leading to efficient catalytic reactions and this has had an explosive effect on developing new 
catalytic systems. Since a large number of processes in the chemical industry now depend on 
catalysts to work efficiently, it is not surprising that catalysis is an extremely active research 
area. 
1.1 Generalities on Catalysis 
Catalysts participate in chemical reactions by changing the kinetics, while the reaction result 
and the overall thermodynamics are the same (Figure 1).  
The following factors can explain the effect of the catalyst on the reaction: 
• stabilization of the transition state; 
• decreasing the entropy of the reactants, by interactions that force their proximity and 
favourable spatial orientation; 
• selective enhancement of one specific pathway over the competing, undesired ones. 
 
Figure 1. Effect of a catalyst on the reaction’s Gibbs energy of activation.  
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 Catalysis is a phenomenon of crucial importance not only for chemical and biochemical 
reactions occurring in nature, but also for chemical laboratories and industry. The production 
of a variety of chemicals involves catalytic reactions, as they consume less energy and 
generate less waste than stoichiometric ones.  
 Although catalysis, as a tool for performing reactions, had already been exploited much 
earlier, the term “catalysis” was first introduced by Jöns Jakob Berzelius, who in 1835 noted 
that certain chemicals have the property of accelerating a reaction. Later, Humphry Davy 
discovered that the oxidation of coal gas is catalyzed by platinum. In the 1880’s, Wilhelm 
Ostwald at the Leipzig University gave the definition that a catalyst does not influence the 
thermodynamic equilibrium, but only affects the chemical rate of the reaction. For this work, 
Ostwald received in 1909 the Nobel Price in Chemistry.1  
 From a physical point of view, catalysts have traditionally been divided into two groups:   
• homogeneous catalysts: they are present in the reaction mixture in the same phase as 
the reactants / products. As a result, they have good contact with the reactants and 
therefore a high efficiency, allowing the use of mild reaction conditions. 
• heterogeneous catalysts: they are present in a different phase than the reactants. They 
offer the advantage of easy separation and recycling. 
 According to their chemical nature, homogeneous catalysts can also be classified into 
organocatalysts and organometallic catalysts (transition metal complexes). One special class 
of homogeneous catalysis is the enzymatic catalysis.  
 Homogeneous catalysis by transition metal complexes has been intensely studied since the 
1940’s. The pioneering work of G. Wilkinson2 on alkene hydrogenation using a rhodium-
based catalyst (Scheme 1) had a considerable impact on the development of homogeneous 
catalysis for the synthesis of organic compounds.3  
 
Scheme 1. Wilkinson’s catalyst for alkene hydrogenation. 
 Even though it was early discovered that fermentation processes are of catalytic nature, it 
was not until about one hundred years ago that biocatalysis started to be employed to perform 
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chemical transformations on non-natural organic compounds. In the past decades there has 
been an enormous increase in the application of enzymes to produce fine chemicals, 
especially in the pharmaceutical industry.4  
1.2 Catalyst Performance 
The successful application of a catalytic transformation for organic synthesis depends on 
several key parameters that influence the total cost of the process. The activity of a catalyst is 
defined as the amount of product produced by a unit weight of catalyst in a certain time. In 
chemocatalysis, the degree of activity is described in terms of turnover frequency (TOF, 
moles product formed by a mole of catalyst per unit time), while in biocatalysis the term 
employed is the specific activity (µmoles of product formed per unit mass of enzyme per unit 
time).  
 Knowledge of enzyme kinetics is useful to understand the enzymatic activity. The basic 
equation of enzyme kinetics follows Michaelis-Menten theory, which divides the catalytic 
reaction into two steps (Equation 1). First, the enzyme (E) and the substrate (S) associate in a 
rapid and reversible step to give the enzyme-substrate complex (ES, dissociation constant KS). 
The chemical processes take place during the second step with formation of the product (rate 
constant k2). Other enzyme-bound intermediates can also occur during the reaction, like for 
example the enzyme-product complex. An apparent dissociation constant can be defined, KM, 
which can be treated as the overall dissociation constant of all the enzyme-bound species.5 In 
the simple Michaelis-Menten mechanism, in which there is only one ES complex and the 
binding steps are fast, k2 can be assimilated with the overall catalytic rate constant, kcat, while 
KM = KS.   
 
 If the purity and the molecular mass of the enzyme are known, the specific activity of the 
enzyme is determined by the value of kcat (moles of converted substrate per moles of catalyst 
per time unit). The kcat/KM constant determines the specificity of the enzyme for competing 
substrates and thus its general synthetic utility. For application in a catalytic process, an ideal 
enzyme would have a high specific activity and would be subject to minimal substrate 
inhibition.5 
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 Another parameter that affects the practicality of a catalyst is its stability. This factor is 
associated with the turnover number (TON, moles of product formed per mol of catalyst), 
which reflects the amount of product formed before inactivation of the catalyst.  
1.3 Chirality: Importance and Synthesis of Chiral Compounds 
Chirality is defined as the geometric property of a rigid object of not being superimposable on 
its mirror image, called enantiomer. Chirality is a property of matter that can be found in 
biological systems, from the basic building blocks such as amino acids, carbohydrates and 
lipids to the layout of the entire organism. Life is based on chirality at the molecular level and 
therefore understanding and creating chiral processes is one of the most challenging areas in 
organic chemistry.  
 To date, chiral compounds have mostly gained attention in pharmaceutical industry.6 
Enantiomers of a chiral molecule have identical physical and chemical properties in an achiral 
environment. However, because living systems are chiral, each of the enantiomers of a chiral 
drug can behave very differently in vivo, thus displaying different pharmacologic activities 
(see Scheme 2 for an example of two enantiomers with different effects).7 In addition to 
pharmaceuticals, chiral technology is important in other industries, e.g. biochemicals, 
pesticides, aroma and flavour compounds, dyes and pigments, liquid crystals, nonlinear 
optical materials, polymers and others.  
 
Scheme 2. The two enantiomers of propoxyphene display different biologic activities: the (R,R)-isomer is an 
analgesic, while the (S,S)-isomer has antitussive effect.  
 The combination of both enantiomers of a chiral compound in equal amounts forms a 
racemic mixture. The degree of enantiomeric enrichment of a non-racemic mixture can be 
analyzed using polarimetric, spectroscopic (NMR) or chromatographic techniques with a 
chiral stationary phase and is usually expressed in terms of enantiomeric excess (ee = ([R]-
[S]) / ([R]+[S]) × 100). 
 Several different strategies are available for the preparation of enantiopure compounds, the 
most obvious being the chemical modification of “chiral pool” molecules, i.e. naturally 
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occurring chiral molecules such as amino acids, carbohydrates, terpenes, alkaloids etc. 
Resolution techniques (diastereomeric crystallization or enzymatic kinetic resolution) are 
widely used methods, especially on an industrial scale.6 The recently developed dynamic 
kinetic resolution techniques (Scheme 3) are of particular interest in this area, as they allow 
the transformation of a racemic starting material into a single enantiomer.8 
 
Scheme 3. Chemoenzymatic dynamic kinetic resolution of racemic 1-phenylethanol.  
 Asymmetric synthesis refers to synthetic paths starting from achiral compounds. There are 
four main approaches in asymmetric synthesis, all of which involve the use of chiral material 
(Scheme 4).7 The asymmetric catalysis approach, in which the chirality is amplified rather 
than transferred, has clear economic advantages over the stoichiometric methods for the 
preparation of enantiomers. 
 
Scheme 4. Asymmetric synthesis of chiral compounds. 
1.4 Homogeneous Asymmetric Catalysis 
. There are three types of homogeneous asymmetric catalysts:  
• organometallic catalysts 
• biocatalysts: enzymes or whole cells 
• organocatalysts 
 The first two categories have found most applications in enantioselective synthesis.4,9-11 A 
complementary method, which has attracted renewed interest in recent years, is the 
enantioselective organocatalysis, in which the reaction is mediated by a small chiral organic 
molecule.12  
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1.4.1 Transition Metal-Mediated Enantioselective Catalysis 
1.4.1.1 Historical Perspective 
The development of chiral catalysts started in the 1960’s with the pioneering work of William 
S. Knowles, who extended the use of Wilkinson’s catalyst by placing the rhodium metal in a 
chiral environment provided by enantiopure phosphine ligands.13 Knowles exploited the 
chirality at the phosphorous atom to obtain the first transition metal catalysts for the 
asymmetric hydrogenation of dehydro amino acids. A major breakthrough in this area was 
provided by Kagan, who showed that the chirality can be transferred from ligands bearing the 
asymmetry at the carbon backbone, like the bidentate C2-symmetric diphosphine DIOP.14  For 
the commercial synthesis of L-DOPA (a drug useful in treating Parkinson disease) through 
rhodium-catalyzed asymmetric hydrogenation, up to 95% ee was obtained using the chelating 
biphosphane ligand DIPAMP (Scheme 5).15  
 
Scheme 5. Synthesis of L-DOPA and some chiral phosphine ligands used for the catalytic hydrogenation. 
 The soluble metal-ligand complexes for asymmetric hydrogenation have started a new era 
in catalytic processes. Ryoji Noyori discovered the BINAP-ruthenium(II) complexes, which 
proved to be excellent catalysts in the asymmetric hydrogenation of various functionalized 
alkenes and ketones with very high enantioselectivities.16 Parallel to the progress in catalytic 
asymmetric hydrogenation, Barry K. Sharpless developed chiral catalysts for asymmetric 
oxidation reactions.17 For their work in the field of asymmetric catalysis, W. Knowles, R. 
Noyori and B.K. Sharpless were awarded the 2001 Nobel Prize in Chemistry. Their 
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discoveries have had a significant impact on academic and industrial efforts to obtain chiral 
compounds.  
1.4.1.2 General Principles 
A variety of transition metals and chiral ligands have been used in the past decades to develop 
asymmetric catalysts.18 The design of active and selective catalysts relies on a successful 
combination of metal centre, which interacts with the substrate and is responsible for the 
activity, and ligand, which modulates the steric and electronic properties of the catalyst and 
determines the selectivity. Some important trends in metal-ligand stabilities are outlined in 
Figure 2.10  
 
Figure 2. General trends in σ-bonding of early and late transition metals to common ligands. 
 In terms of ligand choice, in most cases chemists design their systems inspired by nature’s 
catalysts, the enzymes. However, unlike enzymes, certain synthetic catalysts are not limited to 
a specific class of substrates, but display high activity and selectivity for a large panel of 
substrates and, more interestingly, for a wide range of different reactions. The discovery of 
such “privileged” ligands (named by analogy with the pharmaceutical compounds that are 
active against several biological targets) has greatly contributed to the rapid development of 
practical catalytic asymmetric processes (Scheme 6).19 
 The interactions that take place in the immediate vicinity of the metal are called first 
coordination sphere interactions. They are usually well-defined and can account for the 
enantioselectivity of the reaction. Yet, despite intensive computational, structural and 
mechanistic studies, predicting the outcome of an enantioselective catalytic transformation 
remains very challenging, since the difference in the two transition state energies leading to 
the two possible enantiomers is too small to be reliably computed (at 0°C, 95% ee represents 
a difference in energy of about 2 kcal / mole).20 Moreover, the enantioselection path is 
decisively influenced by weak, non-bonding contacts between the substrate and the catalytic 
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environment, i.e. solvent, counter ions, salts etc.,21 constituting the second coordination 
sphere.22 To overcome this difficulty, combinatorial methods have been developed and 
implemented for the discovery of new, effective enantioselective catalysts.23-26 
 
Scheme 6. Examples of privileged ligands.  
1.4.2 Enzymatic Catalysis 
Enzymes are models of energy-efficient, extremely selective and environmentally friendly 
chemical agents and they represent a permanent source of inspiration for designing synthetic 
catalysts. Unlike man-made catalysts, enzymes not only provide a chiral first coordination 
sphere, but their second coordination sphere is naturally evolved to maximize their efficiency 
inside organisms. Their catalytic site is deeply buried inside well-defined binding pockets and 
can be accessible through a narrow channel that contributes to the stereoselectivity of the 
reaction. These features, difficult to mimic in organometallic catalysis, are responsible for the 
high specificity and selectivity.5  
 Exploiting the natural chirality of biomolecules for enantioselective catalysis has 
depended for a long time on the discovery of recombinant DNA technology, which provided 
an efficient way to express and produce reasonable quantities of enzymes in the laboratory.5 
Biocatalysis has greatly expanded over the past decades and found a number of applications 
in industrial processes (one example is given in Scheme 7).27 However, there are some 
practical issues associated with developing biocatalysts. Among these, the high substrate 
specificity, the availability of only one enantiomer, the lack of stability under particular 
reaction conditions and the extent of substrate / product inhibition are of particular 
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importance.28 Nowadays, the ability to manipulate functions and structures of proteins 
through genetic engineering offers a means to optimize these features and to make enzymes 
more suitable for industrial use.4,29,30 Recent advances regarding promiscuity in biocatalysis – 
the capacity of enzymes to catalyze transformations other than the ones they evolved for – 
suggest new applications in organic synthesis.31,32 
 
Scheme 7. Lonza process for the production of enantiomerically pure piperazine-2-carboxylic acids.  
 Biocatalytic reactions can be carried out either with isolated enzymes or with whole cell 
systems. Although the procedure employing the entire microorganism to perform a 
transformation is attractive as it avoids eventual co-factor regeneration and the use of special 
equipment for protein purification,33 sometimes isolated enzymes are preferred, because they 
form fewer side products and there are no problems associated with membrane permeability 
and cell toxicity of the substrate.34 
 The following section of this chapter will describe some applications of homogeneous 
organometallic and enzymatic catalysis (only purified enzymes will be treated) in 
enantioselective reduction and oxidation reactions. 
2 Enantioselective Catalytic Reduction and Oxidation Reactions 
2.1 Transfer Hydrogenation of Carbonyl Bonds 
2.1.1 Transition Metal-Mediated Catalytic Methods 
Chiral alcohols are important intermediates in the synthesis of various high value-added 
chemicals.35 The asymmetric reduction of carbonyl bonds is one of the most straightforward 
and energetically viable routes to access this class of compounds.  
 Although it appears as a simple transformation, the stereoselective reduction of ketones 
was for a long time a serious challenge for synthetic chemists. The chemical paths involved 
the use of stoichiometric reducing agents, like borane reagents,36 BINAL-H37 or the Corey-
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Bakshi-Shibata method (CBS) using a chiral oxazaborolidine catalyst and a stoichiometric 
borane reagent.38 The work of Noyori et al. on catalytic asymmetric reduction of simple and 
functionalized ketones initiated a new era in this field.35 Ruthenium-BINAP-based systems 
for the hydrogenation of unsaturated compounds represent nowadays a tool of choice for the 
synthesis of enantiomerically enriched pharmaceuticals or their precursors (Scheme 8).16 
Because hydrogen is a clean and cheap resource, its use in industrial and research applications 
is very attractive.39 
 
Scheme 8. Catalytic asymmetric hydrogenation of hydroxyacetone to (R)-1,2-propanediol, an intermediary in the 
industrial synthesis of the antibacterial levofloxacin.  
 Asymmetric hydrogen transfer reactions are a practical alternative to hydrogenation 
processes, in that they are easy to implement, they usually take place under mild conditions 
and they do not use hazardous hydrogen gas. They are particularly suitable for small- and 
medium-scale syntheses.  
 Transfer hydrogenation refers to the reduction of an unsaturated molecule using a 
hydrogen donor other than H2. The first example of hydrogen transfer to the carbonyl group is 
the Meerwein-Ponndorf-Verley reduction discovered in 1925.40-42 The past decade witnessed 
an extensive development of highly active and selective catalytic systems for the transfer 
hydrogenation of carbon-heteroatom unsaturated bonds.43-45 Designed by Hashiguchi, Ikariya, 
Noyori et al., d6 piano-stool ruthenium complexes in conjunction with aminosulfonamides 
such as TsDPEN (N-(p-toluenesulfony1)-1,2-diphenylethylenediamine 1, Scheme 9) represent 
one of the most significant discoveries in this field.46 
Metal complexes. A variety of bi-, tri- or tetradentate ligands bearing usually nitrogen, 
oxygen or phosphorous atoms have been developed for the successful reduction of various 
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carbonyl compounds with outstanding selectivities. An overview of some of the most 
effective ligands developed in the past years is presented in Scheme 9.39,45,47 The most 
successful, in terms of activity as well as enantioselectivity, are the monotosylated diamines 
such as 1 and 2,46,48 the 1,2-aminoalcohols, such as 3a, 3b and 443,49,50 and some phosphino-
oxazoline derivatives such as 5.51,52 Recently, Reetz et al. described a selective catalyst with a 
very large scope, the BINOL-derived diphosphonite 8.53  
 
Scheme 9. Some of the most effective ligands for the enantioselective transfer hydrogenation of ketones. 
 The typical metal fragment which associates with the bidentate ligands (1,2-
diaminoalcohols or monotosylated 1,2-diamines) is constituted of half-sandwich pi-
complexes, such as Ru-arene or Rh- / Ir-cyclopentadienyl moieties, possessing an additional 
anionic ligand, typically a halide (Scheme 10).  
 
Scheme 10. Schematic representation of RuII, RhIII and IrIII complexes for asymmetric transfer hydrogenation. 
Hydrogen source. Isopropanol (i-PrOH), formic acid / triethylamine azeotropic mixture 
(HCOOH / Et3N) or aqueous sodium formate (HCOONa) are the most common hydrogen 
sources for the transfer hydrogenation. i-PrOH is the conventional hydrogen donor, since it is 
a cheap and easy to handle compound. Activation of the starting complex is achieved in the 
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presence of a base, like potassium hydroxide.54,55 During the reaction, i-PrOH is transformed 
into acetone, which represents a possible substrate for the Ru catalyst. Therefore, the 
reduction of ketones by i-PrOH is reversible and governed by the oxidation potential of the 
relevant ketone / alcohol couple. Moreover, since the major enantiomer is more susceptible to 
the reverse reaction, the enantioselectivity decreases with increasing conversion. The 
reversibility of the reaction constitutes the major limitation of the reductions with i-PrOH.43 
Other hydrogen sources have been developed to overcome this problem. Using HCOOH / 
Et3N or HCOONa in an open system allows an irreversible hydride transfer to the Ru 
complex, due to the formation and continuous elimination of gaseous CO2.56,57 However, 
some complexes tend to decompose faster upon contact with formic acid.45 
Mechanism. Depending on the metal, ligand and hydrogen donor used, different mechanistic 
pathways can be envisaged for the hydrogen transfer from a catalyst to a carbonyl group 
(Scheme 11). “Direct hydrogen transfer” usually occurs with main group metals, while 
transition metal catalysts follow the “hydridic route”, in which a mono- or a dihydride metal 
species is involved.58-61 The monohydridic transfer can either occur via ketone coordination to 
the metal, or via an outer sphere variant. Still further, when no substrate-metal bonding is 
involved, the mechanism can be concerted or stepwise.  
 
Scheme 11. Possible transition states for the mechanism of hydrogen transfer to a ketone.  
 The currently accepted mechanism for the Noyori-type transfer hydrogenation catalyzed 
by Ru-, Rh- or Ir-complexes is the outer sphere concerted hydride transfer and relies on 
metal-ligand cooperation.54,60 Both the metal and the ligand participate to the bond breaking 
and forming process and the transition state does not involve direct coordination of the 
substrate to the metal. Ligands possessing an acidic group, namely primary or secondary 
amines upon complexation with the Lewis acidic metal, facilitate the hydride delivery to the 
carbonyl by forming an NH···O=C hydrogen bond in the transition state.   
 The full catalytic cycle is depicted in Scheme 12 for the highly effective [Ru(p-cymene) 
(R,R-TsDPEN)Cl] complex.43,55,60 The true catalytic species is the 16e- Ru complex B formed 
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from the catalyst precursor A by elimination of HCl in the presence of a base. Deprotonation 
of the hydrogen donor leads to the 18e- Ru-hydride complex C. The hydride and the axial NH 
proton are transferred simultaneously from the 18e- Ru complex to the substrate via a six-
membered ring transition state, to re-form the 16e- complex B.  
 
Scheme 12. Catalytic cycle for the transfer hydrogenation of an aromatic ketone using the [Ru(p-cymene)(R,R-
TsDPEN)Cl] complex and i-PrOH as hydrogen donor. 
Origin of enantioselection. The enantioselectivity of the reaction illustrated in Scheme 12 is 
a consequence of a judicious combination of steric and electronic factors.60 The formation of 
the hydride complex from the planar 16e- species is sterically controlled by the enantiopure 
ligand to give one major diastereomer that is chiral at the Ru centre.55 The conformation of 
the five-membered chelate ring containing the Ru atom is also defined by the ligand, with the 
bulky groups (phenyl groups in the case of TsDPEN) occupying equatorial positions.55 The 
discrimination between the two prochiral faces of the ketone is a consequence of the 
interaction between the η6-arene ligand at Ru and the aryl group of the ketone.62 
Computational investigations showed that the CaromaticH-pi attraction (C(sp3)H-pi attraction in 
the case of the ηn-CnRn ligands, R ≠ H) at this level contributes to the stabilization of the more 
spatially congested transition state and thus is the major factor influencing the 
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enantioselectivity (Scheme 13).60 Therefore, the outcome of the reaction can be modulated by 
carefully choosing the arene substituents. Polyalkylated capping arenes with increased pi-
donation power have a greater contribution to the CaromaticH-pi  attraction and thus generally 
provide higher ee’s than their unsubstituted counterparts.45  
 
Scheme 13. Structures of the two possible transition states for the transfer hydrogenation of acetophenone. The 
chirality of (R,R)-TsDPEN determines the (S)-configuration at the Ru centre. The CaromaticH-pi interaction 
between the η6-arene ligand and the aryl substituent of the ketone leads to a more stable transition state.  
Water compatible systems. In the context of increasing concern about implementing 
environmentally benign processes, aqueous-phase transfer hydrogenation reactions have been 
developed recently.47 Even though water-soluble ligands, bearing polar solubilizing groups 
like sulfonic acids, have been synthesised and successfully used in aqueous-phase hydrogen 
transfer reactions,63 recent results show that the non-modified water-insoluble ligands are 
more active and more enantioselective.47 In order to overcome substrate and catalyst solubility 
problems, surfactants can be added to the reaction mixture but, in most cases, ketone 
insolubility does not affect the reaction rate.47 The reduction rates are considerably faster 
using HCOONa than the HCOOH / Et3N azeotrope or i-PrOH.64 Studies by the groups of Ogo 
and Xiao have shown that both the reaction rate and the enantioselectivity of aqueous transfer 
hydrogenation reactions critically depend on the pH.65,66 The presence of two catalytic cycles 
has been suggested, each one favoured at a given pH.66  
Asymmetric transfer hydrogenation of non-aromatic ketones. Phenyl alkyl ketones are the 
substrates of choice for the catalytic hydrogen transfer with d6 piano-stool metal complexes 
and their reduction proceeds with good to excellent enantioselectivities.43 In contrast, dialkyl 
ketones are challenging, as the postulated critical enantiodiscriminating CaromaticH-pi 
interaction between the η6-arene ligand and the substrate’s aryl group is absent for these 
substrates.60,62 To circumvent this limitation, Woggon et al. tethered a ruthenium piano-stool 
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complex to a β-cyclodextrin, thus providing a pre-organized hydrophobic cavity for 
enantioselective reduction of purely aliphatic substrates (ee 42-95%).67 Tethered ruthenium 
catalysts, in which the η6-arene ring and the diamine ligand are connected, have also been 
used with some success (69% ee in the reduction of cyclohexyl methyl ketone).68 Some 
alternative systems based on Ru-phosphino-oxazoline catalysts have been developed for the 
asymmetric transfer hydrogenation of selected dialkyl ketones.52,69,70 Finally, Reetz et al. 
designed a general system for the reduction of aliphatic ketones, using Ru-diphosphonite 
ligands such as 8 (see Scheme 9).53 However, the reduction of these substrates under transfer 
hydrogenation conditions remains a challenge for homogeneous catalysis.  
Applications. Although transfer hydrogenation reactions occur with very high 
enantioselectivities, they cannot compete with the hydrogenation systems in terms of substrate 
scope and catalytic activity.39 The reported TONs and TOFs for the piano-stool catalysts are 
moderate and limit their industrial application.39 At the laboratory scale, this method is 
interesting as it avoids the use of gas and pressure equipment and it provides mild conditions 
for the reduction of ketones bearing sensitive functionalities. For example, the transfer 
hydrogenation of the multifunctionalized ketone 9 catalyzed by [Ru(mesitylene)(R,R-
TsDPEN)Cl] gives the corresponding (R)-alcohol in 92% ee, an intermediate for the synthesis 
of a leukotriene antagonist (Scheme 14).43 
 
Scheme 14. Synthetic application of the Ru-catalyzed transfer hydrogenation reaction.  
2.1.2 Biocatalytic Methods 
The biocatalytic production of chiral alcohols can be performed following several synthetic 
pathways: oxidoreductases catalyze redox reactions (for example, the reduction of ketone 
bonds or oxidation of carbon-hydrogen bonds); hydrolases mediate the cleavage of carbon-
oxygen single bonds in esters thus forming chiral alcohols through (dynamic) kinetic 
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resolution; and lyases catalyze the formation of carbon-carbon bonds (for example, by 
reacting two ketone substrates, hydroxy-ketones are available).34  
 The second coordination sphere of oxidoreductases such as alcohol dehydrogenases is 
exquisitely tailored to perform highly regio- and enantioselective transfer hydrogenations 
(Figure 3a).71 In the context of asymmetric synthesis of optically active aliphatic alcohols, 
they represent some of the most versatile catalysts, thanks to optimization through directed 
evolution techniques.72,73 
a)        b) 
   
Figure 3. a) Structure of the active site of horse liver alcohol dehydrogenase complexed with NAD+ and 2,3-
difluorobenzylalcohol, PDB reference code 1MG0; the oxygen atom of the alcohol (red) is directly coordinated 
to the Zn2+ ion (blue), while the side chain interacts with the hydrophobic cavity of the protein; the amino acids 
directly coordinated to Zn are highlighted. b) General scheme for the asymmetric reduction of prochiral ketones 
using a NAD(P)H-dependent alcohol dehydrogenase and a co-factor regeneration system. 
 The majority of alcohol dehydrogenases are zinc metalloenzymes dependent on 
nicotinamide co-factors such as NADH or NADPH (Figure 3).5 In horse liver dehydrogenase, 
for example, the Zn2+ ion is coordinated to three amino acid residues (C46, H67 and C174) 
and an additional water molecule. During catalysis, the relevant oxygen atom of the substrate 
displaces the latter, while its side chain binds in a hydrophobic pocket. The reduction occurs 
selectively via hydride ion transfer of one of the two diastereotopic hydrogen atoms in the 4-
position of the nicotinamide ring to the substrate (Figure 3a).5  
 Given the high cost of nicotinamide co-factors, an important parameter of the reaction is 
their regeneration during catalysis (Figure 3b). Chemical, electrochemical, photochemical or 
enzymatic pathways have been reported.34  
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2.2 Sulfoxidation 
2.2.1 Oxidation Systems Based on Transition Metals 
2.2.1.1 Generalities 
Oxidation reactions are powerful tools for the introduction or modification of functional 
groups and they offer an important methodology for the transformation of petroleum-based 
materials into higher oxidation state compounds. Their enormous potential in organic 
synthesis has lead to the extensive development of a variety of oxidative reactions. The 
difficulties associated with these methods include the high costs of the reagents, the formation 
of toxic waste, the highly reactive nature of many oxidants and, most importantly, the safety 
factor.74 Thus, many efforts have been directed towards the creation of clean and safe 
oxidation procedures.74-76 
 Transition metal-catalyzed oxidation reactions can be achieved by applying a variety of 
oxidants and transition metals in combination with the appropriate ligands.76 Depending on 
the oxidant – metal complex combination, different mechanistic pathways have been 
proposed, mostly relying either on metal-peroxo or on metal-oxo complexes (Scheme 15).77 
Early transition metal complexes in a high oxidation state, such as Ti(IV), V(V), Mo(VI) and 
W(VI), can facilitate the heterolysis of alkyl or hydrogen peroxides, by forming peroxo 
complexes. Oxidation reactions catalyzed by late (e.g. Ru, Os) or some first row transition 
metals (e.g. Fe, Mn, Cr) generally occur with the formation of high-valent metal-oxo or 
metal-dioxo species. Alkyl and hydrogen peroxides can also be applied as oxidants with Fe- 
or Mn-based systems, although catalyst inactivation can occur upon homolytic cleavage of the 
peroxide bond, leading to radical formation. This problem can be diminished in presence of 
an axial ligand, such as imidazole. 
 
Scheme 15.  Schematic representation of metal-oxo and metal-peroxo intermediates in oxidation reactions.  
  
 
38 
2.2.1.2 Manganese – Salen Complexes for Asymmetric Oxidation 
 Among the potential feedstocks for the chemical industry, alkanes are the most abundant 
and therefore the least expensive hydrocarbon resource. Unfortunately, very few selective 
methods are available for their functionalization.78 In contrast, the selective oxidation of 
alkenes allows easy addition of heteroatoms and therefore is one of the most useful methods 
in organic synthesis.79 Moreover, many simple alkenes are prochiral, thus providing an easy 
access route to the chiral world. 
 The first major breakthrough in asymmetric oxidation using synthetic catalysts was 
realized by Sharpless and Katsuki with the directed asymmetric epoxidation of allylic 
alcohols using titanium tartrate.80 The substrate scope of asymmetric epoxidation was 
extended by Jacobsen and Katsuki using another catalytic system, based on metal-salen 
complexes and very effective for the epoxidation of conjugated alkenes (Scheme 16).81-83 The 
advantage of these catalysts derives from the synthetic accessibility and versatility of the salen 
ligands.84  
 
Scheme 16. Asymmetric epoxidation of alkene derivatives using chiral Mn-salen complexes introduced by 
Jacobsen and Katsuki. 
 Since their discovery, optically active metal-salen complexes bearing manganese,83,85,86 
chromium,85 vanadium,87 titanium,88 ruthenium,89 cobalt90 and nickel91 as metal centre have 
been successfully applied to asymmetric epoxidation,83 sulfoxidation87,92,93 or C-H oxidation 
reactions.94-96 A variety of oxidants were succesfully employed, including alkyl 
hydroperoxides, peroxy acids, hypochlorite, iodosylbenzene, hydrogen peroxide, amine N-
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oxides, periodate and oxone.97 Among these systems, the manganese complexes for 
asymmetric alkene epoxidation using NaOCl or PhIO have been the most extensively studied. 
 The mechanism of the asymmetric epoxidation catalyzed by Mn-salen catalysts has 
generated much controversy over the years.85 Mechanistic studies suggest that different 
oxygen-transfer species can be formed, depending on the oxidant used. With most oxidants, 
the Mn-oxo species (MnV=O ) is believed to transfer oxygen to the substrate, via a concerted 
or a stepwise reaction pathway (Scheme 17a). Radicals and metallaoxetanes were proposed as 
intermediates for the stepwise mechanism. Nowadays, the scientific community seems to 
agree that the mechanism of this reaction can differ as a function of the oxidant or the 
substrate used.85  
 
Scheme 17. a) Proposed concerted and stepwise mechanisms for the epoxidation of conjugated alkenes catalyzed 
by Mn-salen-oxo complexes; b) Enantioselection mechanism for alkene epoxidation using Jacobsen’s catalyst. 
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 In terms of enantioselection, the generally accepted oxo-transfer mechanism relies on a 
perpendicular (“side-on”) approach of the substrate at the Mn-oxo species (the angle between 
the Mn-oxo bond and the new C-O bond is close to 90°). The bulky substituents on the 
salicylide moiety determine the trajectory of the approaching substrate from the side in which 
the stereochemical communication with the dissymmetric diimine bridge is maximized 
(Scheme 17b).98,99 
2.2.2 Catalytic Sulfoxidation with Transition Metals 
Oxidation of heteroatoms like nitrogen or sulfur is also of great importance in organic 
synthesis and several methods exist for such transformations.100 As amines and sulfides are 
easily oxidized to form a number of different products, the development of chemoselective 
systems is highly desirable. This section will deal with the selective oxidation of sulfides to 
sulfoxides in an enantiospecific manner. 
 Upon oxidation by single oxygen transfer, sulfides are converted into sulfoxides. In the 
case of oxidation of unsymmetrical sulfides, the corresponding sulfoxides bear four different 
substituents at the sulfur atom: a lone electron pair, an oxygen atom and two different carbon 
ligands and are therefore chiral. Further oxidation can occur with formation of sulfone and 
thus an important aspect of organosulfur oxidation is to obtain high chemoselectivity for the 
formation of sulfoxide over sulfone (Equation 2). Although this characteristic depends on the 
oxidation system, the reactions generally proceed with good chemoselectivity, as the sulfide is 
more nucleophilic than the corresponding sulfoxide and hence reacts faster with the 
electrophilic reagent.100 
 
 The importance of chiral sulfoxides as efficient chiral auxiliaries in asymmetric synthesis 
and their application in pharmaceutical research due to their biological activity are the reasons 
for increasing interest in the preparation of optically active sulfoxides over the past 
decades.101-103 Among the biologically relevant sulfoxides, it is worth mentioning the gastric 
proton pump inhibitor omeprazole, an antiulcer agent, which was the world’s highest selling 
drug in 1997. First commercialized in racemic form, it is now available as the enantiopure (S)-
enantiomer esomeprazole, reported to have a superior activity (Scheme 18).103  
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Scheme 18. Structure of esomeprazole, an antiulcer agent. 
 The methods to produce optically active sulfoxides are generally based on enantioselective 
oxidation of prochiral sulfides or on nucleophilic substitution on chiral sulfur derivatives.102 
Among these, the most efficient route to chiral sulfoxides is the asymmetric catalytic 
oxidation, using either enzymes or transition metal catalysts.102-104 Although sulfide oxidation 
and alkene epoxidation are fundamentally different reaction classes, they can be effected with 
similar oxidation systems. As sulfides are very reactive substrates, a particular aspect to take 
into consideration is the uncatalyzed oxidation performed by powerful stoichiometric 
oxidants, which leads to racemic sulfoxides, thus lowering the overall ee. 
 An overview of the main homogeneous catalytic routes to the synthesis of optically active 
sulfoxides is presented in Scheme 19. 
Systems based on titanium (Scheme 19a). The pioneering works of Kagan and Modena on 
enantioselective sulfoxidation were based on modifications of the Ti reagent introduced by 
Sharpless for the epoxidation of allylic alcohols.105,106 Careful control of the amount of water 
in the system is necessary and is achieved by the addition of molecular sieves.107 The 
asymmetric Ti-catalyzed sulfoxidation with organic hydroperoxides such as tert-butyl 
hydroperoxide (t-BuOOH) or cumyl hydroperoxide (cumylOOH) also works using chiral 
diols like BINOL (12).108 Although good enantioselectivities can be obtained with the Ti-
based systems, the yields of the corresponding sulfoxides are moderate and overoxidation to 
sulfone represents a non-negligible side-reaction. A highly enantioselective system based on 
dimeric Ti-salen complexes and hydrogen peroxide was reported by Katsuki et al.88  
Systems based on manganese (Scheme 19b). The well established Mn-salen epoxidation 
catalysts are less effective for the homologous oxidation of aryl alkyl sulfides. In this case, 
NaOCl is too reactive for efficient enantiodifferentiation and moderate enantioselectivities are 
obtained using PhIO92 or H2O293 as terminal oxidants. Among the rare efficient catalysts of 
this type is the Mn-salen 13, bearing additional axial chirality, which is used in conjunction 
with PhIO to afford good enantioselectivities (up to 94% ee).109 Although some chiral 
tetraphenyl porphyrin ligands showed good activities in catalytic sulfoxidations with PhIO, as 
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for Mn-porphyrin complexes the enantioselectivities obtained were only moderate (40-68% 
ee).110 
 
Scheme 19. Summary of the main transition metal-based asymmetric sulfoxidation systems.  
Systems based on vanadium (Scheme 19c). The first asymmetric sulfoxidation with a 
vanadium catalyst was investigated by Fujita et al. using a chiral salen ligand and 
cumylOOH.87 Later, remarkable activities and enantioselectivities were obtained by Bolm and 
Bienewald with V-oxo complexes formed in situ from VO(acac)2 and tridentate O-N-O-type 
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Schiff bases such as 15 in the presence of aqueous H2O2.111 The simple catalytic conditions 
that allow performing the reaction in the presence of air, at room temperature and using cheap 
H2O2 as oxidant have made this transformation particularly attractive, and since the initial 
discovery, several ligand modifications have been reported.112 Although an unambiguous 
description of the reaction mechanism is still required, the reaction is believed to proceed 
through a V(V)-oxo-peroxo intermediate.112  
Systems based on iron (Scheme 19d). While Fe-containing enzymatic systems have been 
extensively studied, asymmetric organometallic catalysts based on non-toxic and inexpensive 
Fe are relatively underrepresented in the field of enantioselective oxidations. Structurally 
complex porphyrin113 and bipyridine114 ligands have been reported, but they achieve only 
moderate ee’s. In the spirit of the V-catalyzed sulfoxidation, Bolm et al. have developed a 
highly enantioselective system using a chiral Fe catalyst formed in situ from Fe(acac)3 and O-
N-O-type Schiff bases such as 16. In the presence of a simple carboxylic acid and with H2O2 
as terminal oxidant, the reaction proceeds with remarkable enantioselectivities (up to 96% ee) 
in moderate to good yields.115,116 The use of a Fe-salan system with H2O2 (salan = fully 
reduced salen ligand) also gives good enantioselectivities with a wide range of substrates, 
including the challenging dialkyl sulfides.117 
 The structure of the substrate has a large influence on the outcome of these metal-
catalyzed enantioselective sulfoxidations and the typical reactions have been usually 
optimized for model aryl methyl sulfides, bearing two substituents of very different size.103 
Except for the Ti-based methods, where the amount of water has to be carefully controlled, 
the presence of water is tolerated in the other systems, although the reactions are usually 
performed in organic solvent. A comparison between the main metal-catalyzed sulfoxidation 
reactions is presented in Table 1.103 
Table 1. Comparison between the main homogeneous catalytic sulfoxidation systems.a  
Entry Catalyst Oxidant Solvent Conditions 
1 Ti(Oi-Pr)4 / DET / H2O  t-BuOOH or cumylOOH CH2Cl2 -20°C 
2 Ti(Oi-Pr)4 / BINOL t-BuOOH CCl4 0°C 
3 Mn-salen aqueous H2O2 or PhIO MeCN r.t. 
4 VO(acac)2 / 15 aqueous H2O2 CH2Cl2 r.t. 
5 Fe(acac)3 / 16 aqueous H2O2 CH2Cl2 r.t. 
a
 r.t.= room temperature 
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2.2.3 Biocatalytic Sulfoxidation 
Biocatalytic oxidations performed by redox enzymes (oxidoreductases) represent a cleaner 
alternative to the asymmetric oxidation with chiral chemical agents, as they make use of 
hydrogen peroxide or oxygen as stoichiometric oxidants. According to the oxidant they use 
and the reaction they catalyze, oxidoreductases are classified into four categories: 
dehydrogenases, oxidases, oxygenases (mono- or di-) and peroxidases.118 Among these, 
various peroxidases and monooxygenases have been used as biocatalysts for sulfoxidation 
reactions.100  
 Unlike monooxygenases,119 peroxidases do not require the use of expensive co-factors.118 
This class of enzymes catalyzes oxidative transformations using hydrogen- or alkyl peroxides. 
Based on the structure of their active site, they can be classified into: heme- (Fe-porphyrin 
complex), vanadium- or non-metal peroxidases. They have a variety of biological functions, 
from the synthesis of biomolecules to the detoxification of H2O2 and can accommodate a 
broad range of unnatural substrates in a diversity of reactions.118 
 
 
Scheme 20. Reaction scheme for sulfoxidations catalyzed by peroxidases: a) containing heme as prosthetic 
group; b) containing a vanadate ion in the active site. 
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 One of the most versatile peroxidases is the heme-containing chloroperoxidase from 
Caldariomyces fumago (CPO), which has been shown to catalyze enantioselective 
sulfoxidation, epoxidation and C-H bond oxidation reactions.118 However, a major limiting 
factor for the application of this heme-enzyme is its low stability under oxidizing conditions, 
due to oxidative destruction of the porphyrin ring.120 Vanadium haloperoxidases are non-
heme enzymes and thus are more stable, although their utility is limited due to a narrow 
substrate range.120 Such V-containing enzymes have been explored as potential catalysts in 
the enantioselective oxidation of sulfides with up to 91% ee, but with moderate activities.121 
The two catalytic cycles for oxygen transfer catalyzed by heme- and V-containing 
peroxidases are depicted in Scheme 20. 
3 Artificial Metalloenzymes for Enantioselective Transformations 
3.1 Enzyme Engineering: Modification of Existing Enzymes 
Natural evolution provided a large set of enzymes crucial for the survival and reproduction of 
organisms, not for applying in chemical processes. Although many complicated reactions can 
be efficiently performed by natural enzymes, their use is limited by a narrow range of 
applications in terms of enantiomer accessibility, substrate specificity, thermal stability and 
alternate activity.28  
 To address this issue, one strategy is to use enzymes from organisms living in extreme 
conditions (temperature, pressure, pH), adapt the formulation of the enzyme (by using 
surfactants or immobilization techniques) or change the reaction parameters.30 For example, 
subtle modifications of the substrate and solvent engineering (pH control, use of ionic liquids) 
are simple methods to fine-tune the stereochemical outcome of an enantioselective enzymatic 
transformation.122  
 On the other hand, natural diversity cannot address all the desired reactions, and 
sometimes no natural enzymes with a desired activity or enantioselectivity are found. In this 
case, modifying existing biomolecules with similar activities or structures through enzyme 
engineering represents a viable alternative. 
 The remarkable evolutionary adaptability of enzymes has lead to the development of 
laboratory evolution methods as an attractive means for producing biocatalysts with the 
desired properties. There are two approaches for enzyme optimization: fine-tuning existing 
scaffolds by rational redesign123 or creating random libraries of possible catalysts by 
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combinatorial methods30,124,125 and then improving them by screening30 or selection 
techniques (Scheme 21).126 In the field of asymmetric catalysis, these techniques open new 
perspectives for the application of biocatalysis. 
 
Scheme 21. Main techniques for the engineering of existing biocatalysts: a) rational redesign; b) directed 
evolution. 
 Choosing the best method for an enzyme engineering task depends on available structural 
and functional information, as well as on suitable selection techniques. A comparison between 
the two strategies is presented in Table 2.29,127 
 In terms of mutation target, rational methods focus on mutations close to the active site,123 
as their effect is easier to predict, while random mutagenesis can often find distant mutations 
with better activity and stability.128 Considering enantioselectivity, a study of improved single 
mutants reveals that, even though distant mutations can have a beneficial effect, it is often 
more effective to focus on mutations near the catalytic site.128 
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Table 2. Comparison of rational redesign and directed evolution techniques. 
 Rational redesign Directed evolution 
Protein structure Required Not required 
Mechanism Required Not required 
Gene mutagenesis 
protocol 
Point mutations 
Saturation mutagenesis at 
pre-identified spots 
Error-prone PCR 
Saturation mutagenesis 
Massive mutagenesis 
Gene shuffling 
Synthetic shuffling 
Screening / selection 
techniques 
Sensitive enzyme assay High-throughput screening methods 
High-throughput selection methods 
 
 Reetz et al. were the first to demonstrate that directed evolution methods can be 
successfully applied to the creation of enantioselective enzymes, by evolving (R)- and (S)-
selective lipases for hydrolytic kinetic resolution (Scheme 22).129,130  
 
Scheme 22. Hydrolytic kinetic resolution using (R)- or (S)-selective lipases. 
 Genetic engineering offers the possibility of changing any position of the protein sequence 
to improve a specific property of an enzyme or even to create a completely new activity 
(catalytic promiscuity).31,32 Still, the number of building blocks that can be genetically 
introduced into proteins remains limited. Although the 20 natural amino acids contain a 
variety of functional groups, proteins require a number of other chemical functionalities to 
carry out their functions. These are provided in nature through post-translational 
modifications or by the use of co-factors. In the hands of molecular biologists, this limitation 
can sometimes be overcome by the use of ingenious techniques for the incorporation of non-
natural amino acids.131 Yet, these techniques are mainly successful only for those building 
blocks that have a close structure to the natural ones. 
 Besides the genetic approach, chemical methods also represent a valuable tool for protein 
engineering.132 Chemical modification of amino acid side chains allows incorporation of new 
functional groups into a biocatalyst, but such reactions are in general non-specific, thus 
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creating heterogeneous mixtures of proteins, with consequently varied, imprecise and 
uncontrolled properties.5 However, some successful strategies have been developed, which 
exploit efficient and selective protein chemistry to alter natural catalytic activity or to 
introduce new enzymatic activity within a protein.133  
3.2 Artificial Systems 
The optimization of existing enzymatic systems is well-established and can cope with several 
problems associated with the application of biocatalysts in asymmetric synthesis. 
Nevertheless, there are still many problems for which natural systems cannot even offer a 
suitable starting point for evolution. Sometimes the existing enzymes are not necessarily 
appropriate for the desired transformation and other frameworks can be much better 
functional solutions. In this context, the creation of artificial enzymes represents another 
possible strategy to address uncommon chemical reactions using biomolecules. 
3.2.1 Catalytic Antibodies  
One of the first approaches to artificial systems was the creation of catalytic antibodies. An 
antibody is a large protein produced by the immune system against a foreign molecule 
(antigen). The affinity of an antibody for its antigen is in the range of 105 to 1012 M-1. The 
ability of the immune system to produce receptors with such high affinity against any 
chemical ligand has been exploited to create a new class of catalytic proteins.  
 The method is based on Pauling’s principle of enzymatic catalysis, which states that 
enzymes catalyze a chemical reaction by stabilizing its transition state better than the 
substrate.134 Thus, the complementarity between the active site and the transition state should 
cause an acceleration of the reaction by forcing the substrates to resemble the transition state. 
The first catalytic antibodies were described independently by Lerner and Schultz.135,136 The 
antigens they used, phosphonic esters, are known inhibitors of hydrolases and mimics for the 
transition state of hydrolytic reactions. Theoretically, if the antigen is carefully designed, one 
can perform any catalytic reaction using this method. In practice, the construction of stable 
transition state analogues is a difficult task. Efforts have been made in this field to apply 
catalytic antibodies to a larger range of chemical transformations: cationic cyclizations, Diels-
Alder reactions or pro-drug activation in vivo.137,138  
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3.2.2 Artificial Metalloenzymes  
Approximately half of all proteins contain a metal atom, either as an isolated ion or 
coordinated to an organic component.139 The redox properties and high catalytic activities of 
the transition metals enable them to carry out even the most difficult transformations. The 
complex structures and functions of metalloenzymes have inspired chemists and biochemists 
in designing highly efficient and selective catalytic systems. Several types of interactions 
govern the reactions of a metal centre: the electronic properties of the metal itself, the first 
coordination sphere (e.g. coordination number and geometry, type of ligand), the secondary 
coordination sphere (e.g. hydrogen bonding interactions of the first coordination sphere with 
the close environment) and the long-range interactions (usually electrostatic in nature).140  
 Traditional homogeneous catalysis is based on the use of relatively small organic ligands 
surrounded by a uniform environment (solvent molecules) and thus is characterized mainly by 
the first two types of interaction. In contrast, in metalloenzymes, the metal atom is embedded 
in a highly organized protein framework, which provides exceptional control through second 
coordination sphere and long-range contacts. The creation of artificial metalloenzymes aims 
at combining the features of both homogeneous and enzymatic catalysis and represents a 
rather new approach in the field of asymmetric transformations. Their design is based on 
exploiting second coordination sphere interactions for tailoring the enantioselectivity of the 
reaction.  
 Three main approaches can be identified to date for the creation of enantioselective 
artificial metalloenzymes, based on the manner of incorporation of the metal fragment: the 
dative, the covalent, and the supramolecular anchoring strategy. The metal fragment can be 
either a small metal ion or a metal-containing native or non-native prosthetic group. Since 
several reviews summarizing the latest advances in the field of artificial metalloenzymes for 
enantioselective catalysis have been recently published,141,142 only a brief description of these 
hybrid catalysts will be presented here.  
Dative anchoring. Several natural metalloenzymes contain a metal ion directly bound to the 
protein, without the intermediate of an organic compound. Substitution of these metal ions 
with others having different properties and activities affords artificial metalloenzymes.143-145 
Metal ions can also be accommodated in specific binding sites of certain non-metal-
containing proteins.146,147 For example, Sheldon et al. exploited the structural similarity of the 
active sites of vanadium-dependent haloperoxidases and acid phosphatases to design a 
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semisynthetic peroxidase for enantioselective sulfoxidation (up to 66% ee was obtained upon 
sufoxidation of thioanisole using H2O2 as stoichiometric oxidant).147 
Covalent anchoring. Covalent linkage is based on chemical modification of an amino acid 
residue and allows site-specific incorporation of a metal complex that does not display high 
affinity for the protein. This strategy involves specific modification of an accessible amino 
acid and has been successfully applied to native proteins or mutants containing one or two 
free cysteine residues.148-150 Dual covalent anchoring of a Mn-salen complex into the heme-
binding site of apo-myoglobin, combined with specific orientation of the metal-complex by a 
dative bond with a histidine residue proved to be a successful strategy for the design of 
artificial metalloenzymes for the sulfoxidation of thioanisole (up to 51% ee).150  
Supramolecular anchoring. This non-covalent approach exploits the high affinity of a given 
protein (host) for a small organic molecule (guest). Chemical modification of the guest is 
necessary in order to attach the organometallic moiety and it shouldn’t drastically affect the 
host-guest binding affinity. Ideally, the binding pocket of the protein should be deep enough 
to accommodate the derivatised prosthetic group (Scheme 23).  
 
Scheme 23. Schematic representation of artificial metalloenzymes based on supramolecular anchoring of an 
active catalyst within a host protein. 
 One class of proteins that display high affinity towards a variety of hydrophobic guests are 
the serum albumins, which function as transport proteins in plasma. Their hydrophobicity has 
been utilised for the non-covalent incorporation of metal-containing co-factors that catalyze 
enantioselective reactions.151,152 It is worthy of note that the hydrophobic pockets of bovine 
serum albumin (BSA) also constitute possible binding sites for hydrophobic substrates and 
therefore can provide asymmetric environments for the transition state.153 In this context, 
Klibanov proposed the use of a hydrolytic enzyme with a single well-defined hydrophobic 
pocket (α-chymotrypsin) instead of BSA, as chiral mediator in enantioselective 
sulfoxidations.154   
  
 
51 
 Heme-containing proteins are another class of proteins that possess a hydrophobic cavity 
capable of non-covalent interactions with metal-complexes. Supramolecular incorporation of 
metal-salen complexes into the active site of apo-myoglobin affords semisynthetic 
metalloenzymes that catalyze enantioselective sulfoxidations.155,156  
 Since the supramolecular approach is based on high affinity between the protein and the 
co-factor bearing the metal fragment, the choice of the guest-host couple is very important for 
its success. When it comes to high association constants, the system that naturally comes to 
mind is biotin-avidin, which has one of the highest non-covalent interactions known in nature 
(Ka ∼1015 M-1).157 As early as 1978, Whitesides and Wilson converted avidin into an 
enantioselective homogeneous catalyst by incorporating a biotinylated achiral rhodium-
diphosphine complex into the biotin-binding pocket.158 This was the first example of an 
artificial metalloenzyme. Later, Chan et al. extended the concept to the use of chiral 
ligands.159 Since 2003, Thomas Ward’s group in Neuchâtel has focused on the development 
of artificial metalloenzymes based on the biotin-(strept)avidin technology (hereafter, 
(strept)avidin refers either to avidin or to streptavidin). A detailed description of the system is 
presented in the next section. 
 At the interface between organometallic catalysis and enzyme chemistry, the hybrid 
catalysts represent a complementary approach to asymmetric transformations and may allow 
quick development of a broad reaction range in environmentally benign media. In terms of 
activity, reaction and substrate range, and operating conditions, they take advantage of the 
performance of the organometallic component. In contrast, the enantioselection path is 
determined by the biomolecular scaffold, which controls second coordination sphere 
interactions. The attractive feature of such systems is their optimization potential, which 
combines chemical and genetic methods to screen diversity space.  
4 Biotin-Streptavidin System 
The choice of an appropriate guest-host couple is a crucial step when designing a new hybrid 
catalytic system. Supramolecular anchoring appears more interesting than covalent or dative 
strategies, since it allows separate variation, followed by straightforward combination of the 
chemical and the genetic counterparts. Moreover, no chemical modification step is required 
after the incorporation of the catalyst precursor, thus ensuring the integrity of the 
organometallic species.160 
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 A robust protein scaffold and a very strong affinity between the protein and the 
organometallic host are essential. In this context, the use of the biotin-(strept)avidin system 
presents the following advantages:161 
Guest ⊂ host binding. The affinity constant of either avidin or streptavidin for biotin is one 
of the highest known in nature (Ka = 1.7·1015 M-1 for avidin and Ka = 2.5·1013 M-1 for 
streptavidin).157 This strong binding ensures the immediate and complete formation of the 
protein – metal complex hybrid catalyst. Furthermore, derivatization of the biotin side chain 
to introduce the catalytic functionalities does not cause dramatic change in the affinity 
constant.162 
Stability. Streptavidin has an exceptional stability towards heat (the biotin-containing 
tetramer is stable at 110 °C for several minutes)163, extreme pH conditions (denaturation 
requires 6 M guanidinium chloride at pH 1.5),164 high concentrations of organic solvent (50% 
ethanol) and the presence of surfactants (such as sodium dodecyl sulphate, SDS).165 
Therefore, the use of a large panel of reaction conditions can be envisaged. 
Protein expression. Both avidin, naturally available from egg white164 and streptavidin, 
secreted by Streptomyces bacteria,157 are available as recombinant proteins. Avidin has proven 
difficult to produce in bacteria, but reasonable yields can be obtained in eukaryotic production 
systems like Pichia pastoris.166 In contrast, streptavidin can be expressed from E. coli culture 
at relatively high yields (in our lab the production yields reach typically 200 mg·L-1).167 Both 
proteins are easily purified by affinity chromatography using immobilized 2-iminobiotin. 
Structural and functional information. The exceptional affinity and stability properties 
described above are the reasons for the particular attention that avidin and streptavidin have 
received from the scientific community. The biotin-(strept)avidin system is the basis for a 
great number of practical applications and is an interesting model system to study the affinity 
between a macromolecule and a small ligand.168,169 Therefore, it is not surprising that the 
structural and functional characteristics of these two proteins have been extensively 
studied.170 The crystal structures of a number of (strept)avidin variants have been determined 
and biotin binding is well defined, thus allowing rational tailoring of the artificial 
metalloenzymes.   
 Despite an amino acid similarity of only 41% (amino acid identity 30%),171 the secondary, 
tertiary, and quaternary structures of avidin and streptavidin are almost identical to each 
other.172,173 They fold in an eight-stranded antiparallel β-barrel and their quaternary structure 
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is composed of four identical barrels. Each subunit has a single biotin-binding site placed near 
one end of the barrel and containing two main motifs: the hydrophilic contact residues that 
form hydrogen bonds with biotin (Figure 4a) and the hydrophobic pocket created by several 
aromatic residues (Figure 4b). The binding site residues provide a precise fit to biotin, so that 
in the unoccupied binding site, the position of the solvent molecules is similar to the shape of 
the biotin molecule. After biotin-binding, the flexible loop between the strands β3 and β4 
(loop L3,4) becomes ordered, locking the biotin in the binding site (Figure 4a). A critical 
hydrophobic interaction is provided by a tryptophan residue supplied by a neighbouring 
subunit (Figure 4b) and therefore the two proteins are considered as a dimer of functional 
dimers.  
 It is worthy noting that the deep hydrophobic cavity of (strept)avidin can also bind, albeit 
with significantly reduced affinity, a variety of ligands, including HABA, ANS and different 
oligopeptides,164,168,169,174 suggesting the possibility of second coordination sphere interactions 
with a wide range of functionalities attached to the biotinylated moiety. 
a)             b) 
   
Figure 4. Biotin binding pocket of streptavidin (PDB reference code 1STP).172 a) Hydrogen bonding net 
stabilizing the urea moiety (N23, S27, Y43, S45, D128), the sulfur atom (T90) and the carboxylic acid of the 
valeric side chain (N49 and S88) of biotin; the L3,4 loop (residues 45-52) is highlighted in green; b) 
Hydrophobic interactions with tryptophane residues: W79, W92 and W108 from monomer A (blue) and W120 
from the adjacent monomer B (yellow). 
 Considering the above features, the biotin-(strept)avidin couple appears as an ideal starting 
point for the development of hybrid catalysts. Three decades after Whitesides’ work, the great 
potential of chemogenetic optimization made possible the development of very selective 
catalytic systems. This approach, implemented thus far in our laboratory for hydrogenation 
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reactions, is based on generating chemical and genetic libraries to explore diversity space.175 
A chemogenetic optimization procedure133 implemented for the hydrogenation of α-
acetamidoacrylic and α-acetamidocinnamic acids using streptavidin in conjunction with 
biotinylated rhodium diphosphine complexes allowed rapid generation of (R)- and (S)-
selective as well as substrate specific metalloenzymes (up to 96% ee (R)).175,176 Higher 
activities and selectivities are obtained when streptavidin is used instead of avidin. 
 Chemical optimization of the system can be achieved by modifying the localization of the 
catalytic moiety inside the protein upon introduction of a spacer between the biotin anchor 
and the diphosphine ligand. The nature of the biotinylated ligand determines the general 
activity and selectivity trends. The critical second coordination sphere interactions determine 
the selective coordination of the prochiral face to the catalytic moiety, as well as substrate 
differentiation, and can be fine-tuned by introducing point mutations in the host protein. The 
general principle is summarized in Scheme 24.175,177 
 
Scheme 24. Artificial metalloenzymes based on the biotin-streptavidin system for enantioselective 
hydrogenation reactions. Introduction of a spacer (green) and variation of the diphosphine ligand (blue) allow 
chemical optimization; introduction of point mutations (red) leads to genetic optimization of the host protein. 
 In contrast to the rational design used by the Ward group, another approach to generate 
selective artificial metalloenzymes for hydrogenation reactions has been implemented by the 
group of Manfred Reetz, who first proposed the application of directed evolution methods to 
hybrid catalysts based on biotin-streptavidin.178 Due to problems associated with the protein 
expression system and the air sensitivity of the metal complexes, screening the artificial 
enzymes has proven more difficult than screening classical enzymatic systems.124 However, 
  
 
55 
Reetz et al. demonstrated the possibility of breeding a better catalyst over several evolutionary 
cycles.  
 The creation of such artificial metalloenzymes opens new horizons in the field of enzyme 
application. The real challenge is to generate novel activities that are impossible to obtain 
using classical enzymatic systems. Encouraged by the results on hydrogenation reaction, the 
research in Thomas Ward’s group has focused on more difficult reactions, including transfer 
hydrogenation of ketone derivatives,179-181 oxidation of secondary alcohols182 and, more 
recently, allylic alkylation.183 
5 Scope of this Thesis 
As described above, the artificial metalloenzymes based on the biotin-streptavidin technology 
offer new perspectives for protein engineering by combining chemical and genetic 
modifications to create new activities and to fine-tune the selectivity. The objective of this 
thesis is the development of efficient hybrid catalysts for challenging reduction and oxidation 
reactions. Hence, the work is divided into two distinct parts, dealing with two different 
reactions: the transfer hydrogenation of carbonyl compounds and sulfoxidation.  
 The first part relies on the discovery of a selective artificial transfer hydrogenase based on 
biotin-streptavidin during a previous PhD project in Thomas Ward’s laboratory (PhD thesis of 
Dr. Christophe Letondor).179 The goal of the following studies is the implementation of a 
robust protocol for the chemogenetic optimization of such enzymes and a closer investigation 
of the catalytic system. Furthermore, we aim to exploit the influence of the second 
coordination sphere to create artificial keto-reductases for the reduction of difficult substrates, 
such as dialkyl ketones.  
 Creating artificial metalloenzymes for oxidation reactions represents the second challenge 
of this thesis. From a panel of possible enantioselective oxidations, we selected the 
sulfoxidation reaction as a starting point. Our initial studies focus on the implementation of a 
sulfoxidation system that is compatible with the presence of water and protein. Further 
research is centered on the incorporation of a catalytically active metal ion (vanadyl) into the 
binding pocket of streptavidin. In this way, streptavidin can be transformed into a 
metalloenzyme without the use of the biotin co-factor.  
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1 Transfer Hydrogenation of Carbonyl Compounds 
The starting point of this work is constituted by previous studies conducted in our laboratories 
by Dr. Christophe Letondor.184 His efforts allowed the identification of active and selective 
artificial metalloenzymes for the transfer hydrogenation of acetophenone derivatives based on 
the biotin-streptavidin technology. Moreover, they suggested that both chemical and genetic 
methodologies can be implemented for the optimization of the system. For a better 
comprehension of the following results, a short description of the catalytic system discovered 
by Dr. Letondor will be presented in Section 1.1.179 The results presented in Section 1.2 were 
obtained in collaboration with Dr. Letondor and therefore have already been largely discussed 
elsewhere.180,184 Only a brief account of the outcome of this first optimization protocol will be 
provided. 
1.1 The Catalytic System 
The Noyori-type asymmetric transfer hydrogenation of ketones was chosen as a model 
reaction, considering the nature of the critical non-covalent interactions within the transition 
state (see Chapter 1, Section 2.1.1). In this context, it was reasoned that the second 
coordination sphere contacts between the host protein and the substrate may lead to good 
selectivities. Most importantly, recent examples in the field of chemo-enzymatic catalysis 
demonstrated the compatibility between d6 piano-stool metal complexes and enzymatic 
systems at elevated temperatures, thus suggesting that biotinylated piano-stool complexes 
may perform their task in the presence of streptavidin acting as a host protein.8 
 Derivatisation of an achiral aminosulfonamide ligand with a biotin anchor, followed by 
complex formation with ruthenium afforded the stable and water compatible catalyst 
precursors [η6-(arene)Ru(Biot-q-L)Cl], which were combined with wild-type streptavidin 
(abbreviated hereafter WT Sav) to afford artificial metalloenzymes for transfer hydrogenation 
reactions ([η6-(arene)Ru(Biot-q-L)Cl] ⊂ WT Sav; arene = p-cymene, benzene; q = ortho-, 
meta- or para-position for the biotin anchor, Scheme 1a). Studies of the hydrogen source, pH 
and buffer system, temperature, reaction time and organic co-solvent revealed the best 
conditions for the reduction of the model substrate acetophenone 1 (Scheme 1b and Table 1, 
entry 1). Acetophenone derivatives 2 and 3 afforded even higher conversions and selectivities 
(Table 1, entries 2-3). In the absence of Sav, these complexes catalyzed the aqueous transfer 
hydrogenation of acetophenone to yield racemic 1-phenylethanol in quantitative yield. 
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Scheme 1. a) Schematic representation of artificial metalloenzymes based on biotin-streptavidin for transfer 
hydrogenation reactions ([η6-(arene)Ru(Biot-q-L)Cl] ⊂ WT Sav, arene = p-cymene or benzene, q = ortho-, 
meta- or para-); b) Reaction conditions for the enantioselective reduction of acetophenone derivatives. 
Table 1. Best results obtained after the optimization of the reaction conditions for the transfer hydrogenation of 
acetophenone derivatives with [η6-(arene)Ru(Biot-p-L)Cl] ⊂ Sav. 
Entry η6-(arene) Protein Substrate Conv. (%) ee (%) 
1 p-cymene WT Sav 1 82 68 (R) 
2 p-cymene WT Sav 2 93 87 (R) 
3 p-cymene WT Sav 3 86 91 (R) 
4 benzene WT Sav 1 54 48 (S) 
5 p-cymene P64G Sav 1 90 85 (R) 
6 p-cymene P64G Sav 3 92 94 (R) 
7 p-cymene S112G Sav 1 90 28 (R) 
  
 The nature of the capping arene was found to play a crucial role in determining both the 
activity and the selectivity of [η6-(arene)Ru(Biot-p-L)Cl] ⊂ WT Sav. Most unexpectedly, 
substitution of the η6-(p-cymene)- by an η6-(benzene)-cap produced the opposite enantiomer 
of 1-phenylethanol, under otherwise identical reaction conditions (Table 1, entries 1 and 4). 
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This initial finding suggested an important interaction between the protein and the ruthenium 
complex. 
 
Scheme 2. Suggested weak contacts critical for the observed enantioselectivity in the reduction of acetophenone 
catalyzed by [η6-(p-cymene)Ru(Biot-p-L)H] ⊂ WT Sav. The absolute configuration at Ru may be determined by 
second coordination sphere contacts between the biotinylated catalyst and streptavidin (A); the preferential 
delivery of one prochiral face of the substrate may be biased by second coordination sphere interactions between 
the substrate and streptavidin (B). 
 To rationalize this observation, two complementary enantioselection mechanisms can be 
envisaged. First, the absolute configuration at Ru in the hydride piano-stool complex may be 
controlled by second coordination sphere interactions with Sav. This differs from classical 
Noyori-type catalysts where the Ru-configuration is determined by the chirality of the 
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chelating ligand scaffold.55 Second, additional contacts between the substrate and the protein 
may compete (matched or mismatched) with interactions between the substrate and the η6-
capping arene to favour the approach of one prochiral face of the substrate. These two 
possible enantiodiscriminating events are outlined in Scheme 2 for the (R)-selective [η6-(p-
cymene)Ru(Biot-p-L)Cl] ⊂ WT Sav combination. 
 Introduction of point mutations within the host protein showed that the protein with the 
most remote site of mutation (P64G Sav) significantly increased enantioselectivity, while the 
closest lying mutation (S112G Sav) afforded the greatest variation in enantioselectivity as 
well as the highest conversions (Table 1, entries 5-7). 
1.2 First Round of Evolution: Exploring the Active Site 
With the aim of broadening the substrate scope and gaining mechanistic insight into the new 
system, a library of chemically and genetically modified catalyst variants was produced and 
screened for activity and selectivity for the reduction of prochiral ketones. As no high-
throughput methodology was implemented, we focused on minimal modifications of the 
active site, likely to dramatically affect the reaction outcome: the position of the biotin-
anchor, the capping arene and the metal, as well as the residues predicted to lie close to the 
active site.180 
1.2.1 Screening Strategy 
In order to limit the number of screening experiments, we opted for a representational search 
strategy (positional scanning)23 to optimize the activity and selectivity of the artificial 
metalloenzymes. Three variables were expected to have an important effect on the reaction 
outcome: chemical diversity (catalyst structure), genetic diversity (protein environment), and 
substrate (Scheme 3).  
 
Scheme 3. Screening strategy based on positional scanning for the chemogenetic optimization of the artificial 
transfer hydrogenases. 
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 Successive optimization rounds were carried out by modifying a single parameter at a time 
(Scheme 4).  
 
Scheme 4. Chemical, genetic and substrate diversity used for the chemogenetic optimization of enantioselective 
artificial transfer hydrogenases. 
 The influence of the biotinylated catalyst structure on the asymmetric transfer 
hydrogenation for the three acetophenone derivatives 1-3 was evaluated first. Then, changes 
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of the host protein through targeted mutations were explored by screening with the most 
promising organometallic scaffolds. Finally, the scope of the reaction was assessed using the 
best catalyst ⊂ protein combinations. While this approach did not take into account the 
possible cooperativity effects between the different factors (metal complex, protein and 
substrate), it allowed the identification of selective catalysts using a modest screening effort. 
1.2.2 Insight into the Active Site: Construction of the First Model 
To minimize the number of experiments required for efficient optimization, we focused on 
modifications close to the active site, assuming that these have more influence on cataysis 
than distant ones.123,128 In the absence of crystallographic information on the exact location of 
the catalytic centre, docking studies were performed, in collaboration with Dr. Sylwester 
Mazurek at the University of Ljubljana, to obtain a qualitative model of the hybrid catalyst.  
 The most stable docked structure of the ruthenium hydride catalyst [η6-(p-
cymene)Ru(Biot-p-L)H] ⊂ WT Sav reveals that the Cα atoms of serine S112 and S122 lie 
closest to the ruthenium moiety. However, the S112 side chain points towards the piano-stool 
fragment while the S122 side chain is directed away from the complex.  
1.2.3 Chemical Optimization 
The biotinylated metal complex was modified by varying the capping arene, the position of 
the biotin anchor and the metal centre. A total of twenty-one catalyst precursors was 
generated by combining the three different ligands (ortho-, meta- and para-biotinylated 
sulfonamides Biot-q-LH) with seven d6 piano-stool fragments containing five arene caps and 
three different metals (η5-(C5Me5)RhCl, η5-(C5Me5)IrCl and η6-(arene)RuCl, arene = p-
cymene, benzene, durene, mesitylene, hexamethylbenzene, Scheme 4).  
 Screening of these catalysts in the presence of WT Sav and P64G Sav allowed rapid 
identification of the most promising metal complexes for the reduction of acetophenone 
derivatives 1-3: [η6-(p-cymene)Ru(Biot-p-L)Cl], [η6-(benzene)Ru(Biot-p-L)Cl], [η6-
(durene)Ru(Biot-p-L)Cl], [η6-(C5Me5)Ir(Biot-p-L)Cl] and [η6-(C5Me5)Rh(Biot-p-L)Cl]. The 
two Sav isoforms used in the screening displayed similar trends. It is worthy noting that only 
the para-anchored ligands afforded significant levels of conversion, suggesting that the meta- 
and ortho-anchoring localize the ruthenium centre in a position that is not easily accessible for 
the substrate.  
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1.2.4 Genetic Optimization 
The preliminary results obtained with the S112G Sav mutant, which showed the most 
pronounced changes in conversion and selectivity (see Table 1, entry 7), encouraged the 
selection of position S112 for genetic optimization through saturation mutagenesis. This 
choice was further motivated by the docking studies, which suggested close contacts between 
the S112 amino acid side chain and the ruthenium moiety. Thus, the five biotinylated 
ruthenium complexes were screened in conjunction with the twenty streptavidin isoforms, 
S112X Sav.  
Table 2. Selected results for the chemogenetic optimization of the artificial transfer hydrogenases for the 
reduction of the acetophenone derivatives 1-3. 
Entry Protein Complex Substrate Conv. (%) ee (%) 
1 S112Y Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 1 95 90 (R) 
2 S112Y Sav [η6-(durene)Ru(Biot-p-L)Cl] 2 88 92 (R) 
3 S112T Sav [η6-(benzene)Ru(Biot-p-L)Cl] 2 90 55 (S) 
4 S112D Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 1 0 - 
5 S112A Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 3 98 91 (R) 
6 S112A Sav [η6-(benzene)Ru(Biot-p-L)Cl] 3 74 41 (R) 
7 S112K Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 1 50 20 (S) 
8 S112K Sav [η6-(benzene)Ru(Biot-p-L)Cl] 1 37 55 (S) 
9 S112R Sav [η6-(benzene)Ru(Biot-p-L)Cl] 3 23 62 (S) 
 
 General trends emerge from this second optimization step: 
• The nature of the capping arene by-and-large determines the preferred enantiomer: 
(R)-reduction products are obtained with η6-(p-cymene)- and η6-(durene)-bearing 
complexes and (S)-reduction products are obtained with the η6-(benzene)-bearing 
complex (Table 2, entries 1-3 and Figure 1a). The overall performance of the rhodium- 
and iridium-containing metalloenzymes is modest and depends very much on the host 
protein (Figure 1a). 
• Sav mutants bearing a potentially coordinating amino acid side chain at position S112 
(cysteine, methionine, aspartic or glutamic acid, histidine) inhibit the catalytic 
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performance of the artificial transfer hydrogenases (Table 2, entry 4). This confirms 
the initial hypothesis that S112 is close to the organometallic fragment. 
• Introduction of cationic residues (lysine, arginine) at position S112 favours (S)-
reduction products, while hydrophobic residues (tyrosine, phenylalanine, valine, 
alanine) at position S112 favour (R)-reduction products (Figure 1b).  
 The (R)-and (S)-selective proteins and metal complexes can act either in a matched or 
mismatched fashion to afford good levels of selectivity for (R)-reduction products or 
moderate (S)-selectivities (Table 2, entries 5-9). 
 a)            b) 
 
Figure 1. Summary of the enantioselectivity trends of the chemogenetically optimized artificial metalloenzymes, 
arranged from the highest to the lowest ee value, according to: a) the nature of the complex, irrespective of the 
protein and substrate used: [η6-(p-cymene)Ru(Biot-p-L)Cl] (•), [η6-(benzene)Ru(Biot-p-L)Cl] (), [η6-
(durene)Ru(Biot-p-L)Cl] (♦), [η6-(C5Me5)Ir(Biot-p-L)Cl] (▲) and [η6-(C5Me5)Rh(Biot-p-L)Cl] (◄); b) the Sav 
isoform, irrespective of the Ru complex and substrate used: S112Y (•), S112F (♦), S112V (▲), S112A (), 
S112R (□) and S112K (). 
1.2.5 Substrate Scope 
Having identified the most efficient hybrid catalysts, we proceeded to test substrates 4-8, 
bearing bulky (4), coordinating (5) or dialkyl groups (6-8, Scheme 4). The five substrates 
were tested in the presence of the (R)-selective [η6-(p-cymene)Ru(Biot-p-L)Cl] and of the 
(S)-selective [η6-(benzene)Ru(Biot-p-L)Cl] catalysts. These were combined with ten 
representative S112X Sav isoforms (X = A, G and L: aliphatic residues with increasing bulk; 
F and W: aromatic residues with increasing bulk; S and T: polar residues; E: coordinating 
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anionic residue; R: cationic residue; N: neutral amidic residue) and the best results are 
summarized in Table 3. 
 The selectivity and conversion trends are similar to those obtained for the acetophenone 
derivatives 1-3. Only modest activities and enantioselectivities are obtained with the non-
aromatic ketones (Table 3, entries 1-4). High (R)-selectivities are obtained for α-tetralone 
(Table 3, entry 5). Interestingly, the (S)-selective trend of the artificial enzymes bearing 
cationic residues at position 112 (S112K and S112R) is particularly pronounced for 2-
acetylpyridine 5, suggesting that the presence of a positive charge at this position is beneficial 
for this substrate (Table 3, entries 6-7). We speculated that the presence of a hydrogen bond 
between the cationic residue and the pyridine moiety played a key role in this context.  
Table 3. Selected results for the transfer hydrogenation of substrates 4-8 with the most selective combinations 
[η6-(arene)Ru(Biot-p-L)Cl] ⊂ Sav isoform. 
Entry Protein Complex Substrate Conv. (%) ee (%) 
1 S112A Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 6 98 48 (R) 
2 S112A Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 7 97 69 (R) 
3 S112G Sav [η6-(benzene)Ru(Biot-p-L)Cl] 7 73 45 (S) 
4 S112A Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 8 71 30 (R) 
5 S112F Sav [η6-(p-cymene)Ru(Biot-p-L)Cl] 4 70 96 (R) 
6 S112R Sav [η6-(benzene)Ru(Biot-p-L)Cl] 5 93 69 (S) 
7 S112K Sav [η6-(benzene)Ru(Biot-p-L)Cl] 5 97 70 (S) 
 
1.3 Second Round of Evolution: X-Ray Guided Designed Evolution 
1.3.1 From Model to Reality: First X-Ray Structure of a Streptavidin-Based 
Artificial Metalloenzyme 
With the aim of gaining structural and functional insight into the artificial transfer 
hydrogenases, a significant effort was invested into crystallizing the most promising 
combinations of metal complex and Sav isoform. The crystal structure of the (S)-selective 
[η6-(benzene)Ru(Biot-p-L)Cl] ⊂ S112K Sav was determined by Dr. Marc Creus in 
collaboration with Dr. Isolde LeTrong and Prof. Ronald Stenkamp from the University of 
Washington. The refined model (1.58 Å resolution, PDB reference code 2QCB) provides a 
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fascinating insight into the organization of the active site and the close contacts between the 
Ru complex and amino acid residues in several loop regions.181 
 It is important to note that the occupancy of the Ru site is only 20%, probably due either to 
conformational flexibility inside the host protein, to Ru decomplexation during crystallization 
or to steric clash in the case of simultaneous occupation of two adjacent binding sites by the 
Ru complex. Indeed, the metal moiety is located near a subunit-subunit interface and lies too 
close to the neighbouring biotinylated complex (Ru····Ru distance 4.44 Å), thus hindering the 
occupancy of the adjacent biotin binding site (Figure 2a). This short contact suggests that 
substituting the capping η6-benzene by a bulkier η6-p-cymene may force the latter 
biotinylated complex to adopt a different position and / or configuration at the metal to avoid 
steric hindrance. It is also noteworthy that incorporation of the bulky [η6-(benzene)Ru(Biot-p-
L)Cl] within S112K Sav does not lead to a major structural reorganization of the host protein 
(Figure 2b). Compared to WT Sav, a root mean square (RMS) of 0.276 Å is computed for all 
121 Cα atoms present. 
a)        b) 
   
Figure 2. a) Short contact between the two biotinylated complexes [η6-(benzene)Ru(Biot-p-L)Cl] from adjacent 
monomers A and B of S112K Sav. b) Superimposition of the structure of [η6-(benzene)Ru(Biot-p-L)Cl] ⊂ 
S112K Sav (blue schematic representation) with the structure of biotin ⊂ core WT Sav (PDB reference code 
1STP, yellow schematic representation, biotin: yellow stick). Only monomers A and B are displayed for clarity. 
This view emphasizes the minimal structural reorganization of the host protein required to accommodate the 
biotinylated catalyst. 
 Most interestingly, despite the use of a racemic Ru piano-stool complex for crystallization, 
only the (S)-enantiomer of [η6-(benzene)Ru(Biot-p-L)Cl] was localized in the crystal 
structure (Figures 2 and 3). In homogeneous systems, the (S)-Ru configuration of the chloride 
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complex is predicted to afford (S)-reduction products of acetophenone derivatives. The [η6-
(benzene)Ru(Biot-p-L)Cl] ⊂ S112K Sav was the most (S)-selective hybrid catalyst identified 
during the first screening round (see Figure 1b). This observation further supports our 
hypothesis that second coordination sphere interactions enforce a preferential configuration at 
ruthenium (see Scheme 2). 
 The structure also confirms the docking results suggesting that the S112 position lies in 
the immediate vicinity of the Ru atom. Several additional short contacts between the 
biotinylated catalyst and amino acid side chains can be identified (Figure 3). These include 
residues of the L7,8 loop (110-120) of both Sav monomers A and B as well as G48 (part of 
L3,4 loop) and H87 (part of L5,6 loop) of the monomer A in which the biotinylated catalyst 
[η6-(benzene)Ru(Biot-p-L)Cl] is located. Position 121 is of particular interest, as the K121 
residues of both monomers A and B can interact both with the η6-arene (K121B) and with the 
expected trajectory of the incoming substrate (K121A). Other residues in the L7,8 loop of 
monomer A might also influence the approach of the substrate (i.e. N118, A119, W120).  
 
Figure 3. Close up view of the structure of [η6-(benzene)Ru(Biot-p-L)Cl] ⊂ S112K Sav determined by X-ray 
crystallography (only one dimer of the tetramer depicted for clarity: monomer A – blue and monomer B – 
orange). Only monomer A is occupied by the biotinylated Ru complex. Residues K112, K121 and L124 of 
monomer A and K112, K121 of monomer B, close-lying to the Ru atom, are highlighted (stick). Residues G48 
and H87 (Cα-Ru distances < 12 Å), as well as N118, A119 and W120 (possibly interfering in the trajectory of the 
substrate) of monomer A are also highlighted as light blue lines. A possible trajectory of the incoming prochiral 
substrate is also indicated by an arrow. It should be noted that the occupancy of the metal moiety is only 20%. 
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 Detailed inspection of the structure reveals that the side chain of residue L124 displays a 
short contact with the SO2 moiety that links the piano-stool complex to the biotin anchor 
(Figure 3, H3CLeu····OSORR’Ligand distance 3.53Å) and thus may influence the position of the 
biotinylated complex inside the hydrophobic pocket. 
1.3.2 New Challenge: Reduction of Dialkyl Ketones 
Even though the X-ray structure provides some important knowledge about the positioning of 
the biotinylated moiety inside the host protein, it does not offer any precise information about 
the enantioselection mechanism. In this context, further evolution of the artificial 
metalloenzymes cannot rely exclusively on rational redesign, but requires the use of random 
mutagenesis and screening experiments to perfect those elements which cannot be predicted. 
Starting from the previously identified (R)- and (S)-selective variants and from the close-lying 
residues identified from the X-ray structure, we implemented a designed evolution 
methodology185 for the optimization of the artificial transfer hydrogenases. Given the 
difficulty of predicting the effect of a particular amino acid residue on the reaction outcome, 
saturation mutagenesis was performed at the selected positions. 
 During the first chemogenetic optimization step, highly (R)-selective combinations were 
identified for the reduction of aromatic ketones. In contrast, only moderate (S)-selectivities 
were obtained for these substrates, while the dialkyl ketones were reduced with modest 
activities and enantioselectivities (ee’s up to 69% (R) and 45% (S)). Consequently, we 
reasoned that it would be interesting to further evolve the hybrid catalyst to create selective 
systems for the reduction of dialkyl ketones. Moreover, by carefully choosing the mutation 
sites, the modest (S)-selectivity of the artificial enzymes might be improved. 
 Dialkyl ketones are challenging for the homogeneous transfer hydrogenation catalysis, as 
the postulated critical enantiodiscriminating CaromaticH–pi interaction between the η6-arene 
ligand and the aryl group of the ketone is absent for such substrates.60,62 In contrast, in 
enzymatic systems like alcohol dehydrogenases, enantiodiscrimination is controlled by 
second coordination sphere interactions between the substrate and the enzyme, leading to 
highly enantioselective reduction of aliphatic ketones (see Chapter 1, Sections 2.1.1 and 
2.1.2). Considering the streptavidin-based transfer hydrogenases, we hypothesized that the 
second coordination sphere contacts between the host protein and the substrate may lead to 
good selectivities, even for these challenging substrates. However, the first results suggest that 
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the 112 position has little influence on determining the orientation of the approaching dialkyl 
substrates 6-8. 
 In this context, identification of residue K121 as possibly interacting both with the η6-
arene (K121B) and with the incoming substrate (K121A) was of particular interest. We 
targeted residues K121 and L124 for saturation mutagenesis, speculating that the first could 
steer the delivery of the substrate, while the second could alter the position of the metal 
complex within the binding pocket (through the H3CLeu····OSORR’Ligand interaction), thus 
influencing the enantioselectivity of the reaction. 
 Saturation mutagenesis at K121 and L124 positions was performed starting in the genetic 
backgrounds of S112A Sav and S112K Sav ((R)-, respectively (S)-selective mutants), as well 
as that of WT Sav. Although it was not the most (R)-selective mutant identified during the 
first chemogenetic optimization step (see Figure 1b), S112A Sav was chosen since this Sav 
isoform displayed a good level of protein expression, far better than either S112F or S112Y 
Sav. The promising (S)-selectivity trends and the crystallographic information dictated the 
choice of the S112K Sav mutant.  
 
Scheme 5. Parameters optimized during the designed evolution protocol: η6-arene = p-cymene, benzene; Sav 
mutant = K121X, L124X, S112A-K121X, S112A-L124X, S112K-K121X, S112K-L124X; substrate = p-
bromoacetophenone 2, 4-phenyl-2-butanone 6. 
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 A total of 114 new Sav mutants (K121X; L124X; S112A-K121X; S112A-L124X; S112K-
K121X and S112K-L124X) were produced by the molecular biology team of our laboratory 
(Miss Alessia Sardo, Dr. Anita Ivanova and Dr. Marc Creus) and tested in combination with 
the [η6-(p-cymene)Ru(Biot-p-L)Cl] and [η6-(benzene)Ru(Biot-p-L)Cl] complexes. The 
activated para-bromoacetophenone 2 and the challenging 4-phenyl-2-butanone 6 were chosen 
as model aromatic, respectively aliphatic substrates (Scheme 5). 
1.3.3 Extraction-Immobilization Protocol: Quick Screening Strategy 
To accelerate the optimization process, a quick screening protocol had to be implemented. 
The first round of screening for the chemogenetic optimization required the use of milligram 
quantities (3-4 mg per catalytic experiment) of the twenty purified Sav mutants to perform the 
catalytic experiments. Since the set up for the production and purification of Sav in our 
laboratory lasts nearly three weeks for the production of one mutant (including purification 
and lyophilisation), an alternative technique for testing the 114 new Sav mutants was 
necessary. 
1.3.3.1 Catalysis with Streptavidin-Containing Crude Cell Extracts 
In the absence of colony selection techniques, the quickest way to test the performance of the 
Sav mutants is screening for catalysis in crude cell extracts after Sav production in small 
volume E. coli cell cultures. After extraction of the substrate and of the product using an 
organic solvent, the conversions and ee’s can be determined by chiral HPLC analysis of the 
organic phase. The problems associated with this method are the low levels of Sav production 
in the small culture volumes, as well as the presence of a variety of potential catalyst 
inhibitors in the cell extract (for example, anionic DNA constitutes a possible ligand for the 
Ru complex). 
 In a first approach, the use of crude cell extracts containing the S112Y Sav mutant was 
tested in the reduction of acetophenone 1. After protein expression and production in a 50 mL 
E. coli culture, the cell pellet containing ~ 1 mg Sav (determined by titration with biotin-4-
fluorescein)186 was treated with DNA-ase, re-suspended in ~ 800 µL of water and tested for 
catalysis. Following this procedure, the concentration of the artificial metalloenzyme inside 
the reaction mixture is roughly three times more dilute than in the standard experiment. Using 
pure S112Y Sav under these conditions affords much lower conversion and ee than the 
standard experiment with concentrated protein (Table 4, entries 1-2). Moreover, as 
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anticipated, the presence of the cellular extract completely inhibits the catalytic activity of the 
organometallic complex (Table 4, entries 3-4).  
 These results suggest that, in contrast to enzyme optimization via evolutionary techniques 
– where screening can often be performed with either colonies or crude cell extracts –, the 
presence of an exogenous metal sets very stringent protein purity requirements to ensure 
reproducible activity of the artificial metalloenzymes. Indeed, to the best of our knowledge, 
all experiments in the area of artificial metalloenzymes have thus far been performed with 
protein purified to homogeneity. This lengthy purification step is a significant bottleneck for 
artificial metalloenzyme optimization. 
Table 4. Comparison of the results afforded by purified S112Y Sav with the results obtained using crude cellular 
extracts containing S112Y Sav for the reduction of acetophenone 1 using [η6-(p-cymene)Ru(Biot-p-L)Cl]. 
Entry Protein [Sav] (µΜ) Conv. (%) ee (%) 
1 pure 36 95 90 (R) 
2 pure 14.3 59 60 (R) 
3 cell extract 14.3 0 - 
4 pure + cell extract 14.3 0 - 
 
1.3.3.2 Immobilization Technique: Rapid Protein Extraction and Purification 
To overcome this limitation, we reasoned that the tetrameric nature of Sav could be exploited 
to purify the host protein by immobilization using commercially available iminobiotin- or 
biotin-sepharose. Thanks to the very high and selective affinity of biotin (and, to a lesser 
extent, iminobiotin) for Sav, we speculated that the immobilization step could be performed 
directly on the crude E. coli cellular extract. The change in the affinity of Sav for iminobiotin 
with the variation of pH (the binding strength decreases as the pH decreases) can be exploited 
to release pure protein after immobilization (Scheme 6a).187 When biotin-sepharose is used, 
sacrifying one biotin-binding site for immobilization purposes leaves up to three biotin 
binding sites to incorporate the biotinylated piano-stool and to perform catalysis (Scheme 6b). 
 The performances of the two purification techniques for the reduction of para-
methylacetophenone 3 were compared using the most selective artificial metalloenzyme 
identified to date, [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ P64G Sav (Table 5). The results 
suggested that both methods can be used for the rapid purification and testing of Sav-
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containing crude cell extracts, although with some loss with respect to conversion and 
selectivity. However, some disadvantages can be associated with the iminobiotin-sepharose 
extraction and purification protocol: 
• the affinity of Sav for iminobiotin is lower than the affinity for biotin; this feature is 
especially important as the concentration of the protein in the cell extract can be very 
low in some cases; 
• careful adjusting of the pH is necessary after the elution step at pH 2.9 (pHinitial = 6.25 
for optimal results in catalysis – see Section 1.1). This step is associated with an 
increase in the total volume of catalysis and thus with a decrease in Sav concentration. 
 
Scheme 6. Rapid techniques for the extraction and purification of streptavidin from crude cell extracts. a) 
Immobilization on iminobiotin-sepharose, followed by washing (pH = 9.8) and elution (pH = 2.9) steps affords 
pure Sav; b) Using biotin-sepharose affords the immobilized artificial metalloenzyme after several washing 
cycles. 
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 In contrast, immobilization on biotin-sepharose appeared to be a more robust system and 
was selected for further use for the screening of the 114 Sav mutants. Guanidinium chloride 
(1 M solution) and the HCOONa·B(OH)3 mixture (the hydrogen source for catalysis) were 
used as washing solutions for the first and the second washing steps, respectively. 
Table 5. Comparison of the iminobiotin- and biotin-sepharose extraction and purification techniques of 
streptavidin from crude cell extracts. The catalysis were performed using [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ 
P64G Sav for the reduction of para-methylacetophenone 3. The washing steps in the case of biotin-sepharose 
immobilization were realized using H2O / DMF = 100 / 2. 
Entry Purification technique Protein Conv. (%) ee (%) 
1 - pure 92 94 (R) 
2 biotin pure 92 93 (R) 
3 iminobiotin pure 90 87 (R) 
4 biotin cell extract 76 73 (R) 
5 iminobiotin cell extract 57 82 (R) 
 
 Following a growth of 50 mL E. coli cell culture in a 250 mL baffled flask, the cell pellet 
was collected by centrifugation, frozen at –25°C, thawed and re-suspended in 1.5 mL of 
water. The amount of Sav in the crude cell extract was estimated by fluorimetric titration 
using biotin-fluorescein as a probe186 (the titrations were performed in our laboratory by Mr. 
Thibaud Rossel and Miss Alessia Sardo using a 96-well plate microreader). To a suspension 
of biotin-sepharose in water, a solution containing a two-fold excess of tetrameric Sav with 
respect to the capacity of the biotin-sepharose beads was added. Centrifugation followed by 
three washing cycles with 1 M guanidinium chloride and one washing step with water 
afforded immobilized Sav, which was re-suspended in water and thoroughly degassed with 
dinitrogen. Addition of five equivalents (vs. immobilized tetrameric Sav) of biotinylated 
catalyst [η6-(arene)Ru(Biot-p-L)Cl] (arene = benzene or p-cymene) and three washing cycles 
with the HCOONa·B(OH)3 mixture yielded yellow suspensions, which were charged with the 
HCOONa·B(OH)3·MOPS mixture and with the appropriate substrate and heated at 55°C for 
64 hours under an inert atmosphere.  
 Catalysis results comparing purified Sav and Sav from crude cellular extracts immobilized 
via the protocol outlined above are presented in Table 6. The technique was tested with the 
three Sav isoforms selected for the designed evolut
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two Ru complexes and the aromatic substrate 2. From these initial results, it appears that, 
although the purification-immobilization with biotin-sepharose leads to a noticeable erosion 
of both of the activity and the selectivity, this straightforward protocol significantly speeds up 
the screening process to afford valuable trends. We thus set out to exploit the immobilization-
purification strategy to perform a round of directed evolution. 
Table 6. Comparison of the results obtained for the transfer hydrogenation of p-bromoacetophenone 2 using 
biotin-sepharose immobilized- and purified homogeneous artificial metalloenzymes [η6-(arene)Ru(Biot-p-L)Cl] 
⊂ Sav. 
Pure non-immobilized Sav 
Immobilized Sav 
(from cellular extract) Entry η6-(arene) Sav isoform 
Conv. (%) ee  (%) Conv. (%) ee  (%) 
1 p-cymene WT Sav 93 87 (R) 81 65 (R) 
2 benzene WT Sav 43 57 (S) 31 39 (S) 
3 p-cymene S112A Sav 78 87 (R) 57 64 (R) 
4 benzene S112K Sav 25 44 (S) 21 38 (S) 
 
1.3.4 Screening and Trends of the Immobilized Artificial Metalloenzymes 
The catalytic experiments of this screening round were performed with the help of Mr. 
Thibaud Rossel. Using the immobilization strategy, semi-quantitative trends were rapidly 
obtained for the reduction of 4-phenyl-2-butanone 6 as well as for p-bromoacetophenone 2. 
The enantioselectivity trends for the two substrates are displayed in Figure 4 in a fingerprint 
format, associating red with (R)- and blue with (S)-enantioselectivity. This type of display 
allows a rapid identification of the most selective combinations, as well as a comparison 
between the different variables influencing the enantioselectivity outcome. A refined 
comparison between these elements is also presented in Figure 6a-d. 
 The trends identified in this screen can be classified according to the following 
parameters:  
Substrate: aromatic vs. dialkyl ketone. In general, the two substrates behave similarly in 
terms of enantioselectivity. It is noteworthy that the enantioselectivity obtained for the dialkyl 
product is greater or opposite to the ee of the aromatic product for more than half of the 
artificial metalloenzymes, reaching a ∆ee (difference in enantioselectivity) of up to 65% 
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(Figure 5 and Table 7, entries 1 and 2). This suggests that protein-substrate interactions, 
reminiscent of keto-reductases are intimately involved in the enantioselection mechanism, as 
the classical CaromaticH-π interaction cannot be invoked for dialkyl substrates. 
 
 
Figure 4. Fingerprint display of the results for the designed optimization of the reduction of ketones 2 and 6 in 
the presence of biotin-sepharose-immobilized artificial metalloenzymes [η6-(arene)Ru(Biot-p-L)Cl] ⊂ Sav 
mutant (K121X, S112A-K121X, S112K-K121X, L124X, S112A-L124X, S112K-L124X). Catalytic runs that 
could not be performed (insufficient soluble protein expression) are represented by black squares. 
 As expected, in most of the experiments, the activated p-bromoacetophenone 2 affords 
much better conversions than the aliphatic substrate 6. The challenging dialkyl ketone gives 
comparable (R)-selectivity to the acetophenone derivative 2, albeit using different biotinylated 
catalyst ⊂ protein combinations (ee’s up to 83 % (R) for 2 and 82% (R) for 6, Table 7, entries 
3 and 4). In contrast, with some rare exceptions (Table 7, entry 5), only modest (S)-
selectivities are obtained with substrate 6 (Figure 6a). 
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Figure 5. Difference in enantiomeric excess (∆ee) between the aromatic and the aliphatic reduction products, 
calculated for all the immobilized Sav isoforms.  
Capping arene: η6-p-cymene vs. η6-benzene (Figure 6b). As in the previous screening round 
(Section 1.2), the enantioselectivity of the reaction is mainly dictated by the chemical moiety. 
However, while good (R)-selectivities can be obtained with [η6-(p-cymene)Ru(Biot-p-L)Cl], 
the best (S)-selectivities afforded by [η6-(benzene)Ru(Biot-p-L)Cl] remain moderate using 
the immobilized Sav isoforms. Nonetheless, some selective combinations are identified. The 
opposite tendencies of the two complexes are best illustrated in the presence of S112A-
K121N Sav for the reduction of both substrates (Table 7, entries 5-7).  
 Interestingly, some notable deviations from the (S)-trend of [η6-(benzene)Ru(Biot-p-L)Cl] 
are observed in the case of metalloenzymes bearing the S112A mutation ([η6-
(benzene)Ru(Biot-p-L)Cl] ⊂ S112A-K121W Sav 80% ee (R), Table 7, entry 2).  
Nature of the S112X residue: WT, S112A, S112K (Figure 6c). Artificial metalloenzymes 
incorporating the S112A mutation bring more diversity than the WT- and S112K-derived 
isoforms. Some of the best (R)- and (S)-selectivities for both the aromatic and the aliphatic 
substrates are  obtained with catalyst variants bearing the S112A mutation (Table 7, entries  4-
5 and 9-12). 
 Overall, the S112K double mutants are least selective, suggesting that a small side chain 
(alanine or serine) at position 112 may increase the influence of beneficial K121X or L124X 
mutations. The best S112K double mutant is [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ S112K-
L124H Sav which affords 59% ee (S) for the reduction of substrate 2 (Table 7, entry 13). 
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Thus, within this round of designed evolution, the S112K mutation can be regarded as an 
evolutionary dead-end. 
 a)            b) 
 
 c)            d) 
 
Figure 6. Enantioselectivity trends of the immobilized artificial transfer hydrogenases. The results are arranged 
from the highest to the lowest ee value, according to: a) the nature of the substrate: 2 (♦) and 6 (▲); b) the nature 
of the capping arene: p-cymene (♦) and benzene (▲); c) the nature of the S112X residue: S112A (♦), S112K (▲) 
and S112 (•); d) the position of the site of mutation: K121X (♦) and L124X (▲).  
Position of the site of mutation: K121X vs. L124X (Figure 6d). In terms of the site of 
mutation, saturation mutagenesis at position K121 is more effective and creates more 
diversity than the mutations in position L124. It is tempting to speculate that this effect may 
be due to the influence of the K121X side chains both on the piano-stool moiety (K121XA) 
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and on the trajectory of the incoming prochiral substrate (K121XB, see Figure 3). In the case 
of the dialkyl substrate, this latter contact may be crucial, as it provides a second coordination 
sphere interaction with the substrate, reminiscent of natural enzymes. Saturation mutagenesis 
at this position affords the best ee’s for the aliphatic ketone (Table 7, entries 4-5 and 9-10, 
ee’s up to 82% (R) and 62% (S) using immobilized catalysts). 
 A noteworthy exception however is the conservative mutation L124V, which gives the 
best (R)-selectivity for the reduction of substrate 2 with [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ 
L124V Sav (83% ee (R), Table 7, entry 3). In comparison, the best single mutant at position 
121 is [η6-(benzene)Ru(Biot-p-L)Cl] ⊂ K121R (also a conservative mutation) and affords 
64% ee (S) for the reduction of 2 (Table 7, entry 14). 
Table 7. Selected results for the designed optimization of the reduction of ketones 2 and 6 in the presence of 
biotin-sepharose-immobilized artificial metalloenzymes [η6-(arene)Ru(Biot-p-L)Cl] ⊂ Sav mutant. 
Entry η6-(arene) Sav isoform Substrate Conv. (%) ee (%) 
1 benzene S112A-K121W 2 89 16 (R) 
2 benzene S112A-K121W 6 86 80 (R) 
3 p-cymene L124V 2 90 83 (R) 
4 p-cymene S112A-K121T 6 84 82 (R) 
5 benzene S112A-K121N 6 95 62 (S) 
6 p-cymene S112A-K121N 6 81 58 (R) 
7 benzene S112A-K121N 2 99 55 (S) 
8 p-cymene S112A-K121N 2 63 50 (R) 
9 p-cymene S112A-K121F 6 96 73 (R) 
10 p-cymene S112A-K121V 6 92 68 (R) 
11 p-cymene S112A-K121V 2 73 66 (R) 
12 benzene S112A-K121C 2 63 63 (S) 
13 benzene S112K-L124H 2 64 59 (S) 
14 benzene K121R 2 96 64 (S) 
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1.3.5 Evaluation of Homogeneous Purified Sav Isoforms on Representative 
Substrates 
The best results using the immobilized hybrid catalysts were subsequently reproduced using 
the purified Sav mutant in a homogeneous phase and, as expected, some increase in ee and 
conversion could be observed in almost all cases (Table 8, entries 1-7).  
 An interesting behaviour could be seen in the case of some proteins bearing mutations in 
position 121, which afforded opposite enantioselectivities when pure protein was used instead 
of the immobilized form. The most striking examples are the Sav mutants bearing the K121G 
mutation (Table 8, entries 8-9), which invert the enantioselectivity in combination with [η6-
(p-cymene)Ru(Biot-p-L)Cl]. It is tempting to speculate that the presence of the sepharose 
perturbs the spatial arrangement of the bulky [η6-(p-cymene)Ru(Biot-p-L)Cl] within these 
mutants. These results also implicate the residue 121 in the enantioselection process. 
Table 8. Selected results for the designed optimization of the reduction of ketones 2 and 6 in the presence of 
immobilized- and purified artificial metalloenzymes [η6-(arene)Ru(Biot-p-L)Cl] ⊂ Sav mutant. 
ee (conv.) (%) 
Entry η6-(arene) Sav isoform Substrate Immobilized Sav 
(from cell extract) 
Pure non-
immobilized Sav 
1 p-cymene L124V 2 83 (90) 91 (96) 
2 benzene S112A-K121N 2 -55 (99) -75 (98) 
3 benzene S112K-L124H 2 -59 (64) -65 (94) 
4 benzene K121R 2 -64 (96) -68 (95) 
5 p-cymene S112A-K121T 6 82 (84) 88 (99) 
6 benzene S112A-K121W 6 80 (86) 84 (99) 
7 benzene S112A-K121N 6 -62 (95) -72 (100) 
8 p-cymene S112A-K121G 2 -43 (97) 38 (66) 
9 p-cymene K121G 6 -31 (73) 23 (20) 
10 p-cymene S112K-K121C 2 -11 (91) 41 (68) 
  
 The reconstructed evolutionary path of the best (R)- and (S)-selective hybrid catalysts for 
the reduction of 4-phenyl-2-butanone 6 is sketched in Figure 7. It is interesting to note that the 
most selective artificial enzymes identified for this dialkyl ketone substrate ([η6-(p-
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cymene)Ru(Biot-p-L)Cl] ⊂ S112A-K121T Sav and ([η6-(benzene)Ru(Biot-p-L)Cl] ⊂ 
S112A-K121N Sav) are reached by an evolutionary path involving a combination of two 
poorly adapted mutations that would not normally be selected individually. Screening for 
enantioselectivity likely optimizes second coordination sphere interactions between substrate 
and protein, exerting an evolutionary pressure toward substrate specialization. 
 
Figure 7. Reconstructed evolutionary path of the best (R)- and (S)-selective immobilized hybrid catalysts for the 
reduction of 4-phenyl-2-butanone 6. Only the mutations present in the best double mutants are listed. The results 
obtained with the best purified double mutants are also shown. 
 The most efficient protein–Ru complexes were subsequently evaluated with the 
representative substrates 2-8. Using the [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ S112A-K121T 
Sav combination, the aliphatic ketones 7 and 8 were reduced with good enantioselectivities 
(ee’s up to 90% (R) for substrate 7 and 46% (R) for substrate 8, Table 9, entries 1-2). A very 
surprising result was obtained for substrate 8 with the (S)-selective artificial enzyme [η6-
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(benzene)Ru(Biot-p-L)Cl] ⊂ S112A-K121N Sav, which afforded an unexpectedly high (R)-
selectivity in this case (Table 9, entry 3). As expected, the deactivated p-methylacetophenone 
3 afforded the highest ee with the best artificial metalloenzyme identified for the aromatic 
substrates, [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ L124V Sav (Table 9, entry 4). 
 Furthermore, using [η6-(benzene)Ru(Biot-p-L)Cl] ⊂ S112A-K121N Sav, which is the 
most (S)-selective combination identified during the second round of screening with p-
bromoacetophenone 2, the aromatic ketones α-tetralone 4 and 2-acetylpyridine 5 were both 
reduced with 92% (S) (Table 9, entries 5-6). The designed evolution protocol allows the (S)-
selectivity for the reduction of aromatic substrates to be increased from 70% to 92% for 
substrate 5.  
 Interestingly, while methyl alkyl and methyl aryl ketones afford good levels of conversion 
and selectivity, ketones 4 and 8, bearing a longer alkyl group give comparatively modest 
conversions (Table 9, entries 2 and 6-7), suggesting that such artificial metalloenzymes will 
have to be further evolved to display high substrate specificity. This specific behaviour is 
similar to yeast alcohol dehydrogenase, which in general only accepts aldehydes and methyl 
ketones as substrates.  
Table 9. Selected results for the transfer hydrogenation of representative ketones 2-8 with purified homogeneous 
(R)- and (S)-selective artificial metalloenzymes [η6-(arene)Ru(Biot-p-L)Cl] ⊂ Sav mutant, identified during the 
designed optimization step. 
Entry η6-(arene) Sav isoform Substrate Conv. (%) ee (%) 
1 p-cymene S112A-K121T 7 100 90 (R) 
2 p-cymene S112A-K121T 8 50 46 (R) 
3 benzene S112A-K121N 8 63 80 (R) 
4 p-cymene L124V 3 97 96 (R) 
5 benzene S112A-K121N 5 100 92 (S) 
6 benzene S112A-K121N 4 54 92 (S) 
7 p-cymene L124V 4 20 87 (R) 
 
 In an attempt to further optimize these results, we combined the best Sav isoforms 
identified during the designed evolution step (S112A-K121T and L124 Sav) with the P64G 
mutation, previously identified as drastically improving the (R)-selectivity (Section 1.1 and 
Table 10, entries 1-2). While no triple mutant P64G-S112A-K121T Sav could be produced, 
  
 
84 
the double mutant P64G-L124V Sav afforded high production levels and could be easily 
purified in milligram quantities. Its evaluation in combination with [η6-(p-cymene)Ru(Biot-p-
L)Cl] for the transfer hydrogenation of aromatic substrates afforded the highest levels of 
selectivity obtained with the artificial metalloenzymes (Table 10, entries 5-6). 
Table 10. Comparison of the results obtained with purified homogeneous Sav isoforms bearing P64G and / or 
L124V simple or double mutation for the transfer hydrogenation reaction. 
Entry η6-(arene) Sav isoform Substrate Conv. (%) ee (%) 
1 p-cymene P64G 2 97 89 (R) 
2 p-cymene P64G 3 92 94 (R) 
3 p-cymene L124V 2 96 91 (R) 
4 p-cymene L124V 3 97 96 (R) 
5 p-cymene P64G-L124V 2 96 94 (R) 
6 p-cymene P64G-L124V 3 98 98 (R) 
 
1.4 Concluding Remarks 
In summary, identification of (R)- and (S)-selective artificial metalloenzymes by a 
chemogenetic optimization procedure and the information provided by the structural 
characterization of [η6-(benzene)Ru(Biot-p-L)Cl] ⊂ S112K Sav has allowed us to implement 
a designed evolution protocol for the optimization of artificial transfer hydrogenases. The 
method is based on the combination between rational and combinatorial modifications, i.e. the 
mutation sites can be identified from the X-ray structure and the most efficient residues are 
selected after screening of the enzyme variants obtained by saturation mutagenesis. 
 A straightforward optimization step, performed on crude cellular extracts, allowed the 
discovery of [η6-(p-cymene)Ru(Biot-p-L)Cl] ⊂ S112A-K121T Sav for the enantioselective 
reduction of dialkyl ketones. While a single point mutation is sufficient to generate selective 
catalysts for the aromatic ketones (>90% ee), double mutants obtained by the designed 
evolution protocol are required to identify hybrid catalysts for the reduction of dialkyl 
substrates (up to 90% (R)). 
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2 Sulfoxidation 
2.1 Hybrid Catalysts Based on the Biotin-Streptavidin System  
Among the metal catalysts for sulfide oxidations, titanium-based complexes are the most 
famous and have found the most applications in industry.103 However, these systems require 
careful control of the amount of water in the reaction and thus are difficult to use for the 
construction of artificial metalloenzymes.  
 Salen-based complexes form another class of catalysts that has received considerable 
attention in the context of catalytic oxidation. Although their application in asymmetric 
sulfoxidation is limited, manganese- and chromium-salen derivatives are water compatible 
and have already been used in the context of artificial metalloenzymes as mimics of heme, the 
native co-factor of myoglobin.150,156  
 Inspired by these systems, we envisaged the creation of streptavidin-based artificial 
metalloenzymes for sulfoxidation reactions using achiral biotinylated Mn-salen complexes. 
Our choice was also motivated by the proposed mechanism of the oxidation reactions 
catalyzed by Mn- or Cr-complexes, which does not require binding of the substrate to the 
metal (see Chapter 1, Section 2.2.1.2). Hence, the chiral environment provided by the protein 
could have a determinant influence on the transition state. 
 For this purpose, four biotinylated Schiff base tetradentate ligands have been synthesised 
in collaboration with Miss Déborah Mathis (diploma student at the University of Neuchâtel) 
and their Mn complexes formed in situ were tested for activity in the sulfoxidation of 
thioanisole.  
2.1.1 Biotinylated Salen Ligands 
The biotinylated ligands were designed to offer a large structural diversity to maximize the 
possible interactions upon incorporation into Sav. The ligand type (aromatic or aliphatic 
imines), the biotin anchor position (on the diimine backbone or on the 2-
hydroxybenzaldehyde moiety), and the spacer between the biotin and the coordinating moiety 
were varied and the four achiral salen ligands Sal-1 – Sal-4 were synthesized (Scheme 7). 
 The ligands were prepared by condensation of the appropriate diamine with the 
corresponding 2-hydroxybenzaldehydes. 3,5-Di-tert-butyl-2-hydroxybenzaldehyde was used 
to form the symmetric diimines Sal-1, Sal-3 and Sal-4 and the biotin anchor was attached to 
the diamine component before (Sal-1) or after Schiff base formation (Sal-3, Sal-4). The non-
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symmetric diimine Sal-2 was obtained in modest yield mixing ethylenediamine, 3,5-di-tert-
butyl-2-hydroxybenzaldehyde and the aldehyde bearing the biotin anchor. The complete 
description of these syntheses can be found in Chapter 4, Section 4. 
 
Scheme 7. Biotinylated salen ligands Sal-1 – Sal-4 used in this study. 
2.1.2 Activity of the Manganese-Salen Complexes 
The Mn complexes of Sal-1 – Sal-4, abbreviated hereafter Sal-X, were evaluated for the 
sulfoxidation of thioanisole 9 (Scheme 8). Except for Mn-Sal-4, synthesised by treatment 
with manganese acetate, Mn(OAc)2·4H2O, followed by ligand exchange with NaCl 
(replacement of acetate by the chloride ion) and purification on silica gel, the other Mn 
complexes were prepared in situ by reaction with Mn(OAc)2·4H2O.  
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Scheme 8. Sulfoxidation of thioanisole 9 catalyzed by Mn-Sal-1 – Mn-Sal-4.  
 Several oxidants have been reported to perform the oxidation of sulfides catalyzed by Mn-
salen complexes. One of the problems associated with the reaction is the uncatalyzed 
oxidation (background reaction) leading to racemic sulfoxides. Therefore, before performing 
the activity tests for the new complexes, we evaluated the extent of the background reaction 
for the sulfoxidation of thioanisole 9 in water. While NaOCl, NaIO4 and PhI(OAc)2 were 
found to be very powerful oxidants in the absence of catalyst (Table 11, entries 1-3), PhIO 
was not suitable for oxidation in water because of its lack of solubility (Table 11, entry 4). 
Hydrogen peroxide (H2O2) was therefore chosen as the most appropriate reagent for future 
experiments (Table 11, entry 5). 
Table 11. Extent of the background reaction using different oxidants and activity of the Mn-Sal-X complexes for 
the sulfoxidation of thioanisole.a 
Entry Catalyst Oxidant Solvent Conv. (%) 
1 - NaOCl H2O 89 
2 - NaIO4 H2O 84 
3b - PhI(OAc)2 H2O 80 
4b - PhIO H2O 10 
5 - H2O2 H2O 10 
6c Mn-Sal-1 H2O2 H2O 44 
7c Mn-Sal-2 H2O2 H2O 38 
8c Mn-Sal-3 H2O2 H2O 19 
9 Mn-Sal-4 H2O2 H2O 10 
10 Mn-Sal-4 H2O2 H2O / EtOH 1 / 1 50 
a Reaction conditions: 1-1.5% DMF in H2O; thioanisole 9 0.01 M; Mn 2% (if required); oxidant 1 eq.; room 
temperature; 4 h. 
b 1% DMF and 4% MeOH in H2O 
c
 Thioanisole 0.005 M. 
 In combination with H2O2, the Mn-Sal-X complexes showed modest activities (Table 11, 
entries 6-9). Since these compounds were poorly soluble in water, the experiments were 
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repeated in a H2O / EtOH 1 / 1 mixture, thus yielding reasonable activities (Table 11, entry 
10). Reasoning that incorporation into Sav would solve the problem of solubility, we 
proceeded to testing these catalysts in the presence of host protein. 
2.1.3 Sulfoxidation Tests in the Presence of Streptavidin 
The four biotinylated Mn complexes were tested in the presence of several Sav isoforms and 
the best results are listed in Table 12. The choice of the Sav mutants was based exclusively on 
their availability in the laboratory. 
 A slight decrease in conversion was obtained with the catalysts in the presence of Sav, 
except for Mn-Sal-4, which was more active when incorporated into Sav. It is known that 
addition of coordinating ligands such as imidazole or pyridines in the axial position of the 
metal-complex can be beneficial for the Mn-catalyzed reactions with H2O2.188,189 However, 
the activities of the biotinylated catalysts remained low, even upon addition of such ligands to 
the reaction mixture (Table 12, entries 7-8). Very modest enantioselectivities were obtained 
(maximum 13% ee (R), Table 12, entry 2).  
Table 12. Selected results obtained for the sulfoxidation of thioanisole with Mn-Sal-X in presence of Sav.a 
Entry Sav mutant Complex Additive Conv. (%) ee (%) 
1 S112D Sav Mn-Sal-1 - 30 1 (S) 
2 S112D Sav Mn-Sal-2 - 32 13 (R) 
3 S112D Sav Mn-Sal-3 - 3 0 
4 S112D Sav Mn-Sal-4 - 25 5 (S) 
5b WT Sav Mn-Sal-4 - 21 6 (R) 
6b S112G Sav Mn-Sal-4 - 34 11 (S) 
7 S112D Sav Mn-Sal-2 pyridine-N-oxide 36 13 (R) 
8 S112D Sav Mn-Sal-2 N-methylimidazole 35 11 (R) 
a
 Reaction conditions: 1.5% DMF in H2O; Sav 0.00003 M; Mn-Sal-X 0.0001 M; thioanisole 9 0.005 M; H2O2 
0.005 M; additive 0.0002 M; room temperature; 4 h. 
b Thioanisole 0.01 M; H2O2 0.01 M. 
 In this context, we reasoned that the Mn-based complexes are maybe not very appropriate 
for creating Sav-based artificial metalloenzymes, as their activity under the required reaction 
conditions is very modest. In our search for active catalysts for sulfoxidation in water, we 
turned our attention towards other metal-based oxidation systems. 
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2.2 Incorporation of the Vanadyl Ion into Streptavidin 
2.2.1 Preliminary Tests: Vanadium-Salen Complexes 
Vanadium-salen systems have been shown to catalyze sulfoxidation reactions in the presence 
of cumyl hydroperoxide.87 In addition, sulfoxidations with vanadium complexes have been 
reported using tridentate Schiff base ligands with H2O2, suggesting that the catalytic system is 
active in the presence of water.111 Moreover, the peroxidase activity of vanadium-containing 
enzymes has been studied in detail, showing that vanadium bound to ligands with O- and N-
donors can catalyze oxygen transfer in water using peroxides as stoichiometric oxidants.190 
 In the light of these examples, we considered the creation of artificial metalloenzymes 
using the biotinylated Sal-X ligands in conjunction with vanadium. Several Sav mutants were 
employed in this preliminary test. To our satisfaction, oxidation of thioanisole 9 with the 
salophen derivative V-Sal-1 in the presence of S112D Sav and tert-butyl hydroperoxide (t-
BuOOH) as stoichiometric oxidant afforded methyl-phenylsulfoxide in 26% ee (R) (Table 13, 
entry 1). The four biotinylated V complexes, formed in situ by mixing the appropriate 
biotinylated ligand with vanadyl acetylacetonate, VO(acac)2, in organic solvent, afforded 
similar results in the presence of S112D, S112V or S112T Sav mutants (Scheme 9 and Table 
13, entries 1-6). 
 
Scheme 9. Sulfoxidation of thioanisole 9 in the presence of Sav, V-Sal-X and t-BuOOH. 
 It is interesting to note that, irrespectively of the Sav mutant or of the biotinylated ligand 
used, the (R) enantiomer is always obtained (Table 13, entries 1-6). Moreover, the variation in 
ee is very small (within experimental error). This result is quite surprising, since previous 
results obtained in hydrogenation175 and transfer hydrogenation reactions (Section 1 of this 
chapter) have shown that chemical diversity is associated with diversity in selectivity. 
Consequently, we envisaged the possibility that the V complexes dissociate in the presence of 
streptavidin, to form the same catalytic species in all the cases. 
 To test this hypothesis, we investigated the sulfoxidation of thioanisole with VO(acac)2 
incorporated into Sav in the absence of biotinylated ligand, using t-BuOOH as the 
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stoichiometric oxidant. Indeed, the reaction proceeded in an enantioselective manner (Table 
13, entries 7-8). Comparable results were obtained when VOSO4 was used, in which the 
vanadium moiety is devoid of chelating organic ligands (Table 13, entry 9). Hence, we 
hypothesized that the species interacting with Sav is an aqueous form of the vanadyl ion, 
[VO]2+. WT Sav afforded similar results (Table 13, entry 10). In the absence of protein, the 
racemic sulfoxide was obtained with reasonable conversion (Table 13, entry 11). 
Table 13. Selected results obtained for the sulfoxidation of thioanisole in the presence of Sav mutant, V-Sal-X 
and t-BuOOH.a  
Entry V complex Sav mutant Conv. (%) ee (%) 
1 V-Sal-1 S112D Sav 80 26 (R) 
2 V-Sal-1 S112V Sav 98 34 (R) 
3 V-Sal-2 S112D Sav 98 29 (R) 
4 V-Sal-3 S112V Sav 100 32 (R) 
5 V-Sal-4 S112D Sav 91 35 (R) 
6 V-Sal-4 S112T Sav 91 31 (R) 
7 VO(acac)2 S112D Sav 99 34 (R) 
8 VO(acac)2 S112V Sav 100 35 (R) 
9 VOSO4 S112V Sav 100 40 (R) 
10 VOSO4 WT Sav 98 36 (R) 
11 VOSO4 - 88 - 
a
 Reaction conditions: 1% DMF and 1.3% EtOH in H2O; Sav 0.0001 M, V 0.0002 M, thioanisole 0.01 M, t-
BuOOH 0.05 M, room temperature, 4 h. 
2.2.2 Vanadyl Ion as Biotin Mimic 
Two possibilities could be envisaged for the association of the vanadyl ion to streptavidin: 
non-specific binding to coordinating residues at the surface of the protein (e.g. glutamic or 
aspartic acid) or specific incorporation into a suitable binding site.  
 In this context, we reasoned that such a small polar coordination compound could be 
incorporated with reasonable affinity inside the biotin binding pocket of streptavidin. Indeed, 
besides biotin, the deep cavity of Sav can bind, albeit with significantly reduced affinity, a 
variety of ligands, including HABA, ANS, different oligopeptides etc.164,168,169,174 In apo-
streptavidin (Sav devoid of biotin), several water molecules occupy the binding site and their 
positioning is very similar to the shape of the biotin molecule. This network of water 
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molecules is displaced upon biotin binding.172,173 Therefore, we envisaged that a hydrated 
vanadyl ion could interact with the biotin-binding residues via hydrogen bonds (Scheme 10). 
Another option for specific vanadyl binding to streptavidin would be interactions with 
coordinating residues via first coordination sphere contacts. 
 In terms of enantioselection, binding of the catalytically active vanadyl ion to the biotin-
binding pocket of streptavidin could provide an asymmetric environment for the approach of 
the substrate during the sulfoxidation process. In addition, the presence of hydrophobic 
residues may favour substrate accumulation within the cavity, resulting in increased turnover 
rates for the catalyzed reaction (Scheme 10).  
 
Scheme 10. Schematic representation of possible interactions during the sulfoxidation of thioanisole catalyzed 
by vanadyl incorporated into streptavidin. 
 Having discovered a promising system for the enantioselective oxidation of sulfides, we 
proceeded with a systematic study to identify the best conditions and to optimize the 
selectivity of this new artificial metalloenzyme.  
2.2.3 Optimization of the Reaction Conditions  
With the aim of identifying suitable reaction conditions, thioanisole 9 was selected as a model 
substrate for the enantioselective sulfoxidation using a V precursor in conjunction with Sav. 
The influence of several parameters (pH, V source, oxidant, V / Sav ratio) on the selectivity 
and activity of the catalyst was tested. The reactions were performed at 0.01 M substrate 
concentration for 4 h – in most of the cases no further conversion was observed after this time 
– and the occurrence of minimal background reaction – non-catalytic oxidation performed by 
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t-BuOOH – was checked. Very little overoxidation to the corresponding sulfone could be 
detected by HPLC (< 2%). 
2.2.3.1 pH and Buffer System 
The reaction of the vanadyl ion, [VO]2+, with hydroperoxides is known to be pH-
dependent.191 Low pH is usually required for the oxidation to take place. When VOSO4 in the 
presence of WT Sav was used with t-BuOOH for the sulfoxidation of thioanisole, high 
activities were obtained at acidic to neutral pH (pH range 3-7), while a decrease in selectivity 
was observed above pH 3 (Figure 8). At this pH, the major species present in an aqueous 
0.0001 M vanadyl solution is [VO(H2O)5]2+.190 In this first screen, a small excess of Sav 
binding sites vs. V was employed (1.2 vs. 1). 
 
Figure 8. pH-dependence profile of the activity () and of the selectivity (•) obtained for the sulfoxidation of 
thioanisole with VOSO4 in conjunction with WT Sav. For comparison, the activity of free VOSO4 (♦) is 
represented by the dotted line. Reaction conditions: 2.3% EtOH; WT Sav 0.00003 M, VOSO4 0.0001 M, 
thioanisole 0.01 M, t-BuOOH 0.05 M; room temperature; 4 h; pH of the solutions adjusted with HCl or NaOH. 
 Next, we studied the influence of the buffer on the activity and the selectivity of the 
asymmetric sulfoxidation reaction. Different buffer systems around pH 3 were tested, and the 
best result was obtained using HCl / KCl buffer (buffering range 1.0-2.2)192 at 0.05 M and pH 
2.2 (Table 14). 
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Table 14. Influence of the buffer system on the activity and selectivity for the sulfoxidation of thioanisole by 
VOSO4 in conjunction with WT Sav.a 
Entry Buffer system pH Conv. (%) ee (%) 
1 HCl / KCl 2.2 77 33 (R) 
2 Citric acid / Sodium citrate 3 4 0 
3 Glycine / HCl 3 90 28 (R) 
4 Phtalic acid / Potassium phthalate 3 84 7 (R) 
5 Formic acid / Sodium formate 3 92 26 (R) 
6 Acetic acid / Sodium acetate 3.5 94 27 (R) 
7 HCl / KClb 2.2 82 35 (R) 
a
 Reaction conditions: 2.3% EtOH in 0.1 M buffer; WT Sav 0.00003 M; VOSO4 0.0001 M; thioanisole 0.01 M; 
t-BuOOH 0.05 M; room temperature; 4 h. 
b
 Buffer at 0.05 M. 
2.2.3.2 Vanadium / Streptavidin Ratio 
To gain some insight into the stoichiometry of vanadyl-binding to streptavidin, we studied the 
variation of the enantioselectivity as a function of the V / WT Sav binding site ratio. 
Increasing the number of V equivalents vs. Sav binding sites leads to a decrease in the ee 
value (Figure 9). Interestingly, the ee is not constant when an excess of binding sites vs. V is 
used (V / WT Sav binding sites ratio < 1), suggesting that not all the V-catalyst is 
incorporated into the Sav binding sites under these conditions. 
 
Figure 9. Variation of the selectivity for the sulfoxidation of thioanisole in function of the V / WT Sav binding 
sites ratio. Reaction conditions: 2.3% EtOH in HCl / KCl 0.05 M buffer at pH 2.2; WT Sav variable 
concentration; VOSO4 0.0002 M, thioanisole 0.01 M, t-BuOOH 0.05 M; room temperature; 4 h. 
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 Moreover, variation of the catalyst loading from 1% to 3%, while keeping the V / WT Sav 
binding sites ratio constant at 0.5 / 1 also affords a modest variation in ee (Table 15).  
Table 15. Influence of the catalyst concentration on the activity and selectivity for the sulfoxidation of 
thioanisole by VOSO4 in conjunction with WT Sav.a  
Entry V (mole %) Conv. (%) ee (%) 
1 1 % 91 41 (R) 
2 2 % 94 46 (R) 
3 3 % 98 51 (R) 
a
 Reaction conditions: 2.3% EtOH in HCl / KCl 0.05 M buffer at pH 2.2; VOSO4 / WT Sav monomer ratio 0.5 / 
1; thioanisole 0.01 M; t-BuOOH 0.05 M; room temperature; 4 h. 
 These results suggest that the enantioselectivity strongly depends on the concentration of 
both vanadium and streptavidin in the reaction mixture. Unlike in the case of biotin, the lower 
affinity of the vanadyl ion for Sav probably leads to partial formation of the artificial enzyme. 
At higher concentrations of the two species, the equilibrium is displaced towards vanadyl 
incorporation into Sav, thus leading to higher ee’s.   
2.2.3.3 Vanadium- and Oxygen Source 
The influence of the V form on the reaction outcome was tested using four vanadyl 
precursors, bearing different ligands and the V atom in different oxidation states. VIVO(acac)2, 
VIVOSO4, VVO(Oi-Pr)3 and Na3VVO4 were used as catalyst precursors. The results obtained 
were similar (Table 16 entries 1-4), confirming our initial hypothesis that the catalytic species 
is the same, irrespective of the V precursor. Based on this observation and considering the 
speciation of vanadyl ions in acidic media,190 we suggest that the V species interacting with 
Sav is the pentahydrated vanadyl ion, [VO(H2O)5]2+. 
 During the reaction, the oxidant binds to vanadium, forming a V-peroxo complex.77,193 
The importance of the nature of the hydroperoxide in the selectivity of an asymmetric reaction 
has been pointed out and the results may be associated with the steric effect of the alkyl or 
aryl groups.194 We reasoned that changing the oxidant might change the interaction of the 
peroxo complex with the protein or the substrate, thus influencing the selectivity. We observe 
a drop in both conversion and ee when changing the oxidant to hydrogen peroxide (HOOH), 
while cumyl hydroperoxide (cumylOOH) gives a slight inversion of selectivity for the 
oxidation of thioanisole (Table 16 entries 5-6). 
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Table 16. Influence of the vanadium source and of the oxidant on the activity and selectivity of the V-containing 
Sav in the sulfoxidation reaction of thioanisole.a  
Entry Vanadium source Oxydant Conv. (%) ee (%) 
1 VOSO4 t-BuOOH 94 46 (R) 
2 VO(acac)2 t-BuOOH 99 46 (R) 
3 VO(Oi-Pr)3 t-BuOOH 99 46 (R) 
4 Na3VO4 t-BuOOH 92 46 (R) 
5 VOSO4 HOOHb 39 0 
6 VOSO4 cumylOOHb 82 15 (S) 
a
 Reaction conditions: 2.3% EtOH in HCl / KCl 0.05 M buffer at pH 2.2; WT Sav 0.0001 M; V 0.0002 M; 
thioanisole 0.01 M; t-BuOOH 0.05 M; room temperature; 4 h. 
b Oxidant 0.01 M (to suppress the background reaction). 
2.2.4 Scope of the Artificial Peroxidases 
Under the previously optimized conditions using 2 mol % V and 1 mol % tetrameric WT Sav, 
the sulfoxidation of thioanisole 9 afforded the corresponding sulfoxide in 94% conversion and 
46% ee (R) (Table 17, entry 1). In the absence of V, very little conversion was observed, 
while the activity of the Sav-free catalyst was only modest (Table 17, entries 2-3). 
 To investigate the substrate scope of the new artificial metalloenzyme (abbreviated 
hereafter [VO]2+ ⊂ WT Sav), we tested prochiral sulfides 10-15 (Scheme 11), which are 
typical substrates for homogeneous sulfoxidation reactions.117 Dialkyl sulfides 14 and 15 are 
particularly interesting, as the classic methods are usually limited to alkyl aryl sulfides.117 
 
Scheme 11. Enantioselective sulfoxidation of prochiral sulfides 9-15 with the V-dependent artificial peroxidase. 
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 For the aromatic sulfides, the sulfoxidation proceeds with high enantioselectivities (Table 
17, entries 4-7). It is interesting to note that increasing the steric bulk of the aromatic moiety 
of the sulfide leads to an increase in selectivity: up to 93% ee for the sulfoxidation of methyl-
2-naphthylsulfide 12. However, the limited solubility of the substrate hampers complete 
conversion. Oxidation of dialkyl sulfides produces the corresponding sulfoxides with 
reasonable enantioselectivity (up to 86 % ee, Table 17, entries 8-9). For all substrates, very 
little overoxidation to the corresponding sulfone could be detected by HPLC (< 2%). 
Table 17. Conversions and selectivities obtained in the [VO]2+ ⊂ WT Sav-catalyzed sulfoxidation of substrates 
9-15.a 
Entry Catalyst Substrate Conv. (%) ee (%) 
1 [VO]2+ ⊂ WT Sav 9 94 46 (R) 
2 [VO]2+ 9 55 0 
3 WT Sav 9 7 4 (R) 
4 [VO]2+ ⊂ WT Sav 10 96 87 (R) 
5 [VO]2+ ⊂ WT Sav 11 100 90 (R) 
6 [VO]2+ ⊂ WT Sav 12 53 93 (R) 
7 [VO]2+ ⊂ WT Sav 13 96 90 (R) 
8 [VO]2+ ⊂ WT Sav 14 100 73 (R) 
9 [VO]2+ ⊂ WT Sav 15 61 86 (R) 
a
 Reaction conditions: 2.3% EtOH in HCl / KCl 0.05 M buffer at pH 2.2; WT Sav 0.0001 M; VOSO4 0.0002 M; 
substrate 0.01 M; t-BuOOH 0.05 M; room temperature; 4 h. 
2.2.5 Exploring the Catalytic System 
 In the context of creation of catalytic activity from a non-catalytic protein, incorporation 
of the vanadyl ion into WT Sav appeared as an attractive idea for the development of new 
metalloenzymes. However, several questions arose regarding this system. Among these, our 
most important concern was: how does [VO(H2O)5]2+ interact with Sav (first or second 
coordination sphere contacts are possible) and how specific is this interaction? 
 First, we proceeded to verify the initial hypothesis regarding the incorporation of the 
vanadyl ion into the biotin-binding pocket. Upon addition to the reaction mixture of 4.25 
equivalents of biotin vs. tetrameric WT Sav, the sulfoxidation of p-methoxythioanisole 11 (the 
most active and selective substrate, Table 18, entry 1) afforded racemic product (Table 18, 
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entry 2). This result suggests that the reaction takes place in the proximity of the biotin-
binding site.  
 Moreover, substituting streptavidin by avidin or bovine serum albumin (BSA) respectively 
afforded sulfoxidation products with very modest enantioselectivities (Table 18, entries 3-4). 
This suggests that Sav provides a specific binding site for the pentahydrated vanadyl ion. 
Table 18. Catalysis results suggesting that the biotin-binding pocket of streptavidin specifically binds the 
vanadyl ion.a 
Entry Protein Conv. (%) ee (%) 
1 WT Sav 100 90 (R) 
2 Biotin (4.25 eq.) ⊂ WT Sav  96 0 
3 Avidin 78 7 (R) 
4 BSA 100 0 
a
 Reaction conditions: 2.3% EtOH in HCl / KCl 0.05 M buffer at pH 2.2; protein 0.0001 M; VOSO4 0.0002 M; 
p-methoxythioanisole 11 0.01 M; t-BuOOH 0.05 M; room temperature; 4 h. 
 Next, we proceeded to a closer investigation of the artificial enzyme, with the aim of 
elucidating critical aspects of the catalytic system: the coordination sphere around vanadium, 
the localization and geometry of the active site, the reaction kinetics and the binding affinity 
of the vanadyl ion to streptavidin. 
2.2.5.1 EPR Studies 
Electron paramagnetic resonance (EPR) spectroscopy is a technique for studying chemical 
species that have one or more unpaired electrons. The vanadyl ion – [VIVO]2+ – exhibits sharp 
eight-line EPR spectra, which are sensitive to the ligand environment around the [VO]2+ 
group.This ion has therefore been used as a probe of the metal-binding sites of several 
proteins.195-197 A marked pH-dependence of the EPR spectra is observed, due to different 
equilibria of [VO]2+ in water.198   
 For the investigation of the coordination environment around [VO]2+ ⊂ WT Sav, EPR 
experiments were performed with the help of Mrs. Carole Duboc at the University of 
Grenoble (FR), using VOSO4 in the presence of WT Sav. At neutral pH, Sav-free and Sav-
containing aqueous solutions of VOSO4 show no EPR signal. This is not surprising, since it 
was shown that EPR inactive, probably polynuclear vanadium hydroxide species such as 
VO(OH)2 form above pH 4.5.198  
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 EPR experiments performed with [VO]2+ ⊂ WT Sav at pH 2.2 (HCl / KCl buffer) yield a 
spectrum very similar to that of [VO(H2O)5]2+ (Figure 10).198 Frozen solutions of 
[VO(H2O)5]2+ display powder pattern eight-line EPR spectra dominated by the hyperfine 
coupling of the vanadium ion (S = 1/2; I = 7/2). The spin Hamiltonian parameters used to 
simulate the experimental data are analogous to those found previously for [VO(H2O)5]2+ 
(these calculations were performed by Mrs. Duboc),199 suggesting that the first coordination 
sphere around vanadium does not change upon incorporation into Sav. Therefore, we 
hypothesize that [VO(H2O)5]2+ interacts only via second coordination sphere contacts with the 
host protein. 
 
Figure 10. Frozen aqueous solution X-band EPR spectra (straight line) of VOSO4 (A) and VOSO4 ⊂ WT Sav 
(B) in a 0.05 M HCl / KCl buffer solution at pH = 2.2. Experiment conditions: VOSO4 0.0002 M (A) and (B) 
and tetrameric WT Sav 0.0001 M (B). Powder simulation spectra (dotted line) have been calculated using the 
following EPR spin Hamiltonian parameters: (A) g// = 1.932, g⊥ = 1.978, A// = 183, A⊥ = 70.10-4 cm-1, W// = 22, 
W⊥ = 19 G and (B) g// = 1.933, g⊥ = 1.976, A// = 182, A⊥ = 69.10-4 cm-1, W// = 25, W⊥ = 25 G. 
 In nature, similar examples are provided by molybdate or tungstate anion-binding 
proteins, in which oriented hydrogen bonds provided by the protein play a major role in 
conferring exquisite specificity towards MO42- (M = Mo, W).200,201 Interestingly, the intensity 
of the EPR spectrum in the presence of Sav is noticeably higher than in its absence, 
suggesting a shielding of the vanadium complex within the binding site. 
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2.2.5.2 NMR Studies 
Another spectroscopic technique used for the characterization of vanadium-containing 
compounds is 51V NMR spectroscopy, which has become a routine tool for studying VV 
complexes. By comparison with existing data, this technique can be used to predict the 
coordination environment around vanadium.190 
   a) 
 
   b) 
 
Figure 11. 51V NMR spectra of VVO(Oi-Pr)3 ⊂ S112D Sav in HCl / KCl buffer at 0.05 M and pH 2.2. a) Spectra 
obtained after gradual addition of S112D Sav to a solution of VVO(Oi-Pr)3; the final concentrations of [VO]3+ 
and S112D Sav are indicated in mM; b) Spectra obtained after addition of 4 eq. of biotin vs. tetrameric Sav to the 
previously obtained solutions of VVO(Oi-Pr)3 ⊂ S112D Sav; the final concentrations of [VO]3+, S112D Sav and 
biotin are indicated in mM.  
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 51V NMR spectra were measured with the help of Dr. Julien Furrer at the University of 
Neuchâtel. Using VVO(Oi-Pr)3 in the presence of S112D Sav (this mutant was chosen for 
solubility reasons and affords similar conversion and ee, when compared to WT Sav) in HCl / 
KCl buffer at pH 2.2, a peak at -543 ppm was obtained, which was assigned to the 
[VO(H2O)5]3+ species, by comparison with the spectrum of a Sav-free aqueous VVO(Oi-Pr)3 
solution (Figure 11a). 
 Gradual addition of S112D Sav to a 0.0002 M solution of VVO(Oi-Pr)3 results in 
broadening of the signal and its disappearance starting with 0.15 mM concentration of 
tetrameric Sav (Figure 11a). It is known that the association of the 51V nucleus with a large 
protein can broaden the signal width due to slow tumbling of the complex in a protein 
environment.190 It is tempting to speculate that slow tumbling of [VO(H2O)5]3+ is due to 
association with the protein. However, these results could not be used to study the binding of 
vanadyl to Sav, as no relation could be established between the concentration of S112D Sav 
and the area of the [VO(H2O)5]3+ peak. 
 Interestingly, no significant shift in the 51V signal was observed, suggesting that there are 
no changes in the first coordination sphere of vanadium.  
 Addition of biotin to the previous reaction mixtures was expected to restore the 51V signal, 
as [VO(H2O)5]3+ should be expelled from the binding cavity. Indeed, the 51V signal reappears 
after biotin binding, although the integrated areas of the resulting peaks are much lower than 
before adding the biotin (Figure 11b) and the signal is slightly shifted. As a change in the 
tertiary and quaternary structure of tetrameric Sav occurs after biotin incorporation, binding of 
[VO(H2O)5]3+ to a different location than in apo-Sav is possible. Yet, no clear conclusions can 
be drawn from these experiments. 
2.2.5.3 Localization of the Binding Site: Docking Studies 
In order to gain insight into the localization of [VO(H2O)5]2+ within Sav, docking experiments 
were carried out in collaboration with Dr. Jaroslaw Panek at the University of Ljubljana 
(SLO).  
 Initial structures of streptavidin for the docking and further molecular dynamics modeling 
were based on the X-ray structures of WT Sav crystallized from a low-pH solution202 and 
deposited in the PDB data bank with references 2IZC (apo-Sav at pH = 2.0) and 2IZG (biotin 
⊂ Sav complex at pH = 2.0). The two structures gave essentially the same results during the 
docking procedure. 
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 Structures in which [VO(H2O)5]2+ was docked outside the biotin-binding pocket were 
rejected from further consideration, based on the observation that [VO(H2O)5]2+ in the 
presence of biotin-loaded Sav affords racemic sulfoxidation product. The remaining sets of 
coordinates (with [VO(H2O)5]2+ inside the pocket) differed only slightly in orientation, but not 
position, of the [VO(H2O)5]2+. The lowest energy docked structure was then tested for 
stability by molecular dynamics simulation using the full tetrameric form of Sav. 
 The optimized structure is depicted in Figure 12. As can be appreciated, residues critical 
for biotin binding (i.e. D128, N23, S27 and S45) are also involved in interactions with 
[VO(H2O)5]2+. The pentahydrated vanadyl cation occupies the same position as biotin’s urea 
group and the surrounding water molecules can act like H-donors / acceptors in interactions 
with binding site residues. Most importantly, the D128 residue, widely recognized as the most 
critical residue for biotin-Sav affinity,172,203-205 displays the closest contact to [VO(H2O)5]2+ in 
the docked structure. 
 
Figure 12. Superimposition of the docked structure [VO(H2O)5]2+ (ball-and-stick representation) ⊂ WT Sav 
(monomers A and B, light blue schematic secondary structure) with the structure of biotin ⊂ WT Sav at pH = 2.0 
(PDB reference code 2IZG; biotin: yellow stick, yellow transparent surface; monomers A and B: yellow 
schematic secondary structure). Close lying D128, N23, S27 and S45 residues are highlighted, as well as the 
residue W120 from the monomer B, which closes the biotin-binding site of the subunit A. Two neighbouring 
loops are also highlighted: the flexible L3,4 loop (residues 48-52, green) and the L7,8 loop of monomer B 
(residues 112-121, violet). 
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 Inspection of the docked model also reveals that there is a significant difference in the 
position of the L3,4 loop compared to the biotin ⊂ streptavidin complex. Crystallographic 
studies of biotin ⊂ streptavidin showed that the L3,4 loop (residues 48-52) becomes ordered 
during binding and locks the biotin in the binding site.171,173 In the vanadyl-containing docked 
structure, this loop appears to have an open conformation (Figure 12). No other major 
reorganization of the host protein is observed. 
 It is interesting to note that the L7,8 loop (residues 112-121) of the adjacent monomer B is 
situated in proximity to the vanadyl-binding site and could interact with the incoming 
prochiral sulfide (Figure 12). Residue W120 from this loop, closing the biotin lid of subunit 
A, also displays a close contact with the vanadyl moiety. 
2.2.5.4 Influence of Site-Directed Mutations 
In the absence of the chemical dimension, the optimization of the new system was based 
entirely on genetic modifications of the host protein. It has already been shown that 
introduction of point mutations in an enzyme scaffold can result in increased and even 
inverted enantioselectivity.206,207 
 On the basis of the docking model, several residues were identified as possibly involved 
either in vanadyl binding or in the catalytic reaction. Some of these residues were replaced by 
the small glycine or alanine amino acids, and the effect of these mutations on the reaction 
outcome was tested. Sulfide 11 was chosen as a model substrate, as it is provides the best 
results with WT Sav in terms of conversion and selectivity. In addition, we selected sulfides 9 
and 15 in an attempt to optimize the moderate selectivities observed with these substrates. 
 The residue D128, which displays the closest contact with the vanadyl ion in the docked 
model, appears to be intimately involved in the binding process. The D128A Sav mutant was 
produced in our laboratory by Dr. Marc Creus and tested for the sulfoxidation of substrate 11. 
This experiment yielded racemic product (Table 19, entry 1), thus strongly supporting the 
hypothesis that the active vanadyl moiety is located within the biotin-binding pocket during 
catalysis.  
 To further explore the catalytic system, we reasoned that modifications in the loop regions 
might provide useful information. We focused on modifications in the L3,4 loop, containing 
residue S45, which is also near to [VO(H2O)5]2+ and possibly involved in H-bonds with 
coordinated water molecules. To perturb the loop structure and thus influence vanadyl binding 
and possibly the selectivity of the reaction, we produced a chimaeric Sav, abbreviated 
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Aviloop, in which the L3,4 loop of streptavidin was replaced with that of avidin (residues 38-
45), thus yielding a loop three residues longer than that of the wild-type protein (Figure 13). 
The chimaeric Aviloop retained strong biotin-binding affinity, as previously reported.171 
Despite avidin’s lack of selectivity as host protein, the artificial metalloenzyme [VO]2+ ⊂ 
Aviloop afforded improved selectivities compared to WT Sav, both for aliphatic and for 
aromatic substrates (Table 19, entries 2-3).  
 
Figure 13. Partial amino acid sequence of the chimaeric Aviloop protein; the L3,4 loop of Sav (residues 48-52) 
was replaced with the longer L3,4 loop of avidin (residues 38-45). 
 The small variations in selectivity obtained with Aviloop suggest that the residues of the 
L3,4 loop are not crucial for vanadyl binding. They might interact with the oxidant and / or 
the substrate during catalysis, thus fine-tuning the selectivity of the reaction. However, the 
results obtained prove that the second coordination sphere, provided by close-lying residues, 
influences enantioselectivity. Based on these initial findings, we hypothesize that improved 
artificial enzymes can be evolved by directed evolution, by further mutagenesis of close-lying 
residues and selection of improved variants.  
Table 19. Influence of site-directed mutations on the activity and selectivity of [VO]2+ ⊂ Sav for the 
sulfoxidation reaction of selected substrates.a 
Entry Protein Substrate Conv. (%) ee (%) 
1 D128A Sav 11 97 0 
2 Aviloop 9 100 60 (R) 
3 Aviloop 15 54 90 (R) 
4 T114G Sav 11 100 74 (R) 
5 T115A Sav 11 100 84 (R) 
6 E116A Sav 11 100 74 (R) 
a
 Reaction conditions: 2.3% EtOH in HCl / KCl 0.05 M buffer at pH 2.2; Sav isoform 0.0001 M; VOSO4 0.0002 
M; substrate 0.01 M; t-BuOOH 0.05 M; room temperature; 4 h. 
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 In addition to the L3,4 loop, the L7,8 loop of the adjacent monomer B, situated in 
proximity to the hydrophobic pocket, was also expected to influence catalysis by interacting 
with the incoming substrate. Several Sav isoforms bearing glycine or alanine mutations in the 
L7,8 loop region were tested for enantioselective sulfoxidation. Some positions of the loop 
afforded a decrease in selectivity, suggesting that these positions might indeed interfere with 
the approach of the prochiral sulfide to the catalytic centre (Table 19, entries 4-6). 
2.2.5.5  Kinetic Studies 
Control reactions performed in the absence of Sav showed that free [VO]2+ has a considerably 
lower activity than [VO]2+ ⊂ WT Sav (see Table 17, entries 1-2), indicating that streptavidin 
acts like an accelerating ligand for the sulfoxidation reaction. Kinetic experiments were 
performed in order to determine the extent of this acceleration. 
 To investigate whether the artificial metalloenzyme follows Michaelis-Menten kinetics, 
the initial oxidation rate vs. substrate concentration was determined. As the substrate has poor 
solubility in water, the reactions were carried out using 43% EtOH in 0.05 M HCl / KCl 
buffer at pH 2.2. For solubility reasons, the S112D Sav mutant was used instead of WT Sav 
(and affords similar conversion and ee, when compared to WT Sav). Saturation kinetics could 
not be achieved under these reaction conditions, due to poor substrate solubility (Figure 14). 
 
Figure 14. Initial oxidation rate vs. substrate concentration for VOSO4 in the absence of streptavidin (•), VOSO4 
⊂ Sav () and VOSO4 + (Biotin ⊂ Sav) (▲). Reaction conditions: 57% buffer HCl / KCl 0.05 M at pH 2.2; 43% 
EtOH; S112D Sav 0.0001 M; VOSO4 0.0002 M; p-methoxythioanisole 11; t-BuOOH 0.05 M; room temperature.  
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 Most interestingly, these experiments confirmed that the presence of biotin-free Sav 
modestly accelerates the sulfoxidation rate (vinit([VO]2+ ⊂ WT Sav) / vinit([VO]2+) = 3). In 
contrast, biotin-loaded streptavidin enhances the rate of the [VO]2+-catalyzed sulfoxidation 
very little (vinit([VO]2+ + Biotin ⊂ Sav) / vinit([VO]2+) = 1.5). This observation further supports 
the hypothesis that the oxidation indeed occurs within the biotin binding pocket. The initial 
rate constants determined for a typical reaction (0.01 M p-methoxythioanisole 11) are ki = 2.7 
min-1 (for Sav-incorporated [VO]2+) and kf = 0.8 min-1(for free [VO]2+). 
 It is also noteworthy that the reaction with substrate 11 proceeds with nearly quantitative 
conversion for a range of concentrations (50, 100, 150 eq. p-methoxythioanisole vs. 
vanadium). These results suggest that product inhibition is insignificant under these 
conditions.  
2.2.5.6 Attempts to Determine the Affinity Constant 
Since both free [VO]2+ and [VO]2+ ⊂ Sav catalyze the sulfoxidation reaction, the ratio 
between the two species, established by the affinity constant, determines the total 
enantioselectivity of the reaction. Hence, it is important to know the affinity of the vanadyl 
ion for the biotin-binding pocket.   
 
Figure 15. Variation of the selectivity with the monomeric Sav concentration. Reaction conditions: 2.3% EtOH 
in HCl / KCl 0.05 M buffer at pH 2.2; WT Sav variable concentration, VOSO4 0.0002 M; p-methoxythioanisole 
11 0.01 M; t-BuOOH 0.05 M; room temperature; 4 h. 
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 In a first approach, we studied the influence of the Sav concentration on the 
enantioselectivity of the reaction, keeping the [VO]2+ concentration fixed at 0.0002 M (thus 
varying the ratio between free [VO]2+ and [VO]2+ ⊂ Sav). Interestingly, the ee reaches a 
saturation point at 90% (R) using [WT Sav monomeric] = 0.0004 M (tetrameric concentration 
0.0001 M), suggesting that maximal incorporation of [VO]2+ into Sav occurs at these 
concentrations of the two species (Figure 15). 
 Based on this dependence of the ee on the ratio between free- and Sav-incorporated 
vanadyl species and considering the kinetic parameters obtained for the [VO]2+- and [VO]2+ ⊂ 
Sav-catalyzed sulfoxidation, we reasoned that we could estimate the affinity constant. For this 
purpose, we performed the previous experiment using the same reaction conditions as for the 
kinetic runs (i.e.  57% buffer HCl / KCl 0.05 M at pH 2.2; 43% EtOH; S112D Sav 0.0001 M; 
VOSO4 0.0002 M; p-methoxythioanisole 11 0.01 M; t-BuOOH 0.05 M) and we obtained a 
maximum selectivity of 78% (R). 
 To determine Ka, the following assumptions were made: 
• only two species containing [VO]2+ are present in the reaction mixture: [VO]2+ and 
[VO]2+ ⊂ Sav; this hypothesis is reasonable, since upon incorporation of biotin, 
[VO]2+ in the presence of Sav follows similar kinetics as free  [VO]2+ (see Figure 14); 
• the intrinsic selectivity of the [VO]2+ ⊂ Sav-catalyzed reaction does not depend on the 
concentration of [VO]2+ ⊂ Sav; we reasoned that this selectivity is equal to the 
“saturation” selectivity, 78% ee (R).  
Table 20. Notations used in equations 1 and 2. 
Term Expression 
free [VO]2+ concentration [VO2+]f 
[VO]2+ ⊂ Sav concentration [VO2+]i 
free Sav concentration [Sav]f 
total Sav concentration c0Sav = [Sav]f + [VO2+]i  
total [VO]2+ concentration c0V = [VO2+]f + [VO2+]i 
rate constant for free [VO]2+ kftotal = kfR + kfS 
rate constant for [VO]2+ ⊂ Sav kitotal = kiR + kiS 
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 Thus, the free [VO]2+ concentration can be expressed as a function of the ratio of R / S 
enantiomers and the rate constants of the reactions catalyzed by free- and Sav-bound [VO]2+ 
in the following manner (the notations used for the different terms is presented in Table 20): 
 
 On the other hand, from the equilibrium constant Ka, the following equation can be 
deduced for the dependence of the free [VO]2+ concentration on the total Sav and [VO]2+  
concentrations: 
   
 Knowing the kinetic parameters kitotal = 2.7 min-1 and kftotal = 0.8 min-1, the total [VO]2+  
concentration (c0V = 0.0002 M) and the dependence of the R / S ratio on the total Sav 
concentration, an algorithm can be used to fit the two equations 1 and 2 that minimizes the 
difference between the two [VO2+]f values while varying the Ka parameter. In this way, a Ka 
value of 1.7⋅104 M-1 was obtained, although significant differences between the experimental 
and the “fitted” ee were observed (Figure 16). Nevertheless, this procedure affords a rough 
estimate of the Ka value. 
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Figure 16. Comparison between experimental (•) and “fitted” ee (), calculated from equations 1 and 2 using Ka 
= 1.7⋅104 M-1. 
2.3 Concluding Remarks 
Incorporation of a vanadyl ion into the biotin-binding pocket of streptavidin affords an 
artificial metalloenzyme for the enantioselective oxidation of prochiral sulfides with good 
enantioselectivities both for dialkyl and alkyl-aryl substrates (up to 93 % ee). 
 Evidence provided by EPR spectroscopy, docking simulations, chemical (i.e. addition of 
biotin) or genetic modification of the host protein suggest that the active pre-catalyst 
[VO(H2O)5]2+ interacts only via second coordination sphere contacts with the biotin-binding 
pocket of streptavidin. 
 Although our efforts to determine the affinity of [VO(H2O)5]2+ for Sav did not succeed, 
catalysis results indicate that the selectivity reaches a maximum at a concentration of ~ 2·10-4 
M of the two species, suggesting that maximum incorporation of [VO(H2O)5]2+ into Sav 
occurs under these conditions.  
 Current efforts aim at elucidating the structure and the mechanism of this artificial 
peroxidase, improving its performance via evolutionary protocols, and investigating the 
crucial aspect of vanadyl and substrate binding.  
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The ex nihilo creation of catalytic activity from a non-catalytic protein scaffold is a very 
challenging task. The design of metalloenzymes is especially difficult, because the 
construction of highly specific binding sites is necessary, tailored in function to the metal ion, 
its oxidation state, preferred geometry and ligand donor set.208,209  
 This study focused on two different strategies for the creation of metalloenzymes: 
introduction of a new metal-binding site within a protein by modifying the protein’s native 
co-factor and exploiting the H-bonding network within the protein’s binding site to 
incorporate a small metal ion. The performance of these enzymes was tested and optimized 
for two different enantioselective reactions: transfer hydrogenation of prochiral ketones and 
sulfide oxidation. 
 In the first case, supramolecular anchoring of carefully designed biotinylated 
organometallic fragments into streptavidin provides facile control over the first coordination 
sphere of the metal through chemical reactions outside the protein. This approach allows 
separate variation and characterization of the metal complex and the protein, followed by 
straightforward combination of the chemical and the genetic moieties. As a consequence, a 
chemogenetic optimization procedure can be easily implemented.  
 Starting from streptavidin-based artificial transfer hydrogenases previously created in our 
laboratory, a round of chemogenetic optimization enabled identification of (R)- and (S)-
selective catalysts for the reduction of acetophenone derivatives. Inspired by the X-ray 
structure of one such (S)-selective variant, we implemented an additional directed evolution 
step that allowed us to further optimize transfer hydrogenases for the reduction of dialkyl 
ketones.   
 The general procedure for designed evolution of the artificial keto-reductase is presented 
in Scheme 1. The activity and selectivity trends of the reaction are ensured by the choice of 
the chemical fragment in a first screening round. Since several interactions are involved in the 
enantioselection mechanism (protein-organometallic fragment and protein-substrate), 
successive rounds of saturation mutagenesis at carefully selected positions of the host protein 
are necessary to fine-tune the selectivity. 
 In this way, artificial transfer hydrogenases for the enantioselective reduction of dialkyl 
ketones were evolved, which optimized second coordination sphere interactions between the 
substrate and the host protein. Such specialized enzymes were obtained from a relatively 
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modest screening effort and via a straightforward protein immobilization step performed on 
crude cellular extracts. 
 
Scheme 1. Designed evolution of an artificial keto-reductase. A search strategy that does not require 
examination of all possibilities is used to accelerate the chemogenetic optimization procedure23.  Rational design 
(choice of mutation sites) and combinatorial methods (structural variation of the chemical component combined 
with saturation mutagenesis) are used to evolve artificial metalloenzymes with the desired properties.   
 Compared to other directed evolution techniques,178 the designed evolution of artificial 
metalloenzymes using chemogenetic tools offers new possibilities for protein engineering. 
Introducing a chemical dimension not only enriches the functionality of the protein sequence 
space to be explored, but also represents a variable with a significant impact on the reaction 
outcome. Variation of the chemical moiety results in a dramatic change in reactivity. Ideally, 
one could envision creating an artificial metalloenzyme for nearly any water compatible 
transition metal-catalyzed reaction,210 thus broadening the scope of enzymatic catalysis. In 
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this spirit, we have envisaged the implementation of more challenging oxidation reactions. 
However, the application of artificial metalloenzymes based on the biotin-streptavidin 
technology in enantioselective sulfoxidation proved to be a difficult task, due to the 
incompatibility of the chosen chemical fragment with the genetic component (i.e. 
streptavidin). 
 A different strategy was therefore developed to address this challenge: the well-tailored H-
bonding network of streptavidin’s deep active site cavity was found to provide a suitable 
binding site for the small hydrated vanadyl ion. The catalytic activity of the metal centre and 
the enantiodiscriminating environment provided by the host protein were exploited to perform 
highly enantioselective oxidations of several prochiral sulfides. This study demonstrates that 
specific metal binding can transform a non-enzymatic protein into an enantioselective 
biocatalyst with synthetic utility and may thus be regarded as an example of functional 
promiscuity.31,32 Moreover, the findings provide insight into how selective enzymes may first 
have evolved in nature from non-catalytic scaffolds.211 
 At this stage, the practical use of artificial metalloenzymes is limited due to the high cost 
of their development and their low activities compared to biocatalysts evolved in nature. 
However, their general scope, as well as the rapid optimization procedure makes their 
application attractive for reactions that are not possible with natural biocatalysts or for 
challenging substrates for homogeneous catalysts. The combination of chemical and genetic 
optimization techniques may result in a rapid expansion of protein functionality and a range 
of novel applications. We therefore believe that hybrid catalysts possess a real potential for 
applications in white biotechnology processes.  
 In addition, the well-defined binding pocket of streptavidin could be exploited to 
incorporate other catalytically active polar coordination compounds to perform 
enantioselective reactions, although the affinity between the catalyst and the protein could 
represent a non-negligible issue. Some studies on the alkene dihydroxylation reaction 
catalyzed by osmium tetroxide have shown promising results in this direction. 
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1 Materials and Reagents 
Solvents were of analytical grade and were purchased from Aldrich, Fluka or Acros and used 
without further purification. Water was purified to milliQ degree of purity. Other chemicals 
were obtained from the following suppliers: 
Table 1. Origin and characteristics of the reagents. 
Reagent Supplier Characteristics 
Acetophenone Fluka ≥ 98% (GC) 
2-Acetylpyridine Fluka ≥ 98% (GC) 
Benzylmethylsulfide Acros 98% 
N-Benzylmaleimide Aldrich 99% 
4-Benzyloxy-2-butanone Fluka ≥ 97% (GC) 
D-Biotin Chanzou 
Huaren 
≥ 99% 
D-Biotin-4-fluorescein Sigma - 
D-Biotin-SepharoseTM CL-4B, 
suspension in TBS buffer pH 7.4,          
0.02% NaN3 
Affiland 4 mg immobilized biotin / mL wet 
gel 
binding capacity: 40 mg / mL wet 
gel 
Boric acid, B(OH)3 Fluka 99.5% 
4-Bromoacetophenone Acros 98% 
tert-Butyl hydroperoxide Lancaster 70% (w / v) aqueous solution 
(7.278 M) 
Cyclohexylmethyl sulfide Alfa Aesar 96% 
Cumyl hydroperoxide Aldrich 80% (techn.) 
3,4-Diaminobenzoic acid Aldrich 97% 
Diethylenetriamine Acros 98.5% 
2,5-Dihydroxybenzaldehyde Aldrich 98% 
3,5-Di-tert-butyl-2-hydroxybenzaldehde Aldrich 99% 
EDC Acros 98% 
Ethylphenylsulfide Acros 97% 
Ethylenediamine Fluka ≥ 99% 
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Reagent Supplier Characteristics 
Guanidinium chloride Merck - 
HOBT Acros 98% 
Hydrogen peroxide,  Sigma 30% (w / w) aqueous solution 
2-Iminobiotin-SepharoseTM 4 Fast Flow, 
suspension in EtOH 20% 
Affiland 1 mg immobilized iminobiotin / 
mL wet gel 
binding capacity: 10 mg / mL wet 
gel 
Iodosylbenzene diacetate Acros 98% 
Lithium aluminium hydride Fluka 97% 
Manganese(II) acetate tetrahydrate, 
Mn(OAc)2·4H2O 
Fluka ≥ 99% 
4-Methoxythioanisole Acros 99% 
Methyl-2-naphtylsulfide Alfa Aesar 98% 
4-Methylacetophenone Acros 95% 
1-Methylimidazole Fluka >99% (GC) 
4-Methylthioanisole Aldrich 99% 
3-morpholino-propanesulfonic acid, 
MOPS 
Fluka ≥ 99.5% 
Palladium on carbon, Pd / C Aldrich 10% Pd w /w 
1-Phenyl-2-butanone Aldrich 98% 
4-Phenyl-2-butanone Aldrich 98% 
Potassium chloride Fluka - 
Pyridine Acros >99% 
Pyridine-N-oxide Aldrich 95% 
Ruthenium chloride, RuCl3, hydrate Umicore 36.55% Ru 
Silica, SiO2 (32-63 60 Å) Brunschwig - 
Sodium azide, NaN3 Aldrich 99% 
Sodium formate, HCOONa Merck 99.5% 
Sodium hypochlorite Acros 5% Cl2 
Sodium orthovanadate Sigma >90% 
Sodium periodate Acros 99% 
  
 
119 
Reagent Supplier Characteristics 
α-Tetralone Aldrich 98% (GC) 
Thioanisole Aldrich 99% (GC) 
Toluene-4-sulfonyl chloride Fluka 99% 
Triethylamine, Et3N Acros 99% 
Trifluoroacetic acid Aldrich 99% 
Vanadium(V) oxytriisopropoxide, 
VO(Oi-Pr)3 
Aldrich - 
Vanadium(IV) oxide sulfate 
pentahydrate, VOSO4·5H2O 
Riedel-de-
Haën 
- 
Vanadium(IV) oxide 
bis(acetylacetonate), VO(acac)2 
Strem 
Chemicals 
98% 
 
Iodosylbenzene (PhIO) was prepared from iodosylbenzene diacetate (PhI(OAc)2) according to 
a published procedure.212 
Protein. Avidin was obtained from Belovo (CH). Bovine serum albumin was obtained from 
Fluka (M~67000, purity >96%). Streptavidin (wild-type and mutants) was prepared by the 
team of biologists in our laboratory according to published results.213 The concentration of 
streptavidin active sites in the cellular extracts, as well as the number of active binding sites in 
purified streptavidin were quantified in 96-well plates using a fluorescence assay (titration 
with biotin-4-fluorescein) adapted from the literature.186 
2 Apparatus 
Liquid chromatography: HPLC. Chiral phase HPLC chromatograms were acquired and 
analyzed on an HP-1100 HPLC apparatus equipped with a UV-Visible diode-array detector 
and a 100-position autosampler. The solvents used (hexane, i-PrOH) were of HPLC-grade. 
The selected chiral columns and the retention times of the products are described in Section 5. 
Gas Chromatography: GC.  Chiral GC chromatograms were acquired and analyzed on a GC 
HP 5890 apparatus using He as a vector gas. The selected chiral columns and the retention 
times of the products are described in Section 5. 
Nuclear Magnetic Resonance: NMR. 1H, 13C and 51V spectra were acquired on a 200 MHz 
(Varian) or on a 400 MHz (Bruker) spectrometer using deuterated chloroform (99.8% D), 
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dimethyl sulfoxide (99.5% D) or methanol (99.8% D) from Cambridge Isotope Laboratories. 
For the 51V spectra, an HCl / KCl buffer at pH 2.2 was used.  
Mass Spectrometry: MS. Mass spectra were recorded using an LCQ-IT (Finnigan) 
spectrometer and an ESI (Electron Spray) or APCI (Atmospheric Pressure Chemical) 
ionisation mode.  
3 Description of Catalytic Experiments 
3.1 Transfer Hydrogenation of Carbonyl Compounds 
The following procedures are described for the catalytic runs from the second round of 
optimization, i.e. the designed evolution step. The catalysts from the first round chemogenetic 
optimization procedure were already described by Dr. Christophe Letondor184 and the reaction 
procedures are similar to those described below for transfer hydrogenation with purified 
protein (in the second screen, the volumes and quantities of the reagents are divided by a 
factor of 3).  
 All the substrates were commercially available. The HCOONa·B(OH)3 mixture was 
obtained by dissolving B(OH)3 (2.10 g, 34 mmol) and HCOONa (2.72 g, 40 mmol) in water 
(40 mL) and adjusting the pH to 6.25 with NaOH pellets. The resulting stock solution 
([B(OH)3] = 0.85 M, [HCOONa] = 1 M) was thoroughly degassed.  
 For immobilization purposes, beads of D-biotin – sepharose (2350 µL wet beads; binding 
capacity 40 mg of avidin per mL of wet beads; Affiland, Belgium) were washed with water 
and then resuspended in water in a total volume of 4000 µL. The stock suspension was 
employed for a batch of maximum 60 catalytic experiments. 
General procedure for transfer hydrogenation with immobilized streptavidin. To a 
solution of cell extract containing streptavidin (0.15 µmol of tetrameric protein determined by 
titration with biotin-4-fluorescein)186 was added a suspension of biotin – sepharose (215 µL 
containing 125 µL wet beads). The resulting suspension, containing a two-fold excess of Sav 
relative to the biotin-sepharose, was vigorously stirred at room temperature for 60 min. The 
beads containing immobilized Sav (0.075 µmol of tetrameric protein) were centrifuged in 1.5 
mL eppendorf tubes and washed three times with 400 µL of a 1 M guanidinium chloride 
solution and once with 400 µL water, then resuspended in degassed water ( total volume 750 
µL). The suspension was thoroughly degassed (nitrogen flushed). 
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 The degassed immobilized protein (337 µL suspension, 0.0337 µmol of tetrameric Sav) 
was mixed in an eppendorf tube with the precursor complex [η6-(arene)Ru(Biot–p-L)Cl] 
(4.27 µL of a 0.0395 M stock-solution in degassed DMF, 0.169 µmol Ru) and shaken at room 
temperature for 10 min. The beads were centrifuged in 1.5 mL eppendorf tubes, washed three 
times with 200 µL HCOONa·B(OH)3 mixture, once with 200 µL water and then resuspended 
in degassed water in a total volume of 340 µL. The HCOONa·B(OH)3 mixture (405 µL) and 
the MOPS buffer (135 µL of a 1 M stock-solution, pH adjusted to 6.25) were added. The 
resulting suspension was divided into two different test tubes (400 µL per test tube, 
containing 0.015 µmol protein, 0.045 µmol Ru, 180 µmol HCOONa) and the corresponding 
substrate (p-bromoacetophenone 2 or 4-phenyl-2-butanone 6, 4.5 µL of a 1 M stock solution 
in DMF, 4.5 µmol) was added to each tube. The test tubes were placed in a magnetically-
stirred multireactor, purged several times with nitrogen and heated at 55°C for 64 hours. After 
completion, the reaction mixture was extracted with Et2O (4 × 0.5 mL) and dried over 
Na2SO4. The organic solution was filtered through a short silicagel plug that was thoroughly 
washed with Et2O, concentrated and subjected to HPLC analysis.  
General procedure for the transfer hydrogenation with purified streptavidin. 
Lyophilized streptavidin was dissolved in milliQ water (100 µM tetrameric concentration). 
The solution was thoroughly degassed (nitrogen flushed). The degassed protein (150 µL 
solution, 0.015 µmol of tetrameric Sav) was mixed in a test tube with the precursor complex 
[η6-(arene)Ru(Biot–p-L)Cl] (1.27 µL of a 0.0395 M stock solution in DMF, 0.05 µmol Ru) 
and stirred at room temperature for 10 min. The HCOONa·B(OH)3 mixture (200 µL), the 
MOPS buffer (67 µL of a 1 M stock-solution, pH adjusted to 6.25) and the corresponding 
substrate (5 µL of a  1 M stock solution in DMF, 5 µmol) were added to each tube. The test 
tubes were placed in a magnetically stirred multireactor, purged several times with nitrogen 
and heated at 55 °C for 64 hours. After completion, the reaction mixture was extracted with 
Et2O (4 × 0.5 mL) and dried over Na2SO4. The organic solution was filtered through a short 
silicagel plug that was thoroughly washed with Et2O, concentrated and subjected to HPLC 
analysis (2-acetylpyridine-containing extracts were not filtered on silica). 
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3.2 Sulfoxidation Reactions 
3.2.1 Sulfoxidation Catalyzed by Metal-Salen Complexes 
The oxidants used were prepared as described in Table 2. 
Table 2. Stock solutions of the different oxidants and volumes added to the reaction mixture for the 
sulfoxidation catalyzed by Mn-Sal-X or V-Sal-X.  
Oxidant [Stock solution] (M) Solvent V added to the reaction (µL) 
NaOCl 0.73 H2O 5.5 
NaIO4 0.25 H2O 16 
PhIO 0.25 MeOH 16 
PhI(OAc)2 0.25 MeOH 16 
H2O2 solution 1 0.11 H2O 17.7 
H2O2 solution 2 1.0 H2O 4 
t-BuOOHa 3.64 H2O / EtOH 1 / 1 5.5 
a
 The stock solution was prepared by mixing EtOH with a commercial solution of 70% t-BuOOH in H2O in a 1 / 
1 (v / v) ratio.  
Background reaction. A suspension of thioanisole (4 µL of a 1 M DMF stock solution) in 
400 µL water was mixed in a test tube with 1 equivalent of oxidant (see Table 2 for the 
volumes added). The test tube was closed and the reaction mixture stirred at room temperature 
for 4 to 5 h. After this time, the reaction mixture was extracted four times with Et2O. The 
organic phase was dried over Na2SO4 and subjected to HPLC analysis. 
Activity tests of Mn-Sal-X complexes. A solution of Mn-Sal-X in 400 µL water (2 µL of a 
0.02 M stock solution in DMF, 100 µM final concentration) was mixed in a test tube with 
thioanisole (2 µL of a 1 M DMF stock solution). The reaction was initiated by adding 1 
equivalent of oxidant (17.7 µL of H2O2 solution 1 – see Table 2 – 0.005 M final 
concentration) and the test tube was sealed. After 4 to 5 h stirring at room temperature, the 
reaction mixture was extracted four times with Et2O. The organic phase was dried over 
Na2SO4, filtered through a short silica gel plug that was thoroughly washed with Et2O and 
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subjected to HPLC analysis. Similar results were obtained with control samples that were not 
subjected to filtration through a silica plug. 
Tests of Mn-Sal-X in presence of Sav. A solution of streptavidin in water (400 µL, 33 µM 
tetrameric concentration) was mixed in a test tube with the biotinylated metal complex, Mn-
Sal-X (2 µL of a 0.02 M stock solution in DMF, 100 µM final concentration). After 5 min 
incubation time, thioanisole was added (2 µL of a 1 M DMF stock solution). The reaction was 
initiated by adding 1 equivalent of oxidant (17.7 µL of H2O2 solution 1 – see Table 2 –) and 
the test tube was sealed. After 4 to 5 h stirring at room temperature, the reaction mixture was 
extracted four times with Et2O. The organic phase was dried over Na2SO4 and subjected to 
HPLC analysis. 
Tests of V-Sal-X in presence of Sav. A solution of streptavidin in water (200 µL, 100 µM 
tetrameric concentration) was mixed in a test tube with the biotinylated metal complex, V-
Sal-X (2 µL of a 0.02 M stock solution in DMF, 200 µM final concentration). After 5 min 
incubation time, thioanisole was added (4 µL of a 0.5 M DMF stock solution). The reaction 
was initiated by adding 5 equivalents of oxidant (2.75 µL of a 3.64 M t-BuOOH stock 
solution in MeOH, 0.05 M final concentration) and the test tube was sealed. After 4 h stirring 
at room temperature, the reaction mixture was extracted four times with Et2O. The organic 
phase was dried over Na2SO4 and subjected to HPLC analysis. 
3.2.2 Sulfoxidation Catalyzed by Vanadyl Ion 
The 0.05 M HCl / KCl buffer at pH 2.2 was obtained by dissolving KCl (298 mg, 4 mmol) in 
water (80 mL) and adjusting the pH to 2.2 with concentrated HCl (36%). 
General procedure for the asymmetric sulfoxidation catalyzed by vanadium-loaded 
streptavidin. A solution of streptavidin in buffer at pH 2.2 (200 µL, 100 µM tetrameric 
concentration) was mixed in a test tube (1 mL capacity) with the vanadium source (4 µL of a 
0.01 M stock solution in water or EtOH, 200 µM final concentration). After 10 min 
incubation time, the substrate was added (4 µL of a 0.5 M stock solution in EtOH, 0.01 M 
final concentration). The reaction was initiated by adding the oxidant (2.75 µL of a 3.64 M t-
BuOOH stock solution in water / EtOH 1 / 1, 0.05 M final concentration) and the test tube 
was sealed. After 4 h stirring at room temperature, the reaction mixture was extracted four 
times with Et2O. The organic phase was dried over Na2SO4 and subjected to HPLC analysis. 
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Catalysis on a milligram quantity of p-methoxythioanisole 11. To a WT Sav (26.3 mg, 
0.35 µmol) solution in buffer at pH 2.2 (3.5 mL) in a round-bottom flask was added an 
aqueous solution of VOSO4·5H2O (35 µL of a 0.02 M stock solution in water). After 10 min. 
incubation time, the substrate was added (35 µL of a 1 M stock solution in EtOH). The 
reaction was initiated by adding the oxidant (48 µL of a 3.64 M t-BuOOH stock solution in 
water / EtOH 1 / 1) and the flask was sealed. After 4 h stirring at room temperature, the 
reaction mixture was extracted four times with Et2O. The organic phase was dried over 
Na2SO4, evaporated under vacuum and the crude product was purified by flash 
chromatography on silicagel using CH2Cl2 / MeOH (100 / 1) to afford 5 mg of methyl-p-
methoxyphenyl sulfoxide (80% yield). 
 1H NMR (400 MHz, Acetone-d6, 298 K): δH (ppm) 2.64 (s, 3H, CH3-S), 3.87 (s, 3H, CH3-
O), 7.12 (d, J = 8 Hz, 2H, 2 × HCaromatic), 7.62 (d, J = 8 Hz, 2H, 2 × HCaromatic). 
 Chiral HPLC: Chiralcel OB-H, hexane / i-PrOH 80 / 20, flow 1.0 mL / min, t1 =15.7 min., 
t2 = 31.9 min., 90% ee (R).  
3.2.3 Kinetic Experiments 
Kinetic experiments were performed in a mixture of 57% HCl / KCl buffer (0.05 M, pH 2.2) 
and 43% EtOH, to ensure complete solubilization of the substrate. For all the catalytic runs, p-
methoxythioanisole 11 was used as model substrate. All the experiments were performed in 
duplicate and the two reactions were quenched after 2, respectively 4 minutes. During this 
interval, the increase in sulfoxide concentration as a function of time followed a straight line. 
Initial rates were calculated over a 4 minute period, starting from the conversion values 
obtained by HPLC analysis. 
Free VOSO4. A solution of p-methoxythioanisole 11 (200 µL, 0.001 – 0.03 M final 
concentration range, see Chapter 2, Section 2.2.5.5, Figure 14) in buffer / EtOH mixture (57 / 
43 v / v) was mixed in a test tube (1 mL capacity) with VOSO4 (4 µL of a 0.01 M stock 
solution in buffer, 200 µM final concentration). After 10 minutes incubation time, the reaction 
was initiated by adding the oxidant (2.75 µL of a 3.64 M t-BuOOH stock solution in water / 
EtOH 1 / 1, 0.05 M final concentration). After 2, respectively 4 minutes, the reaction was 
quenched by adding 100 µL saturated Na2S2O3, followed by 400 µL Et2O. The reaction 
mixture was extracted four times with Et2O. The organic phase was dried over Na2SO4 and 
subjected to HPLC analysis.  
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VOSO4 ⊂ S112D Sav. A solution (200 µL) containing S112D Sav (100 µM final tetrameric 
concentration) and p-methoxythioanisole 11 (0.001 – 0.03 M final concentration range, see 
Chapter 2, Section 2.2.5.5, Figure 14) in buffer / EtOH mixture (57 / 43 v / v) was mixed in a 
test tube (1 mL capacity) with VOSO4 (4 µL of a 0.01 M stock solution in buffer, 200 µM 
final concentration). After 10 minutes incubation time, the reaction was initiated by adding 
the oxidant (2.75 µL of a 3.64 M t-BuOOH stock solution in water / EtOH 1 / 1, 0.05 M final 
concentration). After 2, respectively 4 minutes, the reaction was quenched by adding 100 µL 
saturated Na2S2O3, followed by 400 µL Et2O. The reaction mixture was extracted four times 
with Et2O. The organic phase was dried over Na2SO4 and subjected to HPLC analysis.  
VOSO4 + (biotin ⊂ S112D Sav). A solution (200 µL) containing S112D Sav (100 µM final 
tetrameric concentration), biotin (100 µM final concentration) and p-methoxythioanisole 11 
(0.001 – 0.03 M final concentration range, see Chapter 2, Section 2.2.5.5, Figure 14) in buffer 
/ EtOH mixture (57 / 43 v / v) was mixed in a test tube (1 mL capacity) with VOSO4 (4 µL of 
a 0.01 M stock solution in buffer, 200 µM final concentration). After 10 minutes incubation 
time, the reaction was initiated by adding the oxidant (2.75 µL of a 3.64 M t-BuOOH stock 
solution in water / EtOH 1 / 1, 0.05 M final concentration). After 2, respectively 4 minutes, 
the reaction was quenched by adding 100 µL saturated Na2S2O3, followed by 400 µL Et2O. 
The reaction mixture was extracted four times with Et2O. The organic phase was dried over 
Na2SO4 and subjected to HPLC analysis. 
4 Synthesis of the Biotinylated Metal-Salen Complexes 
4.1 Synthesis of the Ligands Sal-1 – Sal-4 
Biotin pentafluorophenol ester (BPFP) and biotinyl-N-hydroxysuccinimide ester (BNHS) 
were prepared according to reported procedures.157,214  
4.1.1 Synthesis of Sal-1 
Biotinamine.214 
 
A concentrated NH4OH solution (24%, 30 mL) was added dropwise to a solution of BPFP 
(700 mg, 1.8 mmol) in DMF (8 mL). The resulting suspension was stirred at room 
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temperature for 12 h. The white solid was filtered, washed five times with water and three 
times with Et2O and dried under vacuum to give 205 mg (47%) of biotinamide as a white 
solid. To a suspension of biotinamide (198 mg, 0.8 mmol) in THF (15 mL) under nitrogen 
was added LiAlH4 (155 mg, 4 mmol) and the resulting mixture was refluxed for 22 h. The 
reaction was then cooled with an ice bath and water (0.6 mL) was slowly added. The Al salts 
were filtered on celite and washed with CHCl3. The filtrate was evaporated to yield the 
biotinamine (154 mg, 83% yield from biotinamide). 
 1H NMR (200 MHz, DMSO-d6, 298 K): δH (ppm) 1.1-1.8 (m, 10 H, CH2CH2CH2CH2, 
NH2), 2.55 (m, 2H, CH2-S), 2.82 (m, 1H, CH2-S), 3.05-3.18 (m, 1H, CH-S), 3.35-3.40 (m, 
2H, CH2-NH), 4.05-4.18 (m, 1H, CH-N), 4.25-4.35 (m, 1H, CH-N), 6.36 (s, 1H, CH-NH), 
6.45 (s, 1H, CH-NH). 
3, 4-Diaminobenzoic acid, aminobiotinyl amide. 
 
3,4-Diaminobenzoic acid (152 mg, 1mmol), EDC (233 mg, 1.5 mmol), HOBT (202 mg, 1.5 
mmol), Et3N (268 µL, 2 mmol) and biotinamine (401 mg, 1.75 mmol) were mixed in DMF 
(40 mL) and the resulting solution was stirred at 45°C during 24 h. After this time, the DMF 
was evaporated and the crude product was purified by flash chromatography on silicagel 
using CH2Cl2 / MeOH (initial mixture 9 / 1, final mixture 6 / 4) to afford the product (203 mg, 
0.56 mmol, 56% yield). 
 1H NMR (400 MHz, DMSO-d6, 298 K): δH (ppm) 1.21-1.61 (m, 8H, CH2CH2CH2CH2-
CH2NH), 2.58 (d, J = 12.4 Hz, 1H, CH2-S), 2.82 (dd, J = 12.4 Hz, J = 5.1 Hz, 1H, CH2-S), 
3.08-3.14 (m, 1H, CH-S), 3.38-3.52 (m, 2H, CH2-NH), 4.12-4.15 (m, 1H, CH-N), 4.29-4.33 
(m, 1H, CH-N), 4.95 (br, 4H, NH2), 6.39 (s, 1H, CH-NH), 6.47 (s, 1H, CH-NH), 6.47 (d, J = 
8.0 Hz, 1H, HCaromatic), 6.95 (dd, J = 8.0 Hz, J = 1.9 Hz, 1H, HCaromatic), 7.04 (d, J = 1.9 Hz, 
1H, HCaromatic), 7.88 (t, J = 5.6 Hz, 1H, CH2-HN). 
 13C NMR (100 MHz, DMSO-d6, 298 K): δC (ppm) 27.4 (CH2), 29.1 (CH2), 29.2 (CH2), 
30.1 (CH2), 39.7 (CH2-NH), 40.7 (CH2-S), 56.4 (CH-S), 60.1 (CH-N), 61.9 (CH-N), 113.6 
(CaromaticH), 114.7 (CaromaticH), 117.8 (CaromaticH), 124.1 (Caromatic-CO), 134.7 (Caromatic -NH2), 
139.0 (Caromatic-NH2), 163.6 (HN-CO-NH), 167.6 (CO-NH). 
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 ESI+-MS: 386.2 (10, [M+Na]+), 365.1 (20, [M+2H]2+), 364.1 (100, [M+H]+). 
N,N’-Bis-(3,5-di-tert-butylsalicylidene)-3,4-diaminobenzoic acid, aminobiotinyl amide, 
Sal-1.  
 
To a solution of 3,5-di-tert-butyl-2-hydroxybenzaldehyde (386 mg, 1.65 mmol) in MeOH (10 
mL) was added a solution of 3, 4-diaminobenzoic acid, aminobiotinyl amide (200 mg, 0.55 
mmol) in MeOH (10 mL) and the reaction mixture was refluxed during 48 h. After this time, 
MeOH was evaporated and the crude product was purified by flash chromatography on 
silicagel using CH2Cl2 / MeOH (initially pure CH2Cl2, final mixture 95 / 5) to afford Sal-1 as 
a yellow-orange solid (287 mg, 0.36 mmol, 65% yield). 
 1H NMR (400 MHz, CDCl3, 298 K): δH (ppm) 1.33 (s, 18H, 2 × C(CH3)3), 1.45 (s, 18H, 2 
× C(CH3)3), 1.33-1.67 (m, 8H, CH2CH2CH2CH2-CH2NH), 2.62 (d, J = 12.8 Hz, 1H, CH2-S), 
2.82 (dd, J = 12.8 Hz, J = 4.7 Hz, 1H, CH2-S), 3.07-3.12 (m, 1H, CH-S), 3.36-3.51 (m, 2H, 
CH2-NH), 4.19-4.22 (m, 1H, CH-N), 4.39-4.42 (m, 1H, CH-N), 5.67 (s, 1H; CH-NH), 6.68 (s, 
1H; CH-NH), 7.23-7.27 (m, 3H, HCaromatic), 7.46 (d, J = 2.4 Hz, 1H, HCaromatic), 7.48 (d, J = 
2.4 Hz, 1H, HCaromatic), 7.78 (dd, J = 8.2 Hz, J = 1.8 Hz, 1H, HCaromatic), 7.84 (d, J = 1.8 Hz, 
1H, HCaromatic), 8.68 (s, 1H, CH=N), 8.79 (s, 1H, CH=N), 13.41 (s, 1H, OH), 13.45 (s, 1H, 
OH). 
 13C NMR (100 MHz, CDCl3, 298 K): δC (ppm) 27.4 (CH2), 28.9 (CH2), 29.0 (CH2), 29.5 
(CH2), 29.8 (3 × CH3), 31.9 (6 × CH3), 34.6 (3 × CH3), 35.5 (4 × C-CH3), 40.3 (CH2-NH), 
40.9 (CH2-S), 56.3 (CH-S), 60.5 (CH-N), 62.3 (CH-N), 118.6 (Caromatic), 118.7 (Caromatic), 
119.4 (Caromatic), 120.3 (Caromatic), 126.3 (Caromatic), 127.4 (Caromatic), 127.6 (Caromatic), 128.9 
(Caromatic), 129.1 (Caromatic), 133.9 (Caromatic), 137.5 (Caromatic), 137.7 (Caromatic), 141.0 (2 × 
Caromatic), 143.0 (Caromatic), 145.6 (Caromatic), 159.0 (Caromatic), 159.1 (Caromatic), 164.6 (HN-CO-
NH), 166.0 (2 × CH=N), 167.1 (CO-NH). 
 ESI+-MS: 818.6 (10, [M+Na]+), 798.5 (20), 797.4 (50, [M+2H]2+), 796.5 (100, [M+H]+). 
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4.1.2 Synthesis of Sal-2 
5-(O-Biotinyl)-2,5-dihydroxybenzaldehyde.  
 
2,5-Dihydroxybenzaldehyde (1 g, 7.24 mmol), BNHS (2.06 g, 6.03 mmol) and Et3N (1.21 
mL, 9.05 mmol) were mixed in DMF (30 mL) and the resulting solution was stirred at room 
temperature for 48 h. After this time, the DMF was evaporated and the crude product was 
purified by flash chromatography on silicagel using CH2Cl2 / MeOH (95 / 5) to afford the 
product (437 mg, 1.20 mmol, 20% yield). 
 1H NMR (400 MHz, DMSO-d6, 298 K): δH (ppm) 1.57-1.40 (m, 4H, CH2CH2-CH2CO), 
1.63-1.70 (m, 2H, CH2-CHS), 2.58 (t, J = 7.4 Hz, 2H, CH2CO), 2.60 (d, J = 12.7 Hz, 1H, 
CH2-S), 2.85 (dd, J = 12.7 Hz, J = 5.1 Hz, 1H, CH2-S), 3.12-3.17 (m, 1H, CH-S), 4.14-4.18 
(m, 1H, CH-N), 4.31-4.34 (m, 1H, CH-N), 6.39 (s, 1H, CH-NH), 6.48 (s, 1H, CH-NH), 7.03 
(d, J = 12.7 Hz, 1H, HCaromatic), 7.29 (dd, J = 8.9 Hz, J = 3.0 Hz, 1H, HCaromatic), 7.35 (d, J = 
3.0 Hz, 1H, HCaromatic), 10.26 (s, 1H, CHO). 
 13C NMR (100 MHz, DMSO-d6, 298 K): δC (ppm) 25.2 (CH2), 28.8 (CH2), 28.9 (CH2), 
34.1 (CH2CO), 40.7 (CH2-S), 59.2 (CH-S), 60.1 (CH-N), 61.9 (CH-N), 119.1 (CaromaticH), 
121.4 (Caromatic), 123.3 (Caromatic), 130.8 (CaromaticH), 143.6 (Caromatic), 159.3 (Caromatic), 163.6 
(HN-CO-NH), 172.9 (CO-O), 191.1 (CH=O). 
 ESI+-MS: 387.1 (100, [M+Na]+), 365.1 (10, [M+H]+). 
N-((5-O-Biotinyl)-2,5-dihydroxysalicylidene), N’-(3,5-di-tert-butylsalicylidene)-
ethylenediamine, Sal-2. 
 
To a solution of 5-(O-biotinyl)-2,5-dihydroxybenzaldehyde (300 mg, 0.82 mmol) and 3,5-di-
tert-butyl-2-hydroxybenzaldehyde (192 mg, 0.82 mmol) in MeOH (30 mL) was added a 
solution of Et3N (53 µL, 0.8 mmol) in MeOH (10 mL) and the resulting reaction mixture was 
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stirred at room temperature for 10 minutes. The Schiff bases were precipitated by adding 
water (50 mL) and the solid was collected after centrifugation of the resulting suspension, 
dissolved in CH2Cl2 and dried over MgSO4. After evaporation of the CH2Cl2, the three Schiff 
bases were separated by flash chromatography on silicagel using CH2Cl2 / MeOH (initially 
pure CH2Cl2, final mixture 97 / 3) to afford the non-symmetric Schiff base Sal-2 as a yellow 
solid (141 mg, 0.23 mmol, 28% yield). 
 1H NMR (400 MHz, CD3OD, 298 K): δH (ppm) 1.29 (s, 9H, C(CH3)3), 1.41 (s, 9H, 
C(CH3)3), 1.42-1.82 (m, 6H, CH2CH2CH2-CH2CO), 2.60 (d, J = 12.7 Hz, 1H, CH2-S), 2.73 (t, 
J = 7.4 Hz, 2H, CH2-CO), 2.95 (dd, J = 12.7 Hz, J = 4.9 Hz, 1H, CH2-S), 3.18-3.27 (m, 1H, 
CH-S), 3.94-3.96 (m, 4H, NH-CH2CH2-NH), 4.30-4.36 (m, 1H, CH-N), 4.48-4.54 (m, 1H, 
CH-N), 6.87 (d, J = 7.8 Hz, 1H, HCaromatic), 7.04 (m, 2H; 2 × HCaromatic), 7.12 (d, J = 2.4 Hz, 
1H, HCaromatic), 7.37 (d, J = 2.4 Hz, 1H, HCaromatic), 8.41 (s, 1H, CH=N), 8.42 (s, 1H, CH=N). 
4.1.3 Synthesis of Sal-3 
N-Biotinyl-N’,N”-bis(3,5-di-tert-butylsalicylidene)diethylenetriamine, Sal-3. 
 
A solution of 3,5-di-tert-butyl-2-hydroxybenzaldehyde (150 mg, 0.64 mmol) and 
ethylenetriamine (34 µL, 0.32 mmol) in toluene (5 mL) was stirred during 4 h at room 
temperature. The solvent was evaporated and the crude product was purified by flash 
chromatography on silicagel using CH2Cl2 / MeOH (96 / 4) to afford a yellow solid (171 mg, 
quantitative yield). As the product hydrolyzed rapidly in solution, the purification was 
performed very quickly. 
 To a solution of N,N’-bis-(3,5-di-tert-butylsalicylidene)diethylenetriamine (170 mg, 0.32 
mmol) and BNHS (131 mg, 0.38 mmol) in DMF (5 mL) was added Et3N (134 µL, 1 mmol) 
and the reaction mixture was heated at 50 °C during 24 h. The solvent was evaporated and the 
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crude product was purified by flash chromatography on silicagel using CH2Cl2 / MeOH / Et3N 
(95 / 5 / 2) to afford Sal-3 as a yellow solid (168 mg, 69% yield). 
1H NMR (400 MHz, CDCl3, 298 K): δH (ppm) 1.31 (s, 18H, 2 × C(CH3)3), 1.45 (s, 18H, 2 × 
C(CH3)3), 1.59-1.76 (m, 6H, CH2CH2CH2-CH2CO), 2.41 (t, J = 7.5 Hz, 2H, CH2-CO),  2.73 
(d, J = 12.7 Hz, 1H, CH2-S), 2.90 (dd, J = 12.7 Hz, J = 4.9 Hz, 1H, CH2-S), 3.11-3.16 (m, 1H, 
CH-S), 3.68-3.69 (m, 4H, CH2-N=CH), 3.76 (t, J = 5.9 Hz, 2H, CH2-N), 3.84 (t, J = 5.9 Hz, 
2H, CH2-N), 4.26-4.29 (m, 1H, CH-N), 4.47-4.50 (m, 1H, CH-N), 5.24 (s, 1H, CH-NH), 5.68 
(s, 1H, CH-NH), 7.07 (d, J = 2.4 Hz, 1H, HCaromatic), 7.09 (d, J = 2.4 Hz, 1H, HCaromatic), 7.39-
7.40 (m, 2H, HCaromatic), 8.34 (s, 1H, CH=N), 8.37 (s, 1H, CH=N), 13.35 (s, 1H, OH), 13.69 
(s, 1H, OH). 
 13C NMR (100 MHz, CDCl3, 298 K): δC (ppm) 25.5 (CH2), 28.7 (CH2), 29.8 (CH3), 29.8 
(CH3), 31.9 (CH3), 33.2 (CH2), 34.4 (CH2), 34.5 (C-CH3), 35.4 (C-CH3), 40.9 (CH2-S), 48.3 
(CH2-N), 50.3 (CH2-N), 55.7 (CH-S), 57.8 (CH2-N), 58.8 (CH2-N), 60.5 (CH-N), 62.1 (CH-
N), 117.9 (Caromatic), 118.2 (Caromatic), 126.4 (CaromaticH), 126.6 (CaromaticH), 127.5 (CaromaticH), 
127.9 (CaromaticH), 137 (Caromatic), 137.1 (Caromatic), 140.6 (Caromatic), 140.8 (Caromatic), 158.2 
(Caromatic), 158.4 (Caromatic), 163.7 (HN-CO-NH), 168.1 (CH=N), 168.4 (CH=N), 173.9 (CO-
NH). 
 ESI+-MS: 776.4 (20), 763.5 (55, [M+2H]2+), 762.6 (100, [M+H]+). 
4.1.4 Synthesis of Sal-4 
(meso)-N-Benzyl-3,4-dihydroxy-2,5-pyrrolidinedione.215  
 
To a solution of N-benzylmaleimide (3 g, 16.0 mmol) in AcOEt / CH3CN 1 / 1 (total volume 
195 mL) cooled in an ice bath at 0°C was added a solution of RuCl3 (233 mg, 1.13 mmol) and 
NaIO4 in water (32 mL). The biphasic mixture was vigourously stirred for 3 minutes at 0°C, 
following which the reaction was quenched with 100 mL Na2S2O3 saturated solution. The 
organic phase was separated and the aqueous layer was extracted three times with AcOEt. The 
combined organic layers were dried over MgSO4 and evaporated in vacuo to afford the crude 
product, which was purified by flash chromatography on silicagel using CH2Cl2 / MeOH (98 / 
2) to afford a white solid (2.5 g, 70% yield). 
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 1H NMR (200 MHz, CD3OD, 298 K): δH (ppm) 4.48 (s, 2H, N-CH2-Ph), 4.67 (s, 2H, 2 × 
CH-OH), 7.28-7.34 (m, 5H, HCaromatic). 
(meso)-N-Benzyl-3,4-dihydroxypyrrolidine.  
 
This synthesis was adapted from a published procedure.216 All the manipulations were carried 
out using standard Schlenk techniques. To a suspension of LiAlH4 (4.3 g, 113 mmol) in THF 
(130 mL) under nitrogen was added a solution of (meso)-N-benzyl-3,4-dihydroxy-2,5-
pyrrolidinedione (5.0 g, 22.6 mmol) and the reaction mixture was refluxed during 62 h. The 
reaction was cooled with an ice bath and AcOEt (120 mL) was carefully added with 
vigourous stirring, followed by water (18 mL) and 3 M NaOH solution (4.25mL). After 1 h 
stirring at room temperature, the aluminium salts filtered on celite and washed with AcOEt. 
The filtrate was evaporated to yield the crude product, which was purified by flash 
chromatography on silicagel using AcOEt / MeOH / Et3N (95 / 5 / 1) to afford a yellow oil 
(1.13 g, 26% yield). 
 1H NMR (200 MHz, CDCl3, 298 K): δH (ppm) 2.59 (br, 2H, OH), 2.68-2.70 (m, 4H, 2 × 
CH2-N), 3.6 (s, 2H, N-CH2-Ph), 4.16-4.21 (m, 2H, 2 × CH-OH), 7.28-7.37 (m, 5H, HCaromatic). 
(meso)-N-benzyl-3,4-dihydroxypyrrolidine di-p-toluenesulfonate. 
 
This synthesis was adapted from a published procedure.217 To a solution of (meso)-N-benzyl-
3,4-dihydroxypyrrolidine (1.13 g, 5.85 mmol) in pyridine (32 mL) was added p-
toluenesulfonyl chloride (3.4 g, 17.8 mmol) in one portion. The resulting solution was stored 
at 4°C for 4 days. The mixture was then added dropwise to a cooled solution of citric acid 
(160 g in 1 L water) and the resulting aqueous solution was extracted four times with Et2O. 
The combined organic layers were dried over Na2SO4 and evaporated in vacuo. The crude 
product was purified by flash chromatography on silicagel using CH2Cl2 / Et3N (100 / 1) to 
afford a white solid (2.36 g, 81% yield). 
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 1H NMR (200 MHz, CDCl3, 298 K): δH (ppm) 2.47 (s, 6H, 2 × CH3), 2.69-2.76 (m, 2H, 
CH2-N), 3.02-3.11 (m, 2H, CH2-N), 3.6 (s, 2H, N-CH2-Ph), 4.71-4.83 (m, 2H, 2 × CH-OH), 
7.19-7.36 (m, 9H, HCaromatic), 7.74 (s, 2H, HCaromatic), 7.78 (s, 2H, HCaromatic). 
(meso)-N-benzyl-3,4-diazidopyrrolidine. 
 
This synthesis was adapted from a published procedure.218 All the manipulations were carried 
out using standard Schlenk techniques. To a solution of (meso)-N-benzyl-3,4-
dihydroxypyrrolidine di-p-toluenesulfonate (2.0 g, 4.0 mmol) in DMF (22 mL) under nitrogen 
was added solid NaN3 (1.04 g, 16.0 mmol). The resulting suspension was heated at 100°C for 
22 h and then cooled at room temperature. Water (40 mL) was added and the mixture was 
extracted four times with CH2Cl2. The organic layers were dried over Na2SO4 and evaporated 
in vacuo. The crude product was purified by flash chromatography on silicagel using hexane
 
/ 
AcOEt (80 / 20) to afford an incolor oil (880 mg, 90% yield). 
 1H NMR (400 MHz, CDCl3, 298 K): δH (ppm) 2.70 (dd, J = 10.2 Hz, J = 4.7 Hz, 2H, 2 × 
CH2-N), 3.01 (dd, J = 10.2 Hz, J = 6.5 Hz, 2H, 2 × CH2-N), 3.69 (s, 2H, N-CH2-Ph), 4.04-
4.07 (m, 2H, 2 × CH-N3), 7.32-7.38 (m, 5H, HCaromatic). 
 13C NMR (100 MHz, CDCl3, 298 K): δC (ppm) 57.5 (2 × CH2-N), 60.1 (N-CH2-Ph), 62.2 
(2 × CH-N3), 127.8 (CaromaticH), 128.9 (2 × CaromaticH), 129.1 (2 × CaromaticH), 138.2 (Caromatic). 
(meso)-3,4-(N,N’-Bis(3,5-di-tert-butylsalicylidene))-pyrrolidine. 
 
This synthesis was adapted from a published procedure.219 All the manipulations were carried 
out using standard Schlenk techniques. A suspension of palladium on charcoal (10% w/w, 47 
mg, 0.02 mmol) in EtOH / CF3COOH (8 / 2 v / v) was added to a solution of (meso)-N-
benzyl-3,4-diazidopyrrolidine (100 mg, 0.41 mmol) in EtOH / CF3COOH (8 / 2 v / v, total 
volume 2 mL). The suspension was shaken under 5 bar H2 for 16 h, filtered through celite and 
concentrated under vacuum to afford a white solid. The crude residue was dissolved in EtOH 
(3 mL) and neutralized with a solution of NaOH 4.7 M (0.32 mL). Neat 3,5-di-tert-butyl-2-
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hydroxybenzaldehyde (197 mg, 0.84 mmol) was added at once and the reaction was refluxed 
for 2 h. The reaction mixture was then poured into 3.3 mL saturated NaCl solution and 
extracted three times with CH2Cl2. The organic layers were combined, washed with saturated 
NaCl solution, dried over Na2SO4 and evaporated under vacuum. The product was purified by 
flash chromatography on silicagel using AcOEt / MeOH (initially pure AcOEt, then 95 / 5) to 
yield a foamy yellow glass (110 mg, 54% yield over the two steps). 
 1H NMR (400 MHz, CDCl3, 298 K): δH (ppm) 1.28 (s, 18H, 2 × C(CH3)3), 1.29 (s, 18H, 2 
× C(CH3)3), 3.39-3.41 (m, 4H, 2 × CH2-N), 4.05-4.07 (m, 2H, CH-N=CH), 7.04 (d, J = 2.44 
Hz, 2H, HCaromatic), 7.35 (d, J = 2.44 Hz, 2H, HCaromatic), 8.36 (s, 2H, 2 × CH=N), 13.34 (s, 
2H, 2 × OH). 
 13C NMR (100 MHz, CDCl3, 298 K): δC (ppm) 29.8 (C-(CH3)3), 31.9 (C-(CH3)3), 34.5 (2 
× C-CH3), 35.4 (2 × C-CH3), 53.4 (2 × CH2-N), 73.6 (2 × CH-N), 118.0 (2 × Caromatic), 126.2 
(2 × CaromaticH), 127.5 (2 × CaromaticH), 137.1 (2 × Caromatic), 140.2 (2 × Caromatic), 158.5 
(Caromatic), 166.7 (2 × CH=N). 
 APCI+-MS: 546.5 (30), 535.5 (50, [M+2H]2+), 534.5 (100, [M+H]+). 
(meso)-N-Biotinyl-3,4-(N’,N”-bis(3,5-di-tert-butylsalicylidene))-pyrrolidine, Sal-4. 
 
To a solution of (meso)-3,4-(N,N’-bis(3,5-di-tert-butylsalicylidene))-pyrrolidine (36 mg, 0.07 
mmol) and BNHS (25 mg, 0.07 mmol) in DMF (1 mL) was added Et3N (14 µL, 0.1 mmol) 
and the reaction mixture was stirred at room temperature during 24 h. The solvent was 
evaporated and the crude product was purified by flash chromatography on silicagel using 
CH2Cl2 / MeOH (90 / 10) to afford Sal-4 as a yellow solid (45 mg, 86% yield). 
 1H NMR (200 MHz, CDCl3, 298 K): δH (ppm) 1.27-1.37 (m, 36H, 4 × C(CH3)3), 1.40-1.90 
(m, 6H, CH2CH2CH2-CH2CO), 2.41 (m, 2H, CH2-CO),  2.6-3.0 (m, 2H, CH2-S), 3.11-3.25 
(m, 1H, CH-S), 3.8-3.97 (m, 4H, 2 × CH2-N), 4.0-4.25 (m, 2H, 2 × CH-N=CH), 4.30-4.40 (m, 
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1H, CH-N), 4.45-4.50 (m, 1H, CH-N), 5.30 (d, J = 5.6 Hz, 1H, CH-NH), 5.97 (d, J = 9.6 Hz 
2H, CH-NH), 7.05 (dd, J = 2.4 Hz, J = 4.4 Hz, 2H, 2 × HCaromatic), 7.36 (d, J = 2.4 Hz, 2H, 2 × 
HCaromatic), 8.35 (s, 1H, CH=N), 8.42 (s, 1H, CH=N), 13.0 (s, 1H, OH), 13.07 (s, 1H, OH). 
 ESI--MS: 758.7 (100, [M-H]-), 759.7 (50, M), 794.5 (80, [M–H+2H2O]-), 795.4 (40, 
M+2H2O). 
4.2 Preparation of the Metal-Salen Complexes 
(meso)-N-Biotinyl-3,4-(N’,N”-bis(3,5-di-tert-butylsalicylidene))-pyrrolidine, manganeseIII 
chloride complex, Mn-Sal-4. 
This synthesis was adapted from a published procedure.220 To a solution of Mn(OAc)2·4H2O 
(44 mg, 0.18 mmol) in EtOH (1.5 mL) was added a solution of Sal-4 in toluene (1.8 mL) and 
the resulting mixture was refluxed for 1 h. Saturated aqueous NaCl (0.2 mL) was then added 
and air was bubbled through the solution during 30 minutes. The reaction mixture was cooled 
to room temperature, toluene (4 mL) and CH2Cl2 (10 mL) were added and the organic phase 
was separated and washed two times with water. The aqueous phase was extracted with 
CH2Cl2 until it was colourless and the collected organic layers were dried over Na2SO4 and 
evaporated under vacuum. The Mn complex was purified by flash chromatography on 
silicagel using CH2Cl2 / MeOH (75 / 15) to afford a brown solid (28.5 mg, 56% yield). 
 ESI+-MS: 812.5 (100, [M-Cl]+), 813.5 (40, [M–Cl+H]+), 814.3 (10, [M–Cl+2H]+). 
Mn-Sal-1 – Mn-Sal-3. 
The three Mn-Sal-X complexes were prepared by mixing solutions of known concentrations 
of Mn(OAc)2·4H2O (0.08 M) and Sal-X (0.04 M) in DMF (1 / 1 volumes of the two solutions) 
and heating the resulting mixtures in closed tubes at 65°C. Thus, the corresponding Mn-Sal-X 
complexes were available in 0.02 M solutions in DMF and were used without further isolation 
and purification. 
V-Sal-1 – V-Sal-3.  
The V-Sal-X complexes were prepared by adapting a published procedure,194 by mixing 
solutions of known concentrations of VO(acac)2 (0.04 M) and Sal-X (0.04 M) in DMF (1 / 1 
volumes of the two solutions) and heating the resulting mixtures in closed tubes at 65°C. 
Thus, the corresponding V-Sal-X complexes were available in a 0.02 M solutions in DMF 
and were used without further isolation and purification. 
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5 Analysis of the Reduction and Oxidation Products 
The conversions and enantioselectivities of the catalytic runs were determined by HPLC 
analysis using either the Chiralcel OD-H, OB-H or OJ-H columns (Daicel Chemical 
Industries, Tokyo) with hexane / isopropanol as solvent or a (S,S)-ULMO column (Regis 
Technologies Inc., Illinois, U.S.A.) with hexane / 1,2-dimethoxyethane as solvent. 
 For each substrate / product couple, a calibration curve was established, relating the ratio 
of the HPLC integrated surfaces of the corresponding peaks (Ssubstrate / Senantiomer products) to the 
substrate / product molar ratio. Thus, the conversions were determined by comparison of the 
HPLC areas with the calibration curve. The enantioselectivities were directly determined from 
the HPLC integrated surfaces. 
 For the sulfoxidation catalytic runs, control experiments were performed using 
acetophenone as internal standard. The yields of sulfoxides determined in this manner were 
very similar to the conversions obtained by the previous method.  
5.1 Analytical Data for the Reduction Products 
Racemic alcohols were prepared from the corresponding starting ketones by reduction with 
NaBH4 in EtOH and used for HPLC reference purposes. The analytical data for the reduction 
products is presented in Table 3.  
 For the catalytic runs with 2-acetylpyridine 5 affording enantioselectivities >90% ee (S), 
the ee’s were determined by GC analysis on a β-Dex capillary column (Supelco, 30 m × 0.25 
mm × 0.25 µm, 100kPa He) using the following program: initial T(°C) / time(min.) / slope(°C 
/ min.) / T(°C) / time(min.) / slope(°C/min.) / T(°C) / time(min.) / slope(°C/min.) / T(°C) / 
time (min.) : 60 / 5 / 1 / 80 / 10 / 1.5 / 100 / 15 / 5 / 190 / 1. The retention times for the 
alcohols were: t1 = 63.7 min. (R), t2 = 64.7 min. (S). 
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Table 3. HPLC conditions, retention times and absolute configurations for the reduction products a.  
Alcohol Column Conditions t1 (min) t2 (min) Detection 
 
OD-H 
hexane / i-PrOH  95 / 5 
flow 0.7 mL / min 
17.8 
(R) 
22.7 
(S) 
215 nm 
 
OD-H 
hexane / i-PrOH  95 / 5 
flow 0.7 mL / min 
11.6 
(S) 
12.9 
(R) 
225 nm 
 
(S,S)-
ULMO 
hexane / DME  100 / 1.5 
flow 1 mL / min 
16.6 
(R) 
19.5 
(S) 
215 nm 
 
OD-H 
hexane / i-PrOH  100 / 2 
flow 0.9 mL / min 
17.2b 
(S) 
18.5b 
(R) 
215 nm 
 
OD-H 
hexane / i-PrOH  100 / 2 
flow 0.9 mL / min 
19.5b 
(R) 
22.2b 
(S) 
215 nm 
 
OD-H 
hexane / i-PrOH  95 / 5 
flow 0.7 mL / min 
13.9b 
(R) 
20.6b 
(S) 
215 nm 
 
OD-H 
hexane / i-PrOH  95 / 5 
flow 0.7 mL / min 
11.9c 
(S) 
13.5c 
(R) 
215 nm 
 
OD-H 
hexane / i-PrOH 100 / 2 
flow 0.9 mL / min 
11.2 
(S) 
16.6 
(R) 
215 nm 
a
 The absolute configuration was assigned by comparison with published results.179 
b
 The absolute configuration was assigned by comparison with an enantiopure sample. 
c
 The absolute configuration was assigned by comparison with an enantiopure sample prepared from (R)-
butanediol. 
5.2 Analytical Data for the Oxidation Products 
Racemic sulfoxides were prepared from the corresponding starting sulfides by oxidation with 
vanadium sulfate and t-BuOOH in CH2Cl2 and used for HPLC reference purposes.  
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 For the sulfoxidation with [VO]2+ ⊂ Sav, the analytical data of the sulfoxides are 
presented in Table 4. 
Table 4. HPLC conditions, retention times and absolute configurations for the sulfoxidation products a.  
Sulfoxide Column Conditions t1 (min) t2 (min) 
 
OD-H 
hexane / i-PrOH 90 / 10 
flow 0.8 mL / min 
13.1 
(R) 
17.1 
(S) 
 
OB-H 
hexane / i-PrOH 80 / 20 
flow 1.0 mL / min 
9.2 
(S) 
20.0 
(R) 
 
OB-H 
hexane / i-PrOH 70 / 30 
flow 1.0 mL / min 
11.0 
(S) 
21.3 
(R) 
 
OB-H 
hexane / i-PrOH 80 / 20 
flow 1.0 mL / min 
13.6 
(S) 
19.7 
(R) 
 
OD-H 
hexane / i-PrOH 95 / 5 
flow 0.8 mL / min 
15.0 
(R) 
20.7 
(S) 
 
OB-H 
hexane / i-PrOH 70 / 30 
flow 1.0 mL / min 
8.7 
(S) 
11.1 
(R) 
 
OB-H 
hexane / i-PrOH 95 / 5 
flow 1.0 mL / min 
15.4 
(S) 
19.0 
(R) 
a
 UV detection at 215 nm; the absolute configurations were assigned by comparison with published results.117 
 For the sulfoxidation of thioanisole with the biotinylated metal-salen complexes, the ee’s 
and conversions were determined either on an OD-H column with hexane / i-PrOH 90 / 10 at 
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0.8 mL / min (t1 = 15.5 min. (R), t2 = 20.5 min (S)), or on an OJ-H column with hexane / i-
PrOH 100 / 2 at 1.0 mL / min (t1 = 32.5 min. (S), t2 = 34.9 min (R)). 
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